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Abstract 
Phase-tag assisted synthesis of A-heterocycles using the Pummerer 
cyclisation
Linker strategies lie at the heart of solid phase organic synthesis and combinatorial 
chemistry. A new class of traceless linker cleaved using SmL has been developed 
previously within the group. This linker system was based on an oxygen link to resin. A 
novel multi-functional sulfur based linker which not only links the substrate to resin and 
allows traceless cleavage but also enables Pummerer cyclisation chemistry to be carried 
out at the point of attachment has been developed.
Pummerer cyclisations are a powerful method for constructing carbocycles and 
heterocycles. The first Pummerer cyclisations on solid phase have been carried out in a 
convenient route to oxindoles which utilises a traceless sulfur link to resin, a- 
Bromoacetamides are immobilised using a benzyl thiol resin. Oxidation of the linking 
sulfur atom followed by Pummerer cyclisation and traceless cleavage using SmL gives the 
desired oxindole products in good yield and high purity. A variety of oxindoles bearing 
neutral, electron rich and electron deficient aromatic systems have been synthesised using 
our approach. Crucially, the sulfur link to resin remains intact throughout the cyclisation 
leaving the heterocyclic products immobilised. The link can therefore be used again to 
assist further on-resin modification of the product heterocyclic framework prior to 
cleavage.
Fluorous thiols can be applied in a similar manner to solid supported thiols. Fluorous thiols 
can be used to introduce fluorous phase-tags, which when incorporated allow easy, 
convenient purification of the tagged compound using fluorous solid phase extraction 
(FSPE). Fluorous thiols have been applied in a new strategy for the fluorous phase 
synthesis of iV-heterocycles. The sequence involves a fluorous phase, Pummerer cyclative 
capture strategy for rapid, one-pot construction of tagged, heterocyclic frameworks. The 
fluorous tagged heterocyclic frameworks can be modified using a variety of approaches 
including palladium catalysed cross-coupling reactions. Traceless removal of the phase tag 
with Sml2 leads to the desired heterocycle in high purity. FSPE is applied throughout the 
synthetic sequence to assist purification. ’
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Ac acetyl
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GC gas chromatography
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Hz hertz
IR infrared
KHMDS potassium hexamethyldisilazide
LDA lithium diwo-propylamide
LHMDS lithium hexamethyldisilazide
m meta
M molar
mCPBA meta-chloroperbenzoic acid
Me methyl
mg milligram
min minute
ml millilitre
mmol millimole
mp melting point
Ms methanesulfonyl
MS molecular sieves
NBS A-bromosuccinimide
NMR nuclear magnetic resonance
NMM A-methyl morpholine
NMP A-methyl pyrrolidine
o ortho
P para
PEG polyethylene glycol
Ph phenyl
PMB para-methoxybenzyl
Pr propyl
pTSA para-toluene sulfonic acid
PyBop benzotriazol- 1 -yl-oxytripyrrolidinophosphonium 
hexafluorophosphate
py pyridine
q quartet (NMR)
s singlet (NMR)
s secondary
sat. saturated
rt room temperature
t tertiary
t triplet (NMR)
TBAF tetrabutylammonium fluoride
TBAI tetrabutylammonium iodide
TBDPS terr-butyldiphenylsilyl
TBS terr-butyldimethylsilyl
Tf trifluoromethyl sulfonyl
TFA trifluoroacetic acid
TFAA trifluoroacetic anhydride
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TLC thin layer chromatography
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tol tolyl
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[il microlitre
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Chapter 1: Introduction-Sulfur and selenium linkers in solid phase organic synthesis
1.0 Linkers in solid phase organic synthesis
In the early work on solid phase synthesis, linkers were designed for the attachment of 
specific functional groups, e.g. amines, alcohols, acids etc. Linkers were essentially solid 
supported protecting groups for these functional groups. When products were cleaved from 
linkers the cleaved products often contained residual functional groups such as alcohols, 
acids, amines and amides which were a consequence of the linker system that had been
used for their attachment to solid support. Ellman was among the first to apply solid phase
1 0to the synthesis of small organic molecules. ’ Previously, solid phase had only been used 
in peptide synthesis. He carried out the solid phase synthesis of a library of 1,4- 
benzodiazepines as shown in scheme 1 .1 .
He used a polyethylene support with a hydroxymethyl phenoxyacetic acid (HMPA) linker 
to immobilise the substrate. In this linker system it is necessary that the benzophenone 
starting material bears a phenol group in order that it can be attached to the support. Upon 
cleavage of the 1,4-benzodiazepine 6  at the end of the synthesis, the product contains a 
residual phenol functional group which may or may not be desired. This is particularly 
significant if one desires to produce a library of compounds for biological testing as the 
presence of unnecessary functionality can have a dramatic effect on biological activity.
9
2 0 %
piperidine,FMoc 
NH ^ NH;
DMF
HMPA linker
NHFmoc
NHFMoc
1. 20 % piperidine, 
DMF
NH
2. 5 % AcOH, 
DMF
1. base, THF, -78°C
2. R4I, DMF
HO.
85:5:10
R2
6
scheme 1.1
If solid phase combinatorial synthesis was to realise its full potential then it was necessary 
to be able to apply the technology to the synthesis of compounds which did not contain 
residual functional groups resulting from attachment to solid support. This prompted the 
development of “traceless linkers”. A traceless linker is defined as a linker, which upon 
cleavage leads to the formation of a C-H bond and which enables the preparation of pure 
hydrocarbons. 3
The linker system refers to protocols for both attachment to and cleavage from resin. 
Traceless linker systems usually consist of a carbon-heteroatom link between the attached 
organic molecule and the resin, The choice of heteroatom is important; the carbon 
heteroatom bond must be labile to heterolytic cleavage. Ellman has developed a traceless 
silicon linker and applied it to 1,4-benzodiazepine synthesis (scheme 1.2) . 4
10
1. ^ 0 (0 )01, 
NHBpoc Pd2dba3 CHCI3
SnMe3 2 . TFA, CH2CI2 stepsO
7 8
1. TFA:H20:Me2S
2. aqueous HF
9 Ri
r3 o
10
schem e 1.2
In this linker system the organic molecule is attached to resin via an aryl silicon bond. 
After several synthetic steps have been carried out on resin, the 1,4-benzodiazepine can be
The linker therefore does not leave any residual functionality in the product. An analogous
systems many other carbon-heteroatom traceless linker systems have been developed. 
Amongst these new linker systems sulfur and selenium based linkers have proved to be 
very effective for solid phase organic synthesis.
1.1 Sulfur Linkers
1.1.1 Early Sulfur linker systems
Janda was one of the pioneers of the use of sulfur linkers in traceless solid phase synthesis. 
Janda developed a traceless sulfur linker for the cleavage of aliphatic molecules from a 
soluble polymer support.6 MeO-PEG acid soluble polymer 11 was coupled with amino 
thiol 12 to form thiol resin 13 which underwent alkylation with various alkyl halides, such 
as 14 to form a sulfide linkage to the substrate (scheme 1.3).
cleaved in a traceless manner by ipso substitution of the silicon to form an aryl C-H bond.
germanium linker was also developed by Ellman. 5 Since these early traceless linker
11
C F,
h 2n 12
O SH
0 -v A rOH
11 DIC, DMAP, 
THF-CH2CI2
= MeO-PEG
SH
Br-
C sC 03, DMF.20 °C, 
4h, >95 % OMe
CF-
NH
OMe
scheme 1.3
Release of the tethered molecule was achieved using BusSnH and AIBN to cleave the 
carbon sulfur bond giving the desired aliphatic product 16 in a moderate 40 % yield 
together with unreacted starting material 15. A more efficient cleavage strategy involved 
the use of hydrogen and Raney nickel which allowed traceless cleavage of 16 in 94 % yield 
after only three hours (scheme 1.4).
Use of soluble polymers allowed easy isolation and purification of the cleaved product; 
precipitation of desulfurized MeO-PEG resin with ether then concentration of the filtrate 
gave the product in high purity by NMR.
12
c f 3
N
H N PhH, 
reflux, 
18 hO15 OMe
H2, Raney Ni, 
MeOH: EtOH 
(1.5:1),
20 °C, 3h
CF3
N
+
OMe16
94% 99%
O
40 % + sm 
16
OMe
= MeO-PEG
scheme 1.4
The preparation of the original sulfur linker system by Janda had some disadvantages. 
Firstly, aromatic thiols have a tendency to form disulfides thus reducing available thiol 
functionality to react with the alkyl halide. Secondly, there is competing thioester 
formation in the amide coupling step. Two improved traceless linker systems 19 and 22 
were therefore prepared by Janda. 7 In the synthesis of both linkers, the linking thiol unit 
was introduced in the form of a disulfide and then reduced to the corresponding thiol using 
Cleland's reagent (dithiothreitol). Both polymers were prepared in high yield using this 
route. Alkylation and cleavage using the Raney nickel method, previously described, gave 
the aliphatic product in 99 % yield for both linker systems (scheme 1.5).
o
OH
11
h2nj o *
18
1.DCC, DMAP, CH2CI2,
2. DTT, H20 , reflux, 
3.5 h, 98 %
- O k
SH
19
n h 2
20
o  S)2 1. DCC, DMAP, CH2CI2,
HO
21
2. DTT, H20 , reflux, 
3h, 93 %
O SH
22
= MeO-PEG
scheme 1.5
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Janda's original sulfur linker can be cleaved most effectively using Raney nickel, however, 
this method limits the functional groups that can be tolerated in the molecule that is being 
prepared on the polymer support. For example, alkenes, alkynes, epoxides and sulfur- 
containing groups will all be reduced by Raney nickel in the cleavage step. This problem 
may be overcome by using a reducing agent which is more selective for the carbon-sulfur 
bond of the linkage. A Na-Hg reducing system will reduce the carbon-sulfur bond of an 
aliphatic sulfone selectively in the presence of many other reducible functionalities and
o
was employed in an improved cleavage strategy for Janda's linker system (scheme 1.6). 
After attachment of the substrate 23 to the thiol polymer 19 via sulfide formation, the 
sulfur link was oxidised to the sulfone 25 using KHSO5 (Oxone®). Oxone® will oxidise 
sulfides to sulfones without epoxidising double bonds or oxidising ketones to esters, and is 
therefore superior to mCPBA due to this enhanced chemoselectivity. Reduction with 
Na/Hg cleaved the sulfone link to resin and released the aliphatic product 26 which was 
isolated in high yield.
•JUTN
H
19
= MeO-PEG
NH
26
Br
23
CS2CO3, 
DMF, 
20 °C
OMe
OMe
5 % Na-Hg, 
Na2H P04,
MeOH
98%
24
OMe
KHSO5, H20 , 
20 °C, 
94%
° w °  °'s'
25
OMe
scheme 1.6
The traceless sulfur linker systems developed by Janda discussed so far, have amide 
functionality in the linking unit. Although amides tolerate most reaction conditions, 
reagents such as LiAIFU, very strong base or acid would destroy the linker. In order to 
further expand the generality of this series of traceless sulfur linkers, ether-containing 
linking unit 27 was synthesised. Ether linkers are stable to very harsh reaction conditions. 
In order to demonstrate the use of this linker it was applied to the synthesis of alkylated
14
malonate derivatives (scheme 1.7).9 Monoalkylation of the thiol resin 27 with a dialkyl 
halide was followed by addition of a malonate anion. The resulting polymer supported 
malonate 29 was alkylated once more and following oxidation of the sulfide linker to the 
sulfone 31, a malonate derivative 32 was reductively cleaved from the polymer in excellent 
yield. This strategy has also been applied in the synthesis of 3,5-pyrazolidinediones. 10
CIHoC
SH
2827
2930
% P0-o THF:MeOH
94% 3231
Q  = MeO-PEG
scheme 1.7
Suchoeiki has developed the photocleavable (+)-2-methoxy-5-[2(2-nitrophenyl)dithiol]-l- 
oxopropyl)phenyl acetic acid (NpSSMpact) linker 34 for the cleavage of aliphatic 
molecules from solid support. 11,12 This was also one of the earliest linker systems designed 
for cleavage of non-peptide molecules from solid support (scheme 1.8). The linking unit 35 
was constructed by immobilisation of disulfide 34 on amine resin 33. Treatment with p- 
mercaptoethanol gave polymer supported thiol which could be alkylated with benzylic 
halides to give sulfide linked biaryl 36. The benzylic carbon sulfur bond was cleaved 
selectively under photochemical conditions to give 37 in 58 % yield.
15
Me NO;
MeS - S NO;
S - SHO'
PEG-Np e g - n h 2
35
1. (3-mercaptoethanol, 
N/PrEt2, DMF
2. 4-phenylbenzylbromide, 
N/PrEt2, DMF
58 % yield
350 nm light
MeCN
(deoxygenated)
PEG-N
schem e 1.8
Since the development of these early linker systems, the use of sulfur linkers in solid phase 
synthesis has become widely exploited. Sulfur can be used as a linking atom in varying 
oxidation states. In these oxidation states the link can be used to facilitate a wide variety of 
chemistry whilst enabling traceless cleavage of products from the solid-support.
1.1.2 Thioester linkers
Kobayashi has used a sulfur linker for the solid phase preparation of amino alcohols. 13 
Thiol resin 38 was acylated with benzoyl acetyl chloride to give thioester resin 39 (scheme 
1.9). Silyl enol ether 40 was then generated from 39 by treatment with trimethylsilyl 
triflate. Since Lewis acids are required to effect the addition of silyl enol ethers to imines, 
a range of Lewis acids were screened. Catalytic scandium triflate was found to be most 
effective in promoting the addition of the resin bound silyl enol ethers 40 to imines to 
give P-amino thioesters 41. Reduction of the thioester linkage with lithium borohydride 
resulted in cleavage of an amino alcohol 42 from resin in good yield. A range of different 
acylating agents and imines were used in the sequence and a small library of amino 
alcohols was prepared using this methodology in yields ranging from 42-79 %.
16
TMSOTf
NEt3,
c h 2c i 2
N E ts,
CH2CI2
67%  
over 4 steps HO
NHPh 
Ph
LiBH4l
Et20 ,
OBn
42
scheme 1.9
rt,
Sc(OTf)3,
CH2CI2l
rt
OTMS
N 'Ph
pA
O NHPh
Kobayashi has applied polymer supported silyl enol ether 44 to the solid phase synthesis of 
monosaccharides (scheme 1.10) . 14 Resin bound silyl enol ether 44 was treated with chiral 
aldehyde 45 and BF3 OEt2 to give aldol adduct 46 in a > 98/2 dr. After deprotection of the 
TBS groups in 46, spontaneous lactone formation with concomitant cleavage occurred to 
give lactone 47 in 61 % yield. Reduction of lactone 48 with DIBAL gave 6-0-benzyl-2- 
deoxy-L-gulose.
CH3COC1,
CH2CI2i
DIBAL,
CH2CI2i
-78°C
BnO'
47
TBSOTf,
NEt3,CH2CI2l
rt
TBAF,
AcOH,
THF, 40°C, 
61 %
BF3 OEt2) 
CH2CI2i 
-78 °C
TBSO
B nO ^^\^ .C H O
TBSO
45
TBSO
BnO.
TBSO
46
scheme 1.10
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A traceless solid phase synthesis of alcohols and ketones using a sulfur link has been 
described by Bradley. 15 Resin bound thioesters such as 51 can be prepared by treatment of 
Merrifield resin 49 with thioamide 50 and Nal in DMF. The success of this reaction can be 
conveniently monitored by observing the appearance of a C=0 stretch in the IR spectrum. 
Reduction of 51 with LiBFLj results in cleavage of 1° alcohol 52 from resin in good yield 
(scheme 1.11).
49 50
10 eq Nal,
DMF, 
100°C, 
24 h IR C =0 1656 cm ' 1
LiBH4,THF,
rt,5h,
83%
HO
52
scheme 1.11
3° Alcohols and ketones such as 53 and 54, can also be cleaved from the thioamide resin 
upon treatment with Grignard reagents or cuprates, respectively (scheme 1.12).15
PhMgBr
0°C,
OH
Ph
H  Z 0>
53
Bu2CuLi, THF, 
78 °C, 5h, 53%
54
scheme 1.12
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1.1.3 Sulfoxide linkers
Torn has used polymer supported chiral sulfoxides such as 55 in asymmetric conjugate 
additions to methyl cinnamate (scheme 1.13).16 Thermal elimination then occured 
regioselectively, to give alkene product 57 in good yield and enantiomeric excess. 
Stereoselectivity was found to be dependant on the nature of the spacer group. Where the 
spacer was a simple phenyl group a the product was obtained in 48 % yield and 75 % ee, 
however, if a biphenyl spacer b was used, a 51% yield and a signficantly improved 90 % 
ee was obtained. In an alternative cleavage strategy, treatment of 56b with TBAF yields 
desilylated alkene product 58 in 56 % yield and 90 % ee. Additions to other Michael 
acceptors were not reported.
spacer
< V ;- 1. LDA
SiMeq
2.
55a
55b Ph'/<^ ^ O M e
Ph
thermal
elimination
C 0 2Me
spacer
MeSi 57
Ph
C 0 2Me
58
C 02Me
56 a 
56 b
SiMe3
a: 48% yield 75 % ee 
b: 51 % yield 90 % ee spacer
scheme 1.13
Solladie has employed a sulfoxide linker for the synthesis of 1,2-diols employing a 
Pummerer rearrangement cleavage strategy (scheme 1.14).17 p-Hydroxyphenyl-a- 
ketosulfides were constructed in solution phase and attached to the Wang based resin via 
the oxygen atom. Selective oxidation of the sulfide 59 to sulfoxide 61 was carried out 
using oxaziridine 60. The sulfoxide link was then used to control the diastereoselectivity of 
DIBAL reduction of the ketone group. Two diastereoisomers were obtained and a 95 % de 
was reported although the relative stereochemistry of the diastereoisomers obtained was 
not reported. The resin bound alcohol 62 was protected as a silyl ether prior to cleavage of 
monoprotected diol 64 by Pummerer rearrangement followed by hydrolysis and reduction. 
Specific yields are not given although the cleavage was described as being almost 
quantitiative.
19
60
6159
DIBALHOH
TBDMSCI,
imidazole,
DMF
62
1. TFAA, sym-collidine, CH3CN
2. K2C 0 3,
OTBS OTBS
HO.
3. NaBH,
64
63
scheme 1.14
Li has also applied the Pummerer rearrangement strategy in the synthesis of aldehydes and
1 Ralcohols (scheme 1.15). Furfuryl alcohol was immobilised on thiol resin 65. The sulfide 
linker atom was oxidised to the sulfoxide. A range of oxidants were tested in this 
transformation, and the lBuOOH/CSA system was shown to give the best yield, reaction 
rate and the best selectivity with respect to forming sulfoxide over sulfone. The resin 
bound sulfoxide was treated with TFAA to give Pummerer rearrangement product 6 8 . 
Aldehyde 69 was cleaved from resin upon treatment of the Pummerer rearrangement 
product with NEt3 .
SH
65
OH
PPh3, DEAD, 
THF 66
63 % over H 
6 steps
O 69
'BuOOH,
CSA,
CH2CI2
NEt3,
EtOH
67
TFAA, THF
b^CFa 
68 °
scheme 1.15
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Alternatively, alcohols can be cleaved from resin simply by changing the reagents 
employed in the cleavage step (scheme 1.16).18 Thiol resin 64 can undergo alkylation with 
base and an alkyl halide 70 to give 71. After oxidation and Pummerer rearrangement resin 
73 was exposed to a one-pot cleavage reduction strategy to give alcohol 74 in 80 % yield 
over 6  steps which include the two step preparation of the thiol resin.
’BuOOH,
CSA,
c h 2c i2
NEts,
NaBH4,
TFAA,
O 80 % yield 
over 6 steps
scheme 1.16
Safety catch linkers are linker systems which require activation before the final compound 
can be cleaved from solid support. Since cleavage cannot occur until the link has been 
activated, reaction conditions applied prior to this step need not be orthogonal to the final 
cleavage conditions.
Bradley has developed sulfoxide and selenoxide based thermally cleavable safety catch 
linkers and applied these in the solid phase synthesis of indenones. 19 Indanone precursors 
75a and 75b with sulfur or selenium linking atoms a- to the carbonyl group were prepared 
in solution phase and attached to amino methyl polystyrene resin via an amide coupling 
reaction (scheme 1.17). At this stage the linking sulfur or selenium atoms are unactivated 
and cleavage cannot be affected thermally. Selective oxidation conditions were then 
applied in order to selectively oxidise the sulfide to sulfoxide 76a without over oxidation to 
the sulfone. The conditions employed were hydrogen peroxide in 1,1,1,3,3,3- 
hexafluoroisopropanol (HFIP) and dichloromethane (2:1). These conditions allow a vast 
excess of hydrogen peroxide to be used without over oxidation to the sulfone. This is due 
to HFIP acting as an acid catalyst, enhancing the rate of the first oxidation to the sulfoxide 
then co-ordinating to the sulfoxide and making it unreactive in any further oxidation by
21
withdrawing electron density from the lone pairs on sulfur. Similar conditions were 
employed to prepare selenoxide 76b.
After oxidation to sulfoxide 76a or selenoxide 76b, thermal elimination occurred readily to 
release exo 78 and endo 77 indenone from resin in greater than 95 % HPLC purity and 45 
% yield based on the initial resin loading. Using the sulfur linkage it was found that 
thermal elimination only occurred in activated systems. The selenium linker was found to 
be more efficient with cleavage occurring at much lower temperature and with much less 
activated substrates.
75a
75b
n h 2
1. Die, HOBT, DMF
2 . 30 % aq. H20 2, 
HFIP: DCM (2:1)
76a
76b
100°C,
dioxane
O
a, X= S 45 %
b, X=Se 45 %
77
78
OH
79a
79b
scheme 1.17
1.1.4 Sulfonium linkers
Gennari has reported the use of polymer supported sulfonium ylides for the synthesis of 
epoxides and cyclopropanes via an elegant cyclative cleavage strategy. A thiol resin 
prepared from an AgroGel based polymer was used to synthesise supported sulfonium ion 
linked amide 83 (scheme 1.18). Sulfur ylides were generated under mild reaction 
conditions from this sulfonium ion due to the stabilising, electron withdrawing effect of the 
sulfur-group. Treatment of the sulfonium salt with base generates a sulfur ylide, which 
reacts readily with an aldehyde to release an epoxide 84 from the solid support.
22
A major advantage of the cyclative cleavage strategy is that only the desired cyclised 
product is released into solution, any by-products or unreacted components remain 
attached to the polymer, thus products are obtained in high purity.
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1‘ Br^ O E «  
SH NEt3,DMF
2 NaOH 
THF:H20
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•S sA ,
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H
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CH2CI2,rt, 20 h
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82 Ph
MeOTf, 
CH2CI2i rt
Ph"
83
-CHO
DBU, CH2CI2
Ph
AgroGel 41 % 
over 7 steps84
scheme 1.18
This methodology has also been successfully applied to the synthesis of macrocyclic 
lactones bearing a cyclopropane moiety (scheme 1.19).20 Resin bound sulfonium ion 8 6  
bearing a tethered Michael acceptor group was constructed. Treatment with base, promoted 
sulfur ylide formation and subsequent 1,4-addition of the ylide to the Michael acceptor 
followed by cleavage of the macrocycle from resin with concomitant cyclopropane 87 
formation. An advantage of carrying out this type of macrocyclisation reaction on solid 
support is that it mimics the high dilution conditions that would normally be necessary in 
solution phase in order to avoid competing intermolecular reaction. The yield of 
macrocycle is better when an AgroGel based thiol resin is used in place of a Merrifield 
based resin.
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scheme 1.19
Wagner and Mioskowski have developed a safety catch sulfur linker strategy in which a 
new carbon carbon bond was formed upon cleavage thus introducing further diversity to
-i
the molecule in the cleavage step (scheme 1.20). An alkyl thiol resin 8 8  prepared from 
Merrifield resin was alkylated with a benzyl bromide to give benzyl sulfide resin 89. The 
carbon sulfur bond formed is stable to a wide range of reactions involving nucleophiles, 
clectrophiles, acids and bases. Activation of the link was achieved upon treatment with 
triethyloxonium tetrafluoroborate to give a sulfonium salt 90. The sulfonium salt readily 
underwent palladium catalysed cross coupling reactions with a variety of boronic acids. 
The benzylic carbon sulfur bond couples selectively in preference to the alkyl carbon 
sulfur bonds therefore cleaving the compound from the polymer support whilst 
simultaneously constructing a new carbon carbon bond. Numerous biarylmethane 
;ompounds bearing electron donating groups, electron withdrawing groups and 
leterocycles were synthesised in yields ranging between 24 and 99 %.
Et3OBF4
DIPEA, DMF, 
70 °C
Pd(dppf)Cl2,
K2C 0 3i
PhB(OH)2, 
THF, 60 °C
scheme 1.20
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In order to demonstrate that the linker was stable to palladium catalysed coupling 
conditions prior to activation, a Heck reaction was carried out on the polymer supported 
aryl bromide 92 (scheme 1.21). No cleavage was observed during the Heck reaction. Upon 
activation and palladium cross coupling the biarylmethane cinnamate derivative 94 was 
obtained in 57 % yield. 21
1. Et3OBF4
2 . Pd(dppf)CI2, 
K2C 0 3l PhB(OH)2l
THF, 60 °C
scheme 1.21
1.1.5 Sulfone Linkers
In 1997 Kurth reported a sulfone linker for the solid phase synthesis of trisubstituted 
olefins. 22 This was the first in a series of publications on the numerous applications of this 
new type of linker system. Sulfinate resin 95 was prepared from polystyrene resin by 
lithiation followed by treatment with sulfur dioxide (scheme 1.22). Allylation with allyl 
bromide gave allyl phenyl sulfone resin 96 which underwent dialkylation upon treatment 
with n-butyllithium and alkylating agents to give a,a-dialkylated sulfone 97. In the 
example shown, addition of organocopper species derived from isopropyl magnesium 
chloride and copper iodide, results in Sn2 ' displacement of the sulfinate resin and also 
converts the cyano groups to isopropyl ketones. Thus tri substituted olefin 98 was released 
from the resin. Alkylation with different alkylating agents and displacement with various 
dialkyl cuprates or Grignard reagents gave a range of different trisubstituted olefins in 20- 
30 % yield after 3 solid phase steps.
92 Br
Pd(OAc)2l PPh3l 
ethyl acrylate,
K2C 0 3i 
DMF, 70 °C
OEt
25
CN
n-BuLi, THF
.CN
THF,
reflux
NIC"
Cul,
THF,
0°CMgCI
27 % yield 
over 3 steps
scheme 1.22
Kurth also employed the allyl sulfone resin in a synthesis of cyclobutylidenes (scheme 
1.23). Allyl sulfone resin 96 was alkylated with epichlorohydrin to give resin bound 
cyclobutanol 99. Sn2' displacement with a Grignard or cuprate to release the cyclobutanol 
from resin at this stage was not successful. Alternative methods of cleavage were therefore 
investigated. Protection of the hydroxyl group as the benzyl ether gave resin 100. It was 
discovered that cyclobutylidene 101 could be cleaved from solid phase by palladium 
catalysed Sn2' displacement with a nucleophile. Purification after cleavage was necessary 
to remove excess nucleophile and triphenylphosphine. Several cyclobutylidenes were 
synthesised in 30-38 % yields using the allyl sulfone linker, two different alkyl halides 
were used in the O-alkylation step and three different nucleophiles were used in the 
cleavage step.
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scheme 1.23
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Kurth has also applied the sulfone linker in the preparation of isoxazolocyclobutanones and 
isoxazolinocyclobutenones.24 Treatment of polymer supported allyl sulfone 96 with n-butyl 
lithium and 3-chloro-propylene oxide 103 led to an immobilised cyclobutanol moiety 
(scheme 1.24). 1,3 Dipolar cycloaddition on the pendant double bond of 104 occurs upon 
treatment with oxime 105 and NaOCl. Exposure of the resultant resin 106 to Swem 
oxidation conditions performs several functions; the cyclobutanol was converted to the 
cyclobutanone, the basic reaction conditions affected the release of the compound from 
resin by sulfinate elimination leading to an isoxazolinocyclobutenone which finally 
undergoes an isomerisation to give an isoxazolocyclobutanone 107.
\ — S 0 2Na
Br
THF/DMF
"BuLi, THF
103
Cl
NOH
Cl
105
NaOCl (aq), 
CH2CI2mHF
35 % yield 
over 4 steps
Cl
scheme 1.24
Swern
[O] OH
106
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Isoxazolinocyclobutenones 108 and 109 were synthesised by S-alkylation with 3-chloro-2- 
methylpropene or 4-vinyl benzyl chloride in the initial alkylation step. In these examples 
the final isomerisation was not possible and sulfinate elimination yields
several points in this route at which diversity can be introduced thus making the approach 
highly suitable for the construction of small libraries (scheme 1.26). S-Alkylation of the 
sulfinate resin 102 was then followed by dialkylation of sulfone 110 with l,4-dichloro-2- 
butene to give a cyclopentene 111. Oxidation of the double bond with raCPBA leads to an 
epoxide 112 which can undergo ring opening with a variety of nucleophiles. Ring opening 
with azide, Grignard reagents, cuprates and piperidines was demonstrated. Kurth’s 
standard Swem oxidation/elimination strategy was employed to release cyclopentenones 
such as 114 in yields ranging between 18 and 40 %. This five step cyclopentenone 
synthesis further illustrates the utility of Kurth’s sulfone linker system.
isoxazolinocyclobutenones as the final products (scheme 1.25).24 Yields range between 27 
and 38 % for the four solid phase steps.
scheme 1.25
Kurth further applied the sulfone linker in a synthesis of cyclopentenones. 25 There are
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THF/DMF, 
80 °C
114
35 % yield 
over 5 steps
nBuLi, THF, rt
-60 °C
113
LiN3l
DMF,
80°C
mCPBA, 
CHCI3l 
60 °C
scheme 1.26
Isoxazolinopyrroles were also synthesised by Kurth using the traceless sulfone linker. A 
polymer supported diene 117 was synthesised by 1,2-addition of the anion of sulfone resin 
115 to an a-P-unsaturated aldehyde followed by elimination of water (scheme 1.27). A 
regioselective 1,3-dipolar cycloaddition of diene 117 and the nitrile oxide derived from 
oxime 118 was then performed to give isoxazoline 119. Upon treatment with ethyl 
isocyanoacetates, traceless release and cyclisation occurred to give pyrrole 120. A small 
library of isoxazolinopyrrole 2-carboxylates was made in this way. Yields for the sequence 
were low in some cases (6-24 %) although purity of the products was high.
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scheme 1.27
A solid phase synthesis of 4,5,6,7-tetrahydroisoindole derivatives has also been carried out 
using Kurth’s sulfone linker. 27 Sulfinate S-alkylation with trans-3,4-dibromosulfolane gave 
a resin bound sulfolene 121 which extruded SO2 upon refluxing in toluene (scheme 1.28). 
The resulting resin bound 1,3-butadiene 122 underwent a cycloaddition with N- 
phenylmaleimide and other dienophiles to give cycloadducts such as 123. Treatment with 
tosylmethyl isocyanide (TOSMIC™) under basic conditions resulted in traceless cleavage 
of the product from resin with concomitant generation of a pyrrole ring. The cleaved 
4,5,6,7-tetrahydroisoindole 124 was obtained in 28 % overall yield. The cycloaddition was 
monitored using the amide C=0 stretch in the FTIR. For different dienophile examples it 
was necessary to heat the sulfolene resin in xylene at 145 °C for aproximately 36 hours for 
successful extrusion of SO2 and cycloaddition. A range of functionalised 4,5,6,7- 
tetrahydroisoindoles was produced in yields of 32-41 %.
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scheme 1.28
The alkylation of sulfones is usually achieved using bases such as rc-butyllithium or LDA 
at low temperature. There are problems, however, in applying these bases to the 
deprotonation of polymer supported sulfones; since excess reagent can lead to dialkylation 
and it is very difficult to achieve accurate stoichiometry in polymer supported systems. 
Kurth has reported a solid phase synthesis of enones using a sulfone linker (scheme
981.29). The approach is based on the use of dimsyl anion (methylsulfinyl carbanion) as a 
base for the monoalkylation of polymer supported sulfones. Crucially no dialkylation was 
observed even when an excess of base was employed. The fact that this base can be used at 
room temperature also makes it much more convenient for use in combinatorial chemistry. 
A small library of enones was synthesised by a sequence involving the opening of epoxides 
by an a-lithiated sulfone, Swem oxidation and elimination to release enones from the 
polymer. Yields are excellent, ranging from 82-90 % for three steps.
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102 CH3S(0)CH2Li, propylene oxide, 
THF
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90 % yield 
(over 3 steps) 127
(COCI)2,
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NEt3,
CH2CI2
S 0 2 OH
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scheme 1.29
In a related study, Lam has used a sulfone linker for the traceless synthesis of a library of
9Qimidazo[l,2-a]pyridines. Following alkylation of sulfinate resin 102 with 1,3-dichloro- 
propan-2-one, a-halo ketone resin 129 was reacted with an amino pyridine to give 
heterocyclic sulfone 130 (scheme 1.30). Dimsyl anion was used to ensure that dialkylation 
did not occur in subsequent reactions with epoxides. Jones oxidation followed by base 
promoted elimination of the sulfinate resin gave imidazo[l,2-a]pyridine 133 in 15 % yield. 
A small library of imidazo[l,2-a]pyridines was synthesised in yields of 15-26 %.
32
102 129
10 % NaOH, 
CH2CI2
133
acetone,
0°C
Me'
Me
132
15%  yield 
over 5 steps
scheme 1.30
AMe Me LiCH2S(0)CH3l
.OHMe'
Me
131
Lam also used a traceless sulfone linker for the synthesis of pyrazolines and isoxazolines 
(scheme 1.31).30 S-alkylation of sulfinate resin 102 yields resin bound sulfone 110. 
Monoalkylation of sulfone 110 with an epoxide again using dimsyl anion as a base gave y- 
hydroxy sulfone 134. Subsequent Jones oxidation and treatment with a hydrazine or 
hydroxylamine leads to cyclisation and release of pyrazolines 136 and isoxazolines 137 
respectively. This route offers three points at which diversity can be introduced. Several 
examples of pyrazolines and isoxazolines were synthesised in good yields ranging from 
25-45 % over four solid phase steps and with >95 % purity by NMR.
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scheme 1.31
Huang has reported a solid phase route to hydantoin 140a and thiohydantoin 140b using a 
sulfone linker (scheme 1.32).31 Alkylation of sulfinate resin 102 with 2-chloroethanol 
followed by coupling with N-Boc protected glycine and deprotection gave resin 138. 
Treatment with phenyl isocyanate or phenyl isothiocyanate gave polymer supported ureas 
139a and 139b respectively. Treatment with acid gave hydantoin 140a in 29 % yield or 
thiohydantoin 140b in 20 % yield. No further examples were reported.
34
S 0 2Na
102
1. C I ^ 0H 
N(Bu)4I, ki, d m f
2. O 
ho^^NHBoc
DCC, DMAP
3. HCI, then NEt3
VJ
0A ^ nh2
138
PhNCX,
DMF,
rt
a, X = O, 29 %
b, X = S, 20 %
PhN^f
o - Q
H
140a
140b
HCI,
dioxane
H^ NHPh
X
139a
139b
schem e 1.32
Nicolaou has employed a traceless sulfur link in the solid phase synthesis of 3- 
arylbenzofurans via a novel cyclofragmentation-release pathway. Thiophenol resin 141 
was alkylated with bromo-chloro methane in the presence of DBU to give 142 (scheme 
1.33). Chloromethylsulfide resin 142 was then alkylated with a salicyl aldehyde derivative 
143 to give resin bound aldehyde 144. Addition of a functionalised aryl magnesium 
bromide to aldehyde 144 gave benzhydrol 145, which was then oxidised using IBX to give 
benzophenone 146. Treatment of benzophenone 146 with trimethylsulfonium iodide gave 
epoxide 147, which, after oxidation of the sulfur link to the sulfone 148, was ready for 
application in the cyclofragmentation-release strategy. Treatment of sulfone 148 with base 
results in deprotonation at the methylene group adjacent to the sulfone followed by a 5-exo 
tet epoxide opening which triggered loss of formaldehyde and the elimination of 
phenylsulfinate anion thus releasing 3-arylbenzofuran 150 from the solid support in good 
yield. A range of 3-arylbenzofurans were synthesised via this route using a variety of 
salicyl aldehydes and aryl Grignard reagents in yields ranging from 6-29 % for 6  solid 
phase steps.
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scheme 1.33
There are several advantages in applying this route to solid phase synthesis. Firstly, by 
varying the salicyl aldehyde derivative and the aryl Grignard reagent there are two points 
at which diversity can be introduced into the system. Secondly, products undergo traceless 
cleavage from resin during the cyclisation step. Finally, cleaved products are obtained in 
high purity as only the desired benzofuran product can undergo release from resin. For 
example, if any side reactions such as 6-endo cyclisation occur, then the resulting cyclised
36
product cannot undergo the fragmentation-release pathway and therefore remain bound to
resin.
Ganesan has developed a solid phase equivalent of p-tolylsulfonylmethylisocyanide 
(TosMIC™) for the synthesis of oxazoles (scheme 1.34).33 Thiol resin 151 was treated 
with 152 to give sulfide 153. Oxidation of the sulfide to the sulfone was followed by 
dehydration and reduction of the formamide to give TosMIC resin 155. Treatment with 
benzaldehyde or other aromatic aldehydes and base gave 5-aryloxazole 156 in 50 %. When 
a Tentagel thiol resin was used the desired product was obtained in 49 % yield although 
impurities resulting from the breakdown of the PEG linker by K2CO3 were observed. 
TosMIC resin was treated with a range of aromatic aldehydes to give 5-aryloxazoles in 
yields between 25 and 50 %.
Q T ^ SH
151
152
CHO
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scheme 1.34
Barco has developed a solid phase route to substituted piperidin-4-one derivatives which 
utilises 4-benzylsulfonyl-l-triphenylphosphoranylidene resin 161 (scheme 1.35).34 
Michael addition of thiol resin 157 to 3-butenone gave sulfide 158. Oxidation of the sulfide 
link to the sulfone, a-bromination and treatment with triphenylphosphane then base gave 
the key resin bound ylide 161. The ylide underwent Wittig reaction with various aldehydes 
to give enones such as 162. Subsequent treatment with benzyl amine resulted in cleavage 
of substituted piperidin-4-one 163. The amine has two roles in this reaction. It undergoes 
1,4-addition to the enone 162 and also acts as a base to promote the elimination of the 
sulfone resin. Finally, 1,4-addition to the newly generated enone gave the piperidin-4-one
37
skeleton. Five different piperidin-4-ones were synthesised by varying the aldehyde used in 
the Wittig reaction however, yields were not given.
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scheme 1.35
Suto has applied a traceless sulfur-based safety catch linker in the synthesis of a small 
pyrimidine library (scheme 1.36).35 2-Chloro-4-trifluoromethylpyrimidine-5-carboxylate 
164 was immobilised using tentagel thiol resin to give a resin bound pyrimidine 165. The 
sulfide link was stable to a variety of reaction conditions, remaining intact through ester 
hydrolysis, conversion of the resultant acid to the acid chloride and subsequent amide 
formation. The link was activated by oxidation with mCPBA to give sulfone 167. 
Treatment with a nucleophilic amine such as furfurylamine results in nucleophilic cleavage 
of the highly functionalised pyrimidine 168 from resin. Pyrimidines are obtained in high 
yield and purity (determined by GC/MS and HPLC).
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Schultz has developed a similar combinatorial based, resin-capture and release strategy for 
the synthesis of 2,6,9-trisubstituted purines in which a sulfur linker plays a crucial role 
(scheme 1.37). N9 substituted purine 169 was attached to a polymer support at the C6 
position using a sulfide link to resin. Nucleophilic substitution at the C2 position of the 
purine occurred by treatment of resin 170 with an amine and base to give 171. This 
nucleophilic substitution at C2 is not possible if the linker at C6 is amino based rather than 
sulfur-based. Further derivatisation of the purine can be achieved by oxidation of the 
thioether link to give sulfone 172, thus, activating the C6 position to nucleophilic 
substitution. Treatment of 172 with a limiting amount of amine results in release of 2,6,9- 
substituted purines such as 173 from resin. This route has been shown to tolerate the 
introduction of a broad range of substituents on the purine ring. A variety of sterically 
hindered primary and secondary amines can be added at the C2 position. Substitution at C6 
can also be carried out with a wide range of primary and secondary amines and also 
electron rich anilines. A library of substituted purines was produced, with an average yield 
of 80 % and an average >85 % purity by HPLC.
39
A n5
n sRi
169
SH
/Pr2EtN,
BuOH,
80°C 170
r 2r 3n h
/Pr2EtN,
BuOH,
80°C
Ni
R2 Ri
171
mCPBA, 
NaOH (1:1), 
dioxane
R5'N' R4
r3> . ,A ,A m/'N N Ni
R2
173
'1
0.9 eq R4R5NH,
1,4-dioxane, 
80°C
scheme 1.37
R3> j f e
172
Chang has developed a safety catch method for the orthogonal synthesis of tri substituted 
triazines (scheme 1.38). Monosubstituted triazine 175 was immobilised onto thiophenol 
resin 174. The second chlorine atom was substituted with an amine nucleophile 177 to give 
resin bound disubstituted triazine 178. Activation of the thioether link by oxidation was 
followed by nucleophilic displacement from resin with a nucleophilic amine 180 to give 
trisubstituted triazine 181 in very high purity. A range of amines, anilines and alcohol 
nucleophiles were tested in the sulfone displacement step. Unactivated anilines were not 
successful in affecting cleavage, resulting in only a trace of triazine product. Phenol and 
sterically hindered amines such as dibenzyl amine were also ineffective in the cleavage 
step. Unhindered primary and secondary amines gave the best results.
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Suckling has developed a solid phase route to pteridines using the same sulfone safety-
O Q
catch linker approach (scheme 1.39), Merrifield resin bound 6-amino-2- 
sulfanylpyrimidin-4(3H)-one 182 underwent nitration and subsequent reduction to give 
diamino pyrimidine resin 184. Treatment with biacetyl 185 gave resin bound pteridine 
resin 186. Activation of the thioether link was achieved by oxidation with dimethyl 
dioxirane. Treatment with a nucleophile such as allylamine resulted in cleavage of 
pteridine 187 from solid support in 34 % yield. Other nucleophiles such as azide and 
pyrrolidine were used in the cleavage step successfully.
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schem e 1.39
Zhang has constructed 2-substituted indoles using a traceless sulfonyl linker (scheme
on
1.40). The sulfonyl link has a dual role in the synthesis; it facilitates the indole 
cyclisation by providing activation and its activated nature also allows cleavage to be 
affected under mild reaction conditions. 2-Iodoaniline was loaded onto the commercially 
available polystyrene sulfonyl chloride resin 188. Treatment of resin 189 with alkyne, 
catalytic Pd (0), catalytic Cu(I) and NEt3 results in a Sonagashira coupling between the 
aryl iodide and the alkyne, followed by cyclisation to give indole 191. In the absence of the 
activating sulfonyl link to resin, it would be necessary to carry out the coupling and 
cyclisation as a two-pot process, with the cyclisation requiring strong base and high 
temperature. In this case, the activating sulfonyl linker enables the cyclisation to occur 
under milder conditions, thus, the two transformations are carried out in one pot. Treatment 
of 191 with TB AF was found to be the most efficient cleavage strategy releasing the indole 
192 from solid phase in high yield and purity. Again the linker system allows cleavage to 
take place under mild conditions. Bases such as KOH and KOrBu can also be used to 
affect cleavage although their functional group compatibilities are less wide-ranging. To 
prepare diverse array of indoles with yields of 85 - 100 % and with 85 -100 % HPLC 
purities, various different substituted anilines (electron withdrawing and electron donating 
groups on the aryl ring are tolerated) and alkynes were employed.
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scheme 1.40
De Clercq has utilised a sulfone linker in a solid phase Julia-type olefination process 
(scheme 1.41).40 Alkylation of aryl thiol resin 193 followed by mCPBA oxidation gave 
supported sulfone 194. Successive treatment of the resin with rc-butyllithium and an 
aldehyde followed by trapping the alkoxide anion with benzoyl chloride, gave resin bound 
a-benzyloxyphenyl sulfone 195. Olefins 196 and 197 were released from the solid support 
upon treatment with a single electron transfer reagent. Samarium diiodide proved to be the 
most suitable reagent for the process and was used here together with either HMPA or 
DMPU. The E:Z selectivity was found to be strongly dependant on the nature of the 
additive. Yields ranged from 25-29 % over six solid phase steps which included the 
preparation of the thiophenol resin. DMPU was shown to give greater E  selectivity than 
HMPA for the example shown in scheme 1.41.
This is a potentially very useful application of a sulfone linker although the generality of 
the process must be explored. In addition, the stereoselectivity of the olefination process 
requires further study as the E:Z selectivities were seen to depend dramatically on substrate 
structure and, as previously mentioned, the conditions employed in the reductive cleavage.
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1.1.6 Sulfoximine linkers
Gais has used a chiral sulfoximine linker for the asymmetric solid phase synthesis of 
alkenyl oxiranes (scheme 1.42).41 Enantiomerically pure sulfoximine 198 was treated with 
potassium hydride and Merrifield resin to give resin bound chiral sulfoximine 199. 
Deprotonation with w-butyllithium followed by addition of isovaleraldehyde gave alkoxide 
200 which underwent elimination to vinyl sulfoximine 201 upon treatment with methyl 
chloroformate and DBU. Isomerisation to allylic sulfoximine 202 was performed by 
refluxing in DBU. a-Lithiation was followed by titanation and addition of the titanate to 
benzaldehyde to give 203. Addition of allylic titaniums this kind to aldehyde in solution 
has been shown to occur diastereoselectively to give syn homoallylic alcohols. Cleavage of 
the chiral sulfoximine linker group was achieved by treatment of 203 with 2-chloroethyl 
chloroformate, Acylation of the sulfoximine nitrogen occurs to give an aminosulfoxonium 
salt and chloride ion then stereoselectively displaces the linking unit. A mixture of syn and 
anti chlorohydrins was obtained in a 2:1 ratio. Oxiranes 208 and 207 were obtained in a 
2:1 mixture upon exposure to DBU. Low diastereoselectivity was obtained in the addition 
to aldehyde due to incomplete titanation of the lithiated sulfoximine. Use of a solid 
supported chiral sulfoximine linker for stereoselective alkenyl oxirane synthesis is 
promising but requires further optimisation.
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Polymer bound chiral sulfoximines have also been applied in the synthesis of chiral 13- 
hydroxy sulfones (scheme 1.43).42 It was hoped that the sulfoximine moiety would control 
the asymmetry of reactions of the a-anion with aldehydes. Resin bound chiral sulfoximine 
199 was deprotonated with ra-butyllithium and the resulting anion quenched using 
benzaldehyde. Oxidative cleavage from the resin was achieved by treatment with mCPBA 
and HCI and gave sulfone 210. Unfortunately, the released sulfone was obtained in only 26 
% ee suggesting that asymmetric control by the resin bound chiral sulfoximine in the 
reaction with benzaldehyde was poor.
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1.2 Selenium linkers
The Nicolaou group was amongst the first to prepare a series of selenium resins for linker 
construction.43 Treatment of polystyrene with rc-butyllithium followed by 
dimethyldiselenide gave selenoether resin 212 (scheme 1.44). Treatment of 212 with 
bromine gave selenenyl bromide resin 213. Reduction with LiBPLj gave lithium selenide 
resin 214.
n-BuLi, TMEDA,
cyclohexane, 
65°C,
polystyrene ^11 then M eSeSeM e
-SeM e
Br2)
CHCI-q
-SeBr
u b h 4,
THF
-SeLi
212 213 214
scheme 1.44
Alkyl iodide 215 was efficiently loaded onto lithium selenide resin 214 (scheme 1.45). The 
compound could be released from resin in one of two ways. Radical cleavage with tributyl 
tin hydride resulted in release of alkyl compound 217 in 89 % yield over 2 steps 43 
Oxidation of the selenium linker to the selenoxide followed by elimination released alkene 
218 in 78 % yield over 2 steps.
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THF,
23°C
OTBDPS
216
h 2o 2,
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23°C,
n-Bu3SnH,
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tol,
110°C
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78 % 218
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'OTBDPS
217
scheme 1.45
Selenenyl bromide resin 213 has been used in the conversion of PGl2a methyl ester 219 to 
the PGo analogue 220 in 94 % yield (scheme 1.46).43 Capture of substrate 219 using 
selenyl bromide 213 in a selenoetherification reaction, initially gives a resin bound 
cyclisation product which is released into solution by oxidation of the selenium link and 
eliminative-cleavage to give 220.
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Selenenyl bromide resin 213 has also been used in the synthesis of 2-deoxyglycosides 
(scheme 1.47).43 Treatment of tri-O-benzylglucal 221 with selenenyl bromide resin 213 in 
the presence of an alcohol such as 222 resulted in 0-glycosidation and immobilisation of 
the product through selenium at the 2-position. Radical cleavage of the C-Se bond using 
tributyltin hydride released the 2-deoxy glycosylated product in 61% yield as an 8:1 
mixture of a  and P anomers.
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schem e 1.47
Concurrently with Nicolaou, Ruhland developed one of the first traceless selenium linkers 
for the formation of aliphatic C-H bonds upon cleavage (scheme 1.48).44 Sodium 
seleno(triethylborate)resin 224 was prepared from bromopolystyrene resin by lithium- 
bromine exchange, treatment of the resulting lithiated resin with selenium powder and 
finally, treatment with sodium borohydride in ethanol, thus, reducing any diselenide bonds 
and eliminating Se-Se crosslinking. Resin bound selenoate 224 underwent alkylation upon 
treatment with alkyl chlorides and alkyl bromides to give products such as 225 and 228 
respectively. The resin bound alcohols were then subjected to Mitsunobu reactions with 
phenols to give 226 and 229. Traceless cleavage was then carried out using tributyltin 
hydride. Cleavage of the aliphatic C-Se bond occurs preferentially to the aromatic C-Se 
bond to give aryl ethers 227 and 230 in good yields and high purity by GC. A 2 x 3 array
48
of alkyl aryl ethers was synthesised in yields of 57-83 % and GC purities of 78-88 % using 
the selenium linker system.
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scheme 1.48
Fujita has prepared polymer supported selenocyanates for use in solid phase 
oxyselenenylation-deselenenylation reactions. 45 Selenocyanate resin 233 was prepared by 
treatment of Merrifield resin 231 with potassium selenocyanate (scheme 1.49). A 
bromoWang based selenocyanate resin 234 which contains a phenoxymethyl link was also 
prepared in a similar manner from resin 232. Attempts to synthesise the corresponding 
selenenylbromide resin from 233 were unsuccessful. Treatment of 233 with copper (II) 
chloride, £-4-phenyl-3-butenoic acid in toluene at 80°C led to intramolecular 
oxyselenenylation to give polymer supported selenolactone 235. mCPBA oxidation to the 
selenoxide followed by eliminative-cleavage gave lactone 237 in 56% yield over 3 steps. 
The corresponding solid phase synthesis using resin 234 was less successful yielding only 
a trace of 237.
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Aryl selenocyanate resins 241 and 242 were prepared from aminomethyl polystyrene resin 
238 (scheme 1.50).45 In constrast to Fuijita’s previous studies, it was possible to prepare 
selenenyl bromides 243 and 244 from these selenocyanates. Solid phase 
selenolactonisation could then be carried out simply by treating the selenenyl bromide 
resin with (E)-4-phenyl-3-butenoic acid in CH2CI2 at 40°C to give polymer supported 
lactones 245 and 246. Eliminative-cleavage was triggered by oxidation with mCPBA and 
gave 247 in 33 % yield from resin 241 and 46 % yield from resin 242. No further examples 
of the selenolactonisation of enoic acids were reported.
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Wirth has used polymer-bound enantiomerically pure, electrophilic selenium reagents for 
asymmetric addition of nucleophiles to alkenes (scheme 1.51).46 Selenyl bromide resin 248 
was prepared and applied in selenenylation reactions. The use of polystyrene, tentagel and 
mesoporous silica supports were investigated, however, a polystyrene support was found to 
give the best results in the selenylation reactions compared with tentagel resin and, 
although mesoporous silica gave good results in the selenenylation reactions, loadings 
were so low that yields could not be determined. Treatment of polystyrene based resin 248 
with unsaturated alcohol 249 led to asymmetric seleniranium ion formation, followed by 
intramolecular nucleophilic addition of the tethered alcohol, to give polymer bound 
tetrahydrofuran 250 with good stereocontrol. Radical cleavage of the selenium link with 
tributyltin hydride gave tetrahydrofuran 251 in 58 % yield and 71 % ee. The main 
disadvantage of this route is that cleavage requires the use of tin reagents which are 
difficult to separate from the volatile products.
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The asymmetric intermolecular addition of nucleophiles to acyclic alkenes mediated by 
chiral resin 248 has also been studied (scheme 1.52).46 In the example shown, cleavage is 
achieved by oxidation of the selenide link to the selenoxide followed by elimination to give 
chiral allylic ether 252 in 56 % yield and 48 % ee.
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Nicolaou has applied polystyrene based selenyl bromide resins in the cyclisation of 
substituted cyclohexane based enol acetates such as 253 to give substituted [3.3.1] bicyclic 
systems (scheme 1.53).47 The selenyl bromide resin was reacted with an excess of enol 
acetate 253 and SnCU in dichloromethane resulting in clean, capture and cyclisation to 
give resin bound [3.3.1] bicycle 254.
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schem e 1.53
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The solid phase cyclisation reaction was carried out on a range of substrates bearing 
different substitution patterns around the cyclohexane scaffold. For example, resin bound 
cyclisation product 255 bears a 5-membered lactone ring fused to the cyclohexane system 
(scheme 1.54). Several methods for the cleavage of the selenium linker were investigated 
and are shown in scheme 1.54.47 Oxidation to the selenoxide followed by elimination 
yields functionalised bicycle 256 in 90 % yield. Traceless cleavage to give 257 occurs 
upon treatment of 255 with tributyltin hydride. Finally, radical cleavage with 
allyltributyltin results in the introduction of an allyl group at the point of cleavage. 
Although this method allows further functionalisation in the cleavage step it is relatively 
low yielding compared with the other cleavage methods, giving 258 in only 37 % yield.
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scheme 1.54
Nicolaou has also developed a selenium based cycloloading strategy for the solid phase 
synthesis of indolines (scheme 1.55).48 Treatment of 0 -allylanilines with selenyl bromide 
resin in the presence of a Lewis acid results in cyclative-capture to give resin bound 
indoline 260. Further functionalisation on resin can be carried out prior to cleavage. 
Acylation of nitrogen with phosgene gave 261 which was then reacted with amines to give 
262. Traceless cleavage with tributyltin hydride gave functionalised 1-methylindoline 263
53
in good yield. A range of 1-methylindolines were synthesised using this approach with 
yields ranging from 14-34 % for 4 steps. These compounds are of interest to the 
pharmaceutical industry as the 1 -methylindoline structure is found in several drug 
candidates. For example, 1-methyl indoline derivatives act as 5-hydroxytyramine receptor 
antagonists and as muscarinic receptor agonists and antagonists. A disadvantage of this 
route lies in the use of tin reagents in the cleavage step. Purification of the products after 
cleavage is therefore necessary to remove tin residues.
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Further complexity can be introduced in the cleavage step in resin bound indolines when a
j o
suitably positioned tethered alkene is present (scheme 1.56). For example, resin bound 
indoline 264 was coupled with unsaturated carboxylic acid 265. Upon treatment with 
tributyltin hydride a carbon centred radical was generated which underwent cyclisation 
onto the double bond to give polycyclic indoline 266. Complex polycycles can therefore be 
generated rapidly and conveniently using this methodology.
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Nicolaou has exploited the 1,2-selenomigration reaction of carbohydrates in the solid
A tributyltin ether of a resin bound selenol (scheme 1.57) was conveniently synthesised in 
two steps from a selenyl bromide resin. Resin 269 is more air stable than the corresponding 
selenol resin. Treatment of this resin with trichloroacetimidate donor 268 gave resin bound 
sugar 270. Removal of the acetate protecting groups at the C2 and C3 position, and 
reprotection of the C3 hydroxyl gave 271 ready for the 1,2-selenomigration reaction. 
Treatment of 271 with DAST promotes 1,2-migration of the selenium link to resin in a 
stereospecific manner to give 272, which is now linked to resin at the C2 position, whilst 
simultaneously generating an anomeric fluoride donor group. Resin 272 can undergo 
glycosylation with alcohols or sugars. Exposure to Lewis acid and monoprotected diol 273 
selectively gave the a-glycoside 274. Cleavage with tributyltin hydride gave the desired 2- 
deoxyglycoside 275 in excellent yield. A 3 x 3 library of 2-deoxyglycosides was 
synthesised using this approach in overall yields ranging from 11-32 % (from the 1-fluoro- 
2 -seleno donor resin).
supported synthesis of 2-deoxyglycosides, 2-deoxyorthoesters and 2,3-allyl orthoesters.49
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2-Deoxyorthoesters can also be synthesised using the 1,2-selenomigration methodology 
(scheme 1.58).49 Following glycosidation with monoprotected diol 273, removal of the 
benzoate protection gives 276 bearing a tethered alcohol. Oxidation of the selenium link to 
the corresponding selenoxide followed by heating in a sealed tube gave 2 -deoxyorthoester 
277 in 15 % yield from resin 270.
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2,3-Allyl orthoesters can also be made by a slight modification of this route (scheme
1.59).49 Removal of the C3 silyl protecting group from resin 276 gave 278. Oxidation to
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the selenoxide followed by heating in a sealed tube triggers several events: Elimination of 
the C3 hydroxy group occurs with simultaneous migration of the double bond and attack of 
the tethered alcohol at Cl to give the 2,3-allyl orthoester 279 in 19 % yield from 270. A 
small library of 2 -deoxyorthoesters and 2,3-allyl orthoesters were synthesised on solid 
phase with overall yields ranging from 2 - 2 0  %.
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The development of new analogues of the glycopeptide antibiotic vancomycin is crucial to 
treat bacterial infections caused by vancomycin-resistant enterococci (VRE) strains. It is 
known that varying the oligosaccharide moiety can significantly increase the activity of 
vancomycin analogues against VRE. Production of a library of analogues of targets such as 
vancomycin is synthetically very challenging and solid phase synthesis has proved useful 
for the manipulation of this molecule. Vancomycin contains a diverse array of 
functionality therefore the choice of solid phase linker system is crucial. Nicoalou has 
utilised a selenium based safety catch linker for the solid phase semi-synthesis of 
vancomycin. 50 In order to demonstrate that the selenium linker allows the molecule to be 
efficiently loaded and cleaved from solid support, protected vancomycin derivative 280 
was linked to resin through the carboxylic acid group to give a pro-allyl ester 281 (scheme
1.60). Oxidation of selenium with H2O2 , followed by elimination released alloc protected 
vancomycin. Treatment with catalytic palladium (0) and tributyl tin hydride removed the 
alloc group to return protected vancomycin 280.
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Nicoloau has demonstrated that the glycoside moiety in polymer bound vancomycin 282 
can be manipulated (scheme 1.61).49 In the example shown, the glycoside unit of 282 bears 
an alloc protecting group. Deprotection with palladium (0) affords the polymer bound 
monosaccharide 283 leaving the selenium pro-alloc linker intact. Glycosidation with the 
fluoride glycosyl donor 284 then gave 285. Performing these manipulations on solid 
support greatly assisted the purification of compounds en-route to vancomycin. This linker 
has potential as a useful tool for the construction of vancomycin libraries.
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Nicolaou has also applied a selenium linker in the traceless synthesis of molecules 
containing the 2 ,2 -dimethylbenzopyran moiety, a common structural motif in many natural 
products and biologically active compounds.51 ,52 The key benzopyran forming 
cycloloading reaction is shown in scheme 1.62. Treatment of selenyl bromide resin with o- 
prenylated phenols such as 286 results in cyclisation to give a resin bound 2 ,2 - 
dimethylbenzopyran 287. Traceless cleavage can be achieved by oxidation with H2O2 and 
elimination to release 2,2-dimethylbenzopyran 288 in an excellent yield of 93%. The
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generality of the cyclisation was investigated using o-prenylated phenols bearing neutral, 
electron rich and electron poor substituents. Yields of cleaved products were found to be 
excellent ranging between 91 and 93 % regardless of the electronic nature of the aromatic 
ring and purities were consistently greater than 95 %.
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scheme 1.62
Nicolaou has endeavoured to apply this methodology in the production of focused libraries 
of benzopyran natural products and bioactive compounds.51 ,52 After cyclative-loading, 
further modification of the resin bound 2 ,2 -dimethylbenzopyran core can be performed to 
yield a diverse array of biologically active molecules. For example, resin bound 
benzopyran methyl ketone 289 can undergo condensation with aldehydes followed by 
cleavage to give chalcone 291 in 85 % yield (scheme 1.63). A library of 24 chalcone 
analogues were synthesised in yields ranging from 25-90 %.
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scheme 1.63
Pyranocoumarins are natural products which show anti-viral, cytotoxic and anti-platelet 
activity. A library of analogues of these compounds can be produced from resin bound o- 
hydroxy aldehydes 292 (scheme 1.64).51’52 Knoevanagel condensation with a P-ketoester
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gave intermediate 293 which underwent lactonisation to give pyranocumarin 294. 
Oxidation and elimination then gave 295 in 92% yield.
OH
OH
Se
SeH -Me
Mepiperidine,
propionitrile,
95°C 293292
Se
THF,
25°C
-Me
Me
92 % yield -Me
Me
294295
scheme 1.64
The carbohydrate containing benzopyran macrophylloside heptaacetate 300 has been 
synthesised from resin bound benzopyran 296 (scheme 1.65).51’52 Glycosidation of 296 
with trichloroacetimidate 297 gave glycoside 298. Silyl group deprotection and a second 
glycosidation gave 299 as a single anomer. Cleavage from resin gave heptaacetate 
macrophylloside 300 in 18 % yield for 6  steps.
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This selenium linker approach has also been used for the synthesis of a small library of 
aldeosterone biosynthesis inhibitors (scheme 1.66) . 52 Resin bound aryl bromide 301 
underwent lithium-halogen exchange followed by addition to /7-fluorobenzaldehyde to give 
benzhydrol 302. Mitsunobu reaction with imidazole gave 303 which was oxidatively 
cleaved to give aldosterone biosynthesis inhibitor 304. Various analogues of 304 were 
synthesised in this way by varying the aldehyde and the imidazole components.
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Similarly, a small library of phosphodiesterase inhibitors was synthesised from resin bound 
aryl bromide 305 (scheme 1.67), Lithium-halogen exchange followed by treatment with 
DMF gave aldehyde 306. Condensation with nitrile 307 gave resin bound stillbene 308 
which was cleaved to give phosphodiesterase inhibitor 309 in 72 % yield.
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Finally, this benzopyran forming strategy has been applied in the synthesis tetrazole- 
containing targets such as 313 which are known to be potassium channel activators
C'J
(scheme 1.68). Resin bound benzopyran 310 bearing a nitrile group was treated with 
azidotrimethyltin to generate tetrazole 311. Treatment with aqueous TFA removed the 
trimethylstannyl group from the secondary nitrogen thus allowing alkylation to give 312. 
The resin bound tetrazole was then cleaved to give substituted tetrazole 313.
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1.3 Conclusions
The emergence of solid phase and combinatorial synthesis has led to renewed interest in 
sulfur and selenium chemistry. Classical reactions such as selenoxide elimination, sulfone 
alkylation, epoxidation and cyclopropanation reactions of sulfonium ions and radical 
cleavage of selenides have found new roles in high-throughput chemistry.
The scope and utility of sulfur and selenium in traceless linker systems for solid phase 
organic synthesis has been established. These linker systems are highly effective safety 
catch linkers due to their ability to exist in several oxidation states each with orthogonal 
cleavage strategies. In addition, sulfur and selenium can mediate a diverse range of 
chemical transformations and can be used to enable chemistry on, and allow further 
diversification of, resin-bound molecules. In the case of selenium based linkers,
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cycloloading strategies for attachment of the molecule to solid support allows complexity 
to be introduced in the immobilisation step. In both sulfur and selenium linker systems it 
has been shown that a variety of cleavage strategies exist and many of these strategies 
allow different types of functionality to be introduced in the cleavage step thus allowing 
further diversity to be introduced. Sulfur and selenium based linkers are robust and have 
been used in the successful synthesis of a large variety of compounds.
It seems clear that sulfur and selenium-based linker systems will continue to play a major 
role as the area of high throughput synthesis evolves over the coming years.
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Chapter 2: The first Pummerer cyclisations on solid phase. Construction of oxindoles 
enabled by a sulfur link to resin
2.0 Introduction-Traceless Linkers cleaved using SmL
SmL can reduce a-heteroatom substituted carbonyl compounds under mild neutral reaction 
conditions to give the parent carbonyl compounds (scheme 2.1).53’54 The heteroatom may 
be a halogen, an oxygen substituent such as an alcohol, ether or ester, or also sulfides, 
sulfoxides, sulfones, amides and amines. This reaction is very selective and tolerates a 
wide range of functionality.
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scheme 2.1
This selectivity can be observed in Overman’s synthesis of the natural product shahamin 
K. Overman reduced the a-sulfonyl ketone moiety in 314 using Sml2 , selectively in the
presence of a range of other functionality. 55
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THF, MeOH, 
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scheme 2.2
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To investigate the C 10 acetate group for the biological activity of the anti-cancer agent 
taxol 316, Holton has reduced the natural product with Sml2 to give 10-deacetoxy taxol 
317 in excellent yield (scheme 2.3).56 The a-acetoxy ketone moiety of 316 was selectively 
reduced to the ketone in high yield without affecting any other functionality in the sensitive 
molecule.
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s c h e m e  2 .3
This reaction therefore has ideal properties for application to the development of a
co
traceless linker system for solid phase organic synthesis. ’ If the heteroatom links the 
carbonyl compound to a solid support, reduction by Sml2 would then correspond to 
traceless cleavage of the carbonyl compound from resin (scheme 2.4). The term “traceless” 
refers to the replacement of the linking bond with an aliphatic “C-H” bond therefore 
cleavage leaves no trace of the original link to solid support.
R —
Sml2
© v XH
0
X R
OR traceless OR
NR2 cleavage n r2
x=o,s released product
scheme 2.4
An oxygen based traceless linker system based on this idea was developed within the 
group. 59 We refer to this linker system as an a-heteroatom substituted carbonyl or HASC 
linker. This linker system was applied in the traceless synthesis of amides (scheme 2.5) and 
ketones (scheme 2.6). The linker was shown to be stable to a wide variety of reaction 
conditions yet was cleaved readily and selectively by Sml2 at the end of the synthetic 
sequence. y-Butyrolactone 319 was immobilised on phenol resin 318 to give resin bound 
lactone 320. The lactone ring was opened upon treatment with secondary amine 321 and 
trimethyl aluminium to give amide 322 and the resultant alcohol was protected as the tert- 
butyl diphenylsilyl ether to give resin 323. The release of amide 324 was achieved by 
cleavage of the O-link in resin 323 with Sml2 and DMPU additive. Reduction of a- 
heteroatom substituted amides requires an additive such as DMPU to activate Sml2 by 
increasing the reduction potential.
OH 
318
O
Br^ X 0
319N— /
K2C 0 3l 
18-crown-6, 
DMF, 50 °C
Y?
320
HN
321
AIMe3, 
Tol, 50 °C,
31 % yield 
88% HPLC purity
OTBDPS 324
TBDPSCI,
Imidazole,
DMF,
rt
THF, rt
OTBDPS
323
schem e 2.5
This linker system was also used in the synthesis of ketones as shown in scheme 2.6.59 
Following the ring opening of resin bound lactone 320 with morpholine and silyl 
protection of the alcohol, resin 326 was treated with isopropylmagnesium bromide to give 
resin bound ketone 327. Treatment with Sml2 alone was sufficient for the cleavage of 328 
from resin, the use of additives was not required for the reduction of a-alkoxy substituted 
ketones.
y?
320
TBDPSCI,
imidazole, 
DMF, rt
AIMe3,
Tol,
50°C,
OTBDPSOH
325 326
24 % yield 
70 % purity
OTBDPS 328
Sml2 ,
THF,
rt
MgBr
A
THF
OTBDPS
3 2 7
schem e 2.6
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This linker system was applied in the synthesis of a range of ketones and amides in yields 
ranging from 16-31 % (4 or 5 steps on resin respectively) resin and in high purities.
2.1 Solid phase synthesis of A-heterocycles using the Pummerer cyclisation
The aim of my PhD project was to develop an analogous, multifunctional sulfur HASC 
linker. Organosulfur compounds can exist in various oxidation states and can mediate a 
diverse range of reactions. The sulfur atom link would not only be used to attach the 
carbonyl compound to solid support but would also be used to “enable” reactions such as 
the Pummerer cyclisation reaction. 60 ,61 ,62 The addition of nucleophiles to sulfonium ions 
generated from sulfoxides is known as the Pummerer reaction. Tethered nucleophiles such 
as an alkene double bond or an aromatic system give rise to cyclic products. The 
Pummerer cyclisation reaction is a powerful method for generating heterocycles and 
carbocycles. Some examples of Pummerer cyclisation reactions are shown in scheme 
2.7.63,64
xr
+ T TFAA,
',0  -----------
c h 2c i2,
o°c
92%
329
MeS^J*
P
330
y-lactam
MeO.
MeO'
O-
331
pTsOH,
MeO.
benzene, MeO 
reflux 
61 % MeS
332
N— tetrahydro-benzazepin-2-one
schem e 2.7
The basic idea behind our studies is shown in scheme 2.8. A carbonyl compound bearing a 
tethered nucleophile can be linked to resin via an a-sulfur atom. The sulfide link can then 
be oxidised to the sulfoxide, from which an intermediate sulfonium ion can be generated. 
Attack of the tethered nucleophile onto the sulfonium ion gives a resin bound cyclic 
product which can at a later stage be cleaved from resin in a traceless manner using Sml2 . 
Use of the Pummerer cyclisation on solid support is unprecedented in the literature.
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k A <
activation
Nu
0  O
Nu
+ 0
Nuj
Pummerer
cyclisation
SH
traceless
cleavage
Sml2
‘ • A
schem e 2.8
Initially, it was proposed to develop a solid phase route to oxindoles utilising the 
Pummerer cyclisation strategy illustrated above. Oxindoles are key heterocyclic motifs in a 
number of pharmaceutically important compounds and biologically active natural products. 
Some examples of biologically active oxindoles and oxindole based natural products are 
shown in Fig 2.1.
MeO
MeO
Hr n
Maxiprost 
used in treatment 
of strokes
MeO
SU9516 
CDK inhibitor
vasopressin
binder
horsfiline 
natural product
Fig 2.1
progesterone receptor 
anatagonist
A proposed route to oxindoles using this methodology is shown in scheme 2.9. a- 
Bromoacetamide substrates such as 333 will be immobilised onto thiol resin. After 
oxidation of the sulfide link to give resin bound sulfoxide 336, the Pummerer cyclisation
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will be applied to generate a resin bound oxindole 337. Oxindole 337 can be tracelessly 
cleaved to give 338 or the sulfide link can be used again to assist further modification of 
the heterocyclic framework to give 339. Modified oxindole 339 can then undergo traceless 
cleavage to give 340.
B r \ ,X  Ri O k  334
A  immobilisation 
333 R2
S^ N' Ri
335 R2
340
oxidation
SmU
cleavage
Smlc
cleavage
O O
336 ^ \ 2
Pummerer
cyclisation
Modification
339
schem e 2.9
2.2 Choice of solid phase sulfur linker
There are several existing literature methods for the preparation of polystyrene based thiol 
resins. Before attempting the development of a new traceless HASC sulfur linker system, it 
was necessary to evaluate which of these linker systems would be best suited in our route 
to iV-heterocycles using the Pummerer cyclisation. Two literature thiol resins are shown in 
Fig 2.2. Literature routes to both resins are short and begin from Merrifield resin.
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Fig 2.2
The alkyl thiol linker system of resin 341, developed by Wagner and Mioskowski was 
initially considered because literature Pummerer cyclisations for the synthesis of N- 
heterocycles such as oxindoles and tetrahydroisoquinolones were carried out with alkyl 
sulfanyl groups. 65 Resin 341 was prepared in a similar manner to the method used by 
Wagner and Mioskowski (scheme 2.10) . 21 Resin bound alcohol 343 was formed by 
treatment of Merrifield resin with 1,4-butanediol and NaH. Mesylate formation was 
followed by treatment with potassium thioacetate to give thioester 345. The presence of the 
thioester can be detected by the strong IR C=0 stretch at 1689 cm'1. The thioester group 
was converted to the thiol 341 by reduction with LiBH4 . The progress of this reaction can 
be monitored by the disappearance of the C=0 stretch at 1689 cm’1.
ci NaH,
1,4-butanediol, 
DMF, rt
q C 0'
MsCI,
NEt3,CH2CI2
343
u b h 4,
THF
341
,OMs
344
KSC(0)CH3, 
DMF, rt
IR C = 0 ,1689 cm 
345
schem e 2.10
Wagner and Mioskowski prepared thiol resin 341 by treatment of mesylate 344 with 
thiourea instead of potassium thioacetate then treating the thiouronium salt with n- 
butylamine to give 341 (scheme 2.11),
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n-BuNH2l
DMF,
60°C
schem e 2.11
2.2.1 Solution phase model studies - using ethane thiol as a model for thiol resin
Due to the limited methods available for monitoring reactions on resin it was necessary to 
first develop and optimise a route to oxindoles in solution phase using a solution phase 
thiol to mimic the thiol resin. Initially we assumed that ethane thiol would act as an 
adequate model for alkyl thiol resin 341 (scheme 2.12). a-Bromoacetamide 348 was 
prepared by acetylation of A-methyl aniline with bromoacetyl bromide. As a model for 
immobilisation of the a-bromoacetamide 348 onto a thiol resin 341, 348 was treated with 
ethane thiol. Sulfide 349 was obtained in excellent yield indicating that the crucial 
immobilisation step should occur cleanly and efficiently.
It was then necessary to oxidise sulfide 349 selectively to sulfoxide 350 without over 
oxidation to the sulfone. Many of the usual methods for carrying out this transformation 
require careful control of the stoichiometry of the oxidant. This would be very difficult to 
achieve on resin. The oxidation step must also take place in a solvent system which is 
compatible with polystyrene resins. Many of the conventional reagent systems, such as 
NaI0 4 , require polar solvents such as MeOH. Solvents such as MeOH cause shrinking of 
the resin and would therefore result in a slow, inefficient reaction. A very effective reagent 
system which uses H2O2 in the presence of 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) was 
employed.66 Sulfide 349 was selectively oxidised to the sulfoxide 350 even in the presence 
of a vast excess of H2O2 .
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2  0 I? H2° 2 ~ °  ii
HN  ^ Br^ ^ B r  B r ^ ^ X ^  '^ S H  V ^ s v * X N"' ------------- "
----------------------------   I  HFIP:CH2CI2
NEt3, DMF, fi ? || (2:1)
r t > 8 4  %  93 %
348 349 350
schem e 2.12
These sulfoxidation conditions were originally developed by Begue. 66 Treatment of phenyl 
ethyl sulfide 351 with an excess of 30 % aqueous H2O2 in hexafluoroisopropanol solvent 
gave the desired sulfoxide 352 in excellent yield after only 5 min (scheme 2.13). No 
sulfone was observed even if the reaction time was extended to 3 h. Sulfoxide 352 was 
treated with excess H2O2 for 8  h. After work-up, the starting sulfoxide was recovered 
unchanged.
"o
_ 30 % aq H20 2 (2eq), <!> ^
Ph'S^  --------------------------  P l X ^
HFIP, 5 min
351 97 % 352
schem e 2.13
A wide range of sulfides were oxidised to the corresponding sulfoxide using these 
conditions. No evidence of over oxidation was observed. Allylic and vinylic sulfides could 
be oxidised without affecting the double bond as shown in scheme 2.14. The rate of this 
oxidation reaction is rapid. Rate of oxidation of sulfur by H2O2 depends on the 
nucleophilicity of the sulfur atom. It was proposed that the HFIP solvent has two roles in 
this reaction. Firstly, it is thought to accelerate the sulfoxidation step by forming a 
hydrogen bond with the H2O2 thus activating the hydroxyl leaving group. After the first 
oxidation at sulfur, HFIP then prevents any further oxidation to the sulfone by forming a 
strong hydrogen bond to the oxygen of the sulfoxide. This decreases the nucleophilicity of 
the sulfur atom and prevents it from reacting further with H2O2 .66
Ph +
30 % aq H20 2 (2eq),
HFIP, 5 min 
99%
schem e 2.14
Conditions for promoting the Pummerer cyclisation of sulfoxide 350 to give oxindoles 355 
were next investigated (scheme 2.15). Initially, various organic acids such as p-toluene 
sulfonic acid, camphor sulfonic acid and trichloroacetic acid were tried. Cyclisation
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product 355 was obtained as the major product however, the reactions were not clean. In 
the reaction promoted by trichloroacetic acid, by-products 356 and 357 were isolated. 
These products are formed as a result of water intercepting the sulfonium ion before 
cyclisation can occur. In order to avoid the production of these unwanted products, 
reaction conditions must be kept anhydrous. The organic acids used are very hygroscopic 
and extremely difficult to dry. Therefore, it would be difficult to prevent the formation of 
these by-products. Use of anhydrides such as acetic anhydride and trifluoroacetic 
anhydride did not result in Pummerer cyclisation, giving only Pummerer rearrangement 
product. Fortunately, it was discovered that treatment of 350 with TFAA and BF3 OEt2 
resulted in rapid, clean Pummerer cyclisation to give 355 in 74 % yield.
_o o
350
"O O
v U ,
350
c c i3c o 2h
1,2-dichloroethane
£
0
HOv V
0
X
355 356 357
71 % 20% 5 %
TFAA, BF3 OEt2,
0  
\  N
1,2-dichloroethane 
15 min 
74%
f y
355
No by-products
schem e 2.15
Given that an efficient route to oxindoles had been developed, it was then necessary to 
perform a model, traceless “cleavage” of the oxindole. Treatment of model oxindole 355 
with Sml2 in the presence of DMPU as an additive, readily resulted in the rapid cleavage of 
ethanethiol to give oxindole 3.58 in excellent yield (scheme 2.16).
355
Sml2,
DMPU,
THF, rt, 
1h 
77%
358
schem e 2.16
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2.2.2 Solid phase studies
After successfully modelling a route to oxindoles in solution, the solid phase route was 
attempted using thiol resin 341 (scheme 2.17). Thiol resin 341 was treated with a- 
bromoacetamide 348 and an IR carbonyl stretch at 1650 cm ' 1 was observed for the 
resultant resin 359. This is a good indication that the immobilisation step occurred 
successfully as this value compares favourably to the IR carbonyl stretch for corresponding 
model amide 349. Sulfide resin 359 was treated with H2O2 in HFIP: CH2C12, however, it is 
not possible to observe the progress of this reaction using IR spectroscopy as the 
characteristic sulfoxide stretch occurs at - 1 0 2 0  cm-1  and coincides with resin signals. 
Exposure of sulfoxide resin 360 to Pummerer cyclisation conditions resulted in a shift in 
the IR C=0 stretch from 1650 to give two stretches, one at 1718 cm ' 1 and another at 
1781cm'1. The stretch at 1718 cm ' 1 would indicate successful Pummerer cyclisation to the 
oxindole. However, upon Sml2 cleavage only a trace of cyclisation product 358 was 
obtained together with A-methyl-TV-phenylacetamide 362. The route was repeated several 
times with slightly different results on each occasion. The main product, if any, was 
usually A-methyl-A-phenylacetamide which indicated that cyclisation had not occurred.
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,SH
341
361
IR C=0 1718 & 1781 cm'1
Sml2,
DMPU,
THF
O
A ,
b^ n- 
348
NEt3, DMF,18h
TFAA, BF3*OEt2,
1,2-dichloroethane
362 358
trace of oxindole
IR C=0 
1650 cm'1
h2o 2,
HFIP:CH2CI2
(2 :1)
"O O
k X , ^
360
scheme 2.17
After the Pummerer cyclisation a significant stretch at 1781 cm ' 1 was observed in the IR
spectrum (scheme 2.18). An IR stretch in this region might be expected for the C=0 of a
trifluoroacetate ester. This indicated that uncyclised species such as 363 and 364 are still
present and that cyclisation was incomplete.
o
363 364
IR C=0 1781 cm'1 ir  c =0  1781 cm'1
scheme 2.18
In further studies, the number of equivalents of BF3 OEt2 was increased in an attempt to 
drive the cyclisation step to completion. This strategy appeared to be effective, reducing
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the intensity of the C=0 stretch at 1781 cm ' 1 dramatically. However, SmU cleavage still 
only gave a very small trace of oxindole product.
This poor mass return off resin indicated that the loading of oxindole product on resin prior 
to cleavage was very low and that the solid phase route was not efficient. These results 
suggested that perhaps the use of ethane thiol as a model for alkyl thiol resin 341 was too 
simplistic. The main difference between the model and the resin 341 was that the model 
had not incorporated an oxygen atom further along the alkyl chain. The possibility that the 
oxygen atom in the linker could be intercepting the sulfonium ion during the Pummerer 
cyclisation was considered (Fig 2.3).
In order to investigate whether such side reactions were occurring on resin, further solution 
studies were carried out. On this occasion a model thiol that more closely mimicked thiol 
resin 341 was synthesised (scheme 2.19).
1,4-Butanediol was monobenzylated to give 365. In analogy to the synthesis of resin 341, 
monobenzylated alcohol 365 was mesylated and then treated with potassium thioacetate to 
give thioester 367. Both these reactions proceeded in excellent yields. The transformation 
of 367 to sulfide 368 proved slightly less efficient. Thioester 367 was reduced to the thiol 
and then used immediately in the reaction with 348 in order to minimise disulfide 
formation. Use of LiBEU in the reduction step gave the desired sulfide 368 in only 54 %. 
One possible explanation for the low yield obtained in this transformation is that after 
reduction with LiBPLj, thiol is obtained as a thiolate complex with boron which may be 
reducing the nucleophilicity of the thiol. Several methods for hydrolysing thioacetate 367 
to the corresponding thiol were attempted (K2CO3 , LiOH and MeLi) but all of these 
methods were found to be ineffective. Use of LiAIKU instead of LiBPLi. gave a slight 
increase in the yield of 368 to 63%. These studies identified one step in the solid phase 
route which may be problematic and which could be investigated more closely.
Fig 2.3
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HO"
,OH
BnBr,
NaH, THF, 
rt 
44%
BnO"
MsCI, NEt3l
CH2CI2, rt 
100%
BnO"
365
BnO'
368
63%
348
BnO
,OMs 
366
KSCOCH3, 
DMF, rt
93%
367
NEt3, 
DMF, rt
schem e 2.19
The efficiency of the Pummerer cyclisation of the model sulfide 368 was investigated 
(scheme 2.20). These solution studies did not reveal any side reactions or problems 
associated with the use of this linker. Treatment of sulfoxide 369 with TFAA and BF3 OEt2 
gave oxindole 370 in good yield. The crude NMR of the reaction was clean and no by­
products were observed. Sml2 cleavage of the link was also very efficient.
BnO
368
H2O2,
HFIP:CH2CI2
(2 :1 )
75 %
BnO"
369
TFAA, BF3»OEt2, 
1,2 -dichlroethane 
75%
DMPU, THF, 
81 %
schem e 2.20
The solid phase route was attempted once again using thiol resin 341 that had been 
prepared via the thiourea method shown in scheme 2.21 and once using thiol resin 341 that 
had been prepared by reduction of thioacetate resin 345 with UAIFI4 . Neither of these
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modifications improved the results. No significant quantity of oxindole 358 was obtained 
off resin. It is not clear why the attempted use of alkyl thiol resin 341 was unsuccessful. It 
was decided to investigate the use of the benzyl thiol resin 342.
2.3 Benzyl thiol resin
2.3.1 Preparation of benzyl thiol resin
1Benzyl thiol resin 342 was originally prepared by Kobayashi from Menifield resin in two 
steps by the method shown in scheme 2.21a. In addition, we developed a thiourea-based 
approach to 342 (scheme 2.21b), both methods have been used in these studies and have 
been found to be equally effective. The progress of these reactions can be monitored easily 
using IR spectroscopy.
a)
,ci
1.1 mmol/g
KSC(0)CH3i
DMF,
rt
LiBHj
371
Vo
th ioacetate 
SH method
THF,
rt 342
IR C=0 1687 cm '1
b)
J L  C% -  n-BuNH2, r \  thiourea
Cl H2N NH2 V * P \^ S ^ .N H 2 Cl ________________ W ^ / S H  method
DMF, NH2 DMF-
1.1 mmol/g 60°C + 60°C
IR C=N 1660 cm '1
schem e 2.21
2.3.2 Determination of the loading of benzyl thiol resin
The loading of free “SH” sites on benzyl thiol 342 was determined by immobilisation of 
W-methyl-TV-phenyl a-bromoacetamide, followed by Sml2 cleavage and quantification of 
iV-methyl-TV-phenyl acetamide 361. Loading of free “SH” sites for benzyl thiol resin 
prepared via the thioacetate method and the thiourea method were calculated. The loading
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of the two resins was found to be similar at values of 0.56 mmol/g and 0.61 mmol/g 
(scheme 2.22). Sulfur microanalysis results would suggest that the sulfur loading was ~ 1 
mmol/g, this discrepancy is presumably due to oxidative cross-linking of the thiol 
functional groups.
o
Br^ V
Sml2,
DMPU
thioacetate  m ethod loading = 0.56 mmol/g
,SH
thiourea method loading = 0.61 mmol/g 
schem e 2.22
2.3.3 Solution phase model studies
Solution phase model studies were carried out using benzyl thiol as a model for the benzyl 
thiol resin. In order to assist the Pummerer cyclisation step, an electronically activated 
system was used. Secondary aniline 376 is not commercially available but can be prepared 
easily form m-anisidine and benzaldehyde by reductive amination (scheme 2.23). 
Alternatively, the amine can be prepared by benzoylation of m-anisidine followed by 
reduction with LiAlPL* (63% for 2 steps). a-Bromoacetamide 377 can be accessed from 
376 by treatment with bromoacetyl bromide.
0
H
375
O
Ti(OiPr)4 (neat), Brv. J L  ft
NH’ 80°C
2. NaBH4, MeOH, rt II \ NEt3l CH2CI2,
'0Me 93% ^ ^ O M e  99 %
374 376 377
schem e 2.23
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Reaction of a-bromoacetamide 377 with benzyl thiol 378 gave sulfide 379. Following 
selective oxidation to sulfoxide 380, treatment with TFAA gave oxindole 381 as the major 
regioisomer. It is interesting to note that TFAA alone is sufficient to promote Pummerer 
cyclisation in electronically activated systems. The minor regioisomer was separated from 
381 by chromatography before the cleavage step. Cleavage of the benzylsulfanyl group 
was carried out using Sml2 and DMPU to give the desired oxindole 382.
HFIP:CH2CI2
(2 :1),
92%
TFAA,
1 ,2 -dichloroethane, 
63%
DMPU,
THF,
48%
(unoptimised)
scheme 2.24
2.3.4 Solid phase studies using benzyl thiol resin
Given that the solution phase route posed no obvious problems, the sequence was then 
adapted to solid phase (scheme 2.25). A-benzyl-2-bromo-A-(3-methoxy-phenyl)-acetamide 
377 was immobilised using benzyl thiol resin 342. A strong IR amide C=0 stretch at 1650 
cm ' 1 was observed, indicating successful loading had occurred. Following the sulfoxidation 
step no change in the IR can be observed, however, upon treatment of resin 384 with 
TFAA to give resin 385, the IR C=0 stretch shifted to 1715 cm ' 1 suggesting that 
cyclisation had indeed occurred. Gratifyingly, upon treatment of resin 385 with SmU the 
desired oxindole 382 was obtained in 38 % yield over 4 solid phase steps (based on the 
loading of benzyl thiol resin). Oxindole 382 was obtained in high purity off resin after
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filtration through a plug of silica to remove the DMPU. No other by-products were 
observed.
SH
OMe
377
OMe383
IR C=0 1650 cm'1
O O
382 OMe
„Bn Sml2l DMPU,
THF, rt
38 % yield 
over 4 steps on 
solid phase
384 OMe
TFAA,
1 ,2 -dichloroethane
Bn
385 OMe
IR C=0 1715cm'1
scheme 2.25
Oxindole 382 was obtained as the major isomer in a 9:1 mixture (by NMR) of 
regioisomers. The minor regioisomer is formed as a result of attack of the aromatic system 
onto the sulfonium ion at the ortho position to the methoxy group. The regioisomers were 
separated by chromatography and a crystal structure of the major isomer was obtained (Fig 
2.4).
0 1
C 2
C1
C 3 N1C 8
C1C 1 0
C 4
C 7 C11 C 1 5
C 5
C 6 C 1 2 C 1 4
C 1 3
02C 9
Fig 2.4
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2.3.5 Preparation of anilines and a-bromoacetamides
Since a successful solid phase route to oxindoles had been developed the scope of the 
methodology was investigated. It was necessary to establish whether a wide range of 
oxindoles bearing neutral, electron rich and electron deficient aromatic rings could be 
synthesised using our route. As has been described previously, a-bromoacetamides can be 
prepared easily by acylation of the corresponding secondary aniline with bromoacetyl 
bromide. Unfortunately, only a limited number of secondary anilines are commercially 
available. In contrast, a wide range of functionalised primary anilines are available. 
Secondary anilines were prepared by acylation of the aniline with an acid chloride or 
anhydride followed by reduction of the amide with LiAlH4 . Selected examples of the 
anilines prepared are shown in scheme 2.26.
NEt3,
CH2CI2
^ - 0
386
HN
387
LiAIH4l
THF,
35%  
over 
2 steps
HN
^ - 0
388
NH2
389
O O
NEtg,
CH2CI2
HN
390
LiAIH4,
THF,
36%  
over 
2 steps
HN'
391
O O
NH2
Cl
392
NEtg,
CH2CI2
HN
X  
T
Cl 393 
scheme 2.26
LiAIH4,
THF,
8 8 % 
over 
2 steps
HN'
Cl
394
A series of a-bromoacetamides bearing neutral, electron rich and electron deficient aryl 
rings were synthesised (table 2 .1 ).
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A n ilin e  a -B r o m o a c e ta m id e
HN'
HN'
HN'
O
348
O
395
396
8 8 %
35%
45 %
HNX )  BtJ l O
42%
397
A niline
HN'
a -B r o m o a c e ta m id e
O
Br
N'
1 0 0%
Cl
HN^Ph
398
Cl
N Ph
OMe 377
99%
OMe
HN
399 96%o - /
400
Table 2.1
2.3.6 Solution phase model studies on Pummerer cyclisation of deactivated aromatic 
systems
Prior to the application of this wide range of a-bromoacetamides in the solid phase 
synthesis of oxindoles it was necessary to establish if the Pummerer cyclisation of 
unactivated aromatic systems and aromatic systems bearing electron withdrawing 
substituents such as halogen atoms would be possible in our approach. To the best of our 
knowledge, the Pummerer cyclisation of aromatic systems bearing halogen atoms is 
unprecedented in the literature. Further solution phase model studies were therefore carried 
out and are shown in scheme 2.27. Treatment of sulfoxides 403 and 404 bearing an iodine 
and a chlorine atom respectively, on the aromatic system, with TFAA and BF3 OEt2 gave 
the desired oxindoles. Therefore, these conditions are powerful enough to promote 
cyclisation of neutral and deactivated systems.
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HFIP:CH2CI2,
(2 :1),
H20 2,
1 ,2-dichloroeth^..
TFAA,
BF3O E t2,
X
402 X = Cl
401 X = I X
X
403 X= I, 100%
404 X= Cl, 80%
405 X= I, 73%
406 X= Cl, 72%
scheme 2.27
In the synthesis of 1 ,2 ,3 ,4 -te trah y d ro iso q u in o lin es , Sano has shown that both TFAA and 
BF3 OEt2 are necessary to promote the Pummerer cyclisation where there is no electron 
donating group activating the reacting centre on the aromatic ring. BF3 CEt2 will assist 
the reaction by promoting the foimation of the sulfonium ion intermediate, however, 
BF3 OEt2 has also been shown to enhance the rate of Pummerer cyclisation regardless of 
whether the aromatic system is activated or not. It has been postulated that the addition of
/'O
the Lewis acid promotes formation of a dicationic intermediate as shown in scheme 2.28. 
Such a cationic intermediate is thought to act as a super-electrophile thus promoting 
Pummerer cyclisation of aromatic systems which would normally be too deactivated to 
react.
The use of TFAA to generate oxindoles from electronically activated sulfoxide starting 
materials is well established. However, this is the first example of the use of this reaction 
on solid phase. Although Sano has applied the TFAA/BF3 OEt2 reaction conditions in the 
synthesis of 1,2,3,4-tetrahydroisoquinolines from neutral and electronically activated 
sulfoxides, these conditions have not been applied previously in the synthesis of oxindoles. 
Furthermore, there are no previous examples of application of these, or any other 
conditions in the Pummerer cyclisation of substrates bearing halogen atoms or other 
electronically deactivating groups (e.g ester groups).
o - b f 3 o
scheme 2.28
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In the oxindole bearing the aryl iodide moiety there is a possibility that the carbon-iodine 
bond will undergo reduction by Sml2 in the cleavage step. 69 Upon treatment of the model 
oxindole 405 with two equivalents of SmU the carbon sulfur bond underwent 
chemoselective cleavage to give iodo-oxindole 407 (scheme 2.29). The halogen 
functionality remained intact under these conditions. Use of an excess of SmU eventually 
does give some reduction of the carbon-iodine bond however, this excellent 
chemoselectivity means that our methodology should be amenable to the synthesis of 
halogen bearing heterocycles.
+ SM + BnSH
DMPU (8 eq) 
THF
schem e 2.29
2.3.6 Solid phase synthesis of oxindoles using the Pummerer cyclisation
a-Bromoamides shown in table 2.1 were immobilised onto benzyl thiol resin and subjected 
to the solid phase sequence shown in scheme 2.25. Gratifyingly, in each case the desired 
oxindole products were cleaved from solid support at the end of the sequence. Table 2.2 
shows the neutral oxindoles prepared by Pummerer cyclisation on solid phase. Yields for 
the oxindoles are based on the loading of the thiol resin and are therefore for 4 solid phase 
steps.
87
a -B ro m o a ceta m id e o x in d o le
O
395
O
B r^ A
39 7 '
O O
'N "  A  N'
. < - h
408 409
o f  \
N
r \
^= J  410
O
Bk A ,
348
396
411
O
/ /  \  
s= y  412
Table 2.2
63%
(2 :1)
39%
30%
36%
Table 2.3 shows electron rich and electron deficient oxindoles prepared by Pummerer 
cyclisation on solid phase.
a -B ro m o a ce ta m id e o x in d o le
399 413
36%
N Ph
377
OMe
O
398
Cl
N Ph
38%
(9:1)
38%
400
407
2 0 %
Table 2.3
2.4 Modification of the oxindole framework on resin post-cyclisation
The sulfur link to resin remains intact after the Pummerer cyclisation. Further synthetic 
steps on resin would allow access to elaborated oxindole frameworks. Work carried out by 
a project student, Remy de Gentile, under my supervision illustrates this idea. The linking 
sulfur atom in resin 384 was oxidised to the sulfone 416 (scheme 2.30). Subsequent 
alkylation with allyl bromide in the a-position gave modified resin bound oxindole 417 
and was assisted by the increase in oxidation state of the linking sulfur atom. Finally, 
cleavage of the link with Sml2 and DMPU gave 3-substituted oxindole 418 in 28 % yield 
over 6  solid phase steps.
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allyl bromide, 
K2C 03l
oxone,
Sml2,
DMPU,
THF
28% over 
6 steps
schem e 2.30
2.5 Attempted diversification of the oxindole framework through Pd-catalysed cross 
coupling reactions
Further diversity could be introduced into the oxindole after cyclisation through palladium 
catalysed cross coupling reactions of iodo-oxindoles. Solution phase model studies on aryl 
iodide 405 were carried out in order to find suitable conditions for the Suzuki coupling 
with phenyl boronic acid (scheme 2.31).
This reaction proved to be unsuccessful. Several solvents, bases, temperatures and 
palladium catalysts were tested; however, no product was obtained. In all cases starting 
material was returned unchanged from the reaction.
Pd catalyst, 
base, 
solvent
B(OH)2
419405
schem e 2.31
A possible explanation for the lack of catalytic activity in these reactions is that oxindoles 
bearing an a-sulfur atom such as 405 act as very good chelating ligands towards palladium 
thus preventing its participation in the catalytic cycle. This will be discussed in more detail 
in section 3.3.2.
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Some solution phase studies carried out on an uncyclised a-thio-7V-arylamide substrate (see 
section 3.3.2) indicate that palladium catalysed cross coupling reactions should be possible 
prior to cyclisation to the oxindole. On solid phase, Suzuki coupling of aryl bromide 421 
with methylbenzene boronic acid was attempted prior to Pummerer cyclisation. The 
desired product 424 of the sequence was obtained, upon cleavage of resin 423 with Sml2 , 
however, it was impure and was obtained in low yield.
Pd(PPh4)4) 
Na2C03  (aq),
H20
1,4-dioxane, 80 °C
HFIP:CH2CI2i
(2 :1)
B(OH)2
TFAA,
BF3,OEt2)
1,2 -dichloroethane
423424
schem e 2.32
2.6 Stepwise construction of cyclisation substrates on resin
Although an efficient solid phase route to oxindoles had been developed, the methodology 
has some short comings. Although the preparation of a-bromoacetamides in solution phase 
prior to immobilisation is straightforward, it would be more convenient if the cyclisation 
substrates could be built-up on resin to allow diversification to be increased using solid 
phase rather than solution phase steps. We aimed to develop a route such as that shown in 
scheme 2.33. Carboxylic acid resin 425 could be coupled to primary amine to give resin 
bound amide 426. A-alkylation would then give a resin bound cyclisation substrate 427 
which could be oxidised and cyclised as previously described.
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Two approaches were used to synthesise acid resin 425. In the first method, thiol resin 372 
was treated with bromoacetic acid under basic conditions. An IR carbonyl stretch at 1722 
cm ' 1 was observed, apparently indicating the successful preparation of 425. An attractive 
alternative method that was examined to allow 425 to be prepared directly from Merrifield 
resin by treatment with thiol acetic acid. This would negate the need for the preparation of 
a thiol resin. A broad IR carbonyl stretch at 1712cm'1 was obtained.
o
* \ A OH
,SH
O
S v A OH
brom oacetic acid route 
IR C=0 1722cm'1
372 NEt3,
DMF 425
Q _ C I  HS^ o h  t
NEta, 425
Kl 
DMF
schem e 2.34
thiol acetic acid route 
IR C=0 1712cm'1
Acid resin 425 prepared by the bromoacetic acid route was coupled with aniline. A shift in 
the carbonyl stretch from 1722 cm ' 1 to 1684 cm ' 1 was observed, which is consistent with 
the formation of a secondary amide such as 430. TV-alkylation of amide 430 was attempted 
using KHMDS and prenyl bromide 431. However, after oxidation, cyclisation and
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cleavage, only acetamide 433 was obtained suggesting that cyclisation on solid phase had 
not occurred.
o
OH
,SH
O aniline,
O k  EDCI'
372
NEtg,
DMF
OH ---------------
425 HOBt,
CH2CI2
IR 0 = 0  1722 cm ' 1
NH
430
IR C=0 1684 cm□
O
A —
oxidation,
Pummerer
cyclisation
KHMDS,
431
DMF
433
schem e 2.35
432
We then focused on acid resin 425 which had been prepared by the thiol acetic acid route 
(scheme 2.36). Acid resin 425 was coupled with m-anisidine and an appropriate carbonyl 
stretch at 1683 cm ' 1 was observed. After treatment with base and benzyl bromide a shift in 
the carbonyl stretch to 1652 cm ' 1 was observed seemingly indicating successful alkylation. 
Unfortunately, after oxidation, cyclisation and cleavage, only acetamide 437 was obtained. 
In an alternative strategy, acid resin 425 was coupled with N-methyl aniline in order to 
avoid the possibly problematic A-alkylation step. Again, an appropriate carbonyl stretch at 
1655 cm ' 1 for resin 434 seemed to indicate that coupling has occurred successfully. 
However, oxidation, cyclisation and cleavage gave only acetamide 362. It was unclear why 
cyclisation would not occur when the cyclisation substrates were constructed in this 
stepwise manner.
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scheme 2.36
2.7 Application of our solid phase Pummerer methodology to the synthesis of 
biologically active oxindoles
Analogues of generic oxindole 438 shown in fig 2.5 are of pharmaceutical interest as they 
may show biological activity against a kinase protein known as P38. This protein is 
involved in a cascade of reactions in the human inflammatory response.
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438
Fig 2.5
Molecules which inhibit this protein are potential drug candidates for inflammatory 
diseases such as rheumatoid arthritis. Some examples of known inhibitors of p38 are 
shown in fig 2.6. These molecules contain core bicyclic scaffolds. VX-745 inhibits the 
kinase p38 by competitive binding at the ATP-binding site. The important interactions on 
this binding are the formation of a hydrogen bond between the carbonyl oxygen and the 
NH of a methionine residue (Met 109). Binding is also driven by hydrophobic interaction 
between the protein and the dichlorophenyl group. The rigid structure of the molecule is 
thought to assist effective binding. Structural similarities between these known p38 
inhibitors and the oxindole 438 shown (fig 2.5) can be observed which suggests that 
oxindole analogues may bind and inhibit kinase p38 in a similar manner.
VX-745
HN
Fig 2.6
It was envisaged that a small library of analogues of this oxindole could be synthesised 
using the solid phase Pummerer cyclisation methodology that has been developed. 
Oxindoles based on core structure 438 can be derived from immobilisation of a- 
bromoacetamides such as 439 onto thiol resin followed by oxidation of the link and 
Pummerer cyclisation (scheme 3.37). The ester group on one aromatic ring could then be 
modified post-cyclisation in the preparation of analogues. Finally, the desired oxindole 
analogue could be cleaved from resin.
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HN
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2.7.1 Synthesis of diaryl amine 440
a-Bromoacetamide 439 can be synthesised from diaryl amine 440. Amine 440 is not 
commercially available and its preparation is not trivial due to the steric hindrance 
introduced by the two ortho chlorine atoms. Amine 440 can be prepared from a-
HC\chloroacetamide 442 via a Smiles rearrangement. Treatment of 442 with 2,6- 
dichlorophenol 443 and potassium carbonate gave ether 444 which underwent Smiles 
rearrangement upon treatment with stronger base to give a-hydroxy acetamide 445. 
Acetamide 445 was not isolated and underwent hydrolysis to the desired amine 440 in situ.
n h 5
C 02Et
441
O
Cl
NEt3,
CH2CI2,
95%
O
NH
C 02Et 
442
Cl
HN
OH
X T443
44 0
C 0 2Et
K2C 03l 
DMF, 
80 °C
30%
Cl (two steps)
Cl
Cl
444
NH
C 0 2Et
NaOEt, EtOH, 
80 °C
ClO
HO^X
Cl
445 C 02Et
schem e 2.38
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It was necessary to carry out solution phase model studies for the synthesis of oxindole 449 
prior to attempting the solid phase route in order to establish whether our Pummerer 
cyclisation conditions would tolerate ester functionality on the aromatic ring, a- 
Bromoacetamide 439 was prepared by heating amine 440 with neat bromoacetyl bromide. 
Using benzyl thiol as a model for the thiol resin, reaction with 439 gave sulfide 446 in 
good yield. Sulfoxidation followed by treatment with Pummerer cyclisation conditions, 
TFAA and BF3 OEt2 gave the desired oxindole bearing an ester group, indicating that the 
route tolerates ester functionality on the aryl ring. Cleavage of the benzyl sulfanyl group 
using SmU gave the desired oxindole albeit in modest yield.
ci
ci
C 02Et
440
O
Br
449
80 °C, 
100%
Sml2
DMPU,
THF,
4 9%
ClO
B r^ X
Cl
439
C 02Et
BnS
E t02C 448
BnSH, NEt3
DMF, rt 
74%
ClO
BnS^X
TFAA, BF3» OEt2
1 ,2-dichloroethane, 
82 %
Cl
446
O O
BnS^X
C 0 2Et
H20 2 
HFIP: CH2CI2 
(2 :1), 
quant
Cl
Cl
447  C 0 2Et
schem e 2.39
2.7.2 Solid phase studies
Given that a successful solution phase route had been developed, the sequence was 
attempted on solid phase (scheme 2.40). The a-bromoacetamide 439 was immobilised 
using thiol resin. IR spectroscopy showed the carbonyl stretches indicating that 
immobilisation had occurred successfully. Solid state NMR was also used to show that 
immobilisation and sulfoxidation had occurred successfully. However, in contrast to the 
solution phase reactions, cyclisation and SmU cleavage gave the desired oxindole 449 in
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poor yield, low purity and the reaction proved difficult to reproduce. It is hard to explain 
the discrepancy between the solution and solid phase results as the progress of the solid 
phase reactions are difficult to monitor and it was not easy to identify at which stage the 
problem lay.
439
SH
372
450
C 02Et
451
IR C=0 
1716,1687 cm ’1
TFAA, BF3.OEt2, 
1,2-dichloroethane, 
rt
DMPU.THF, rt
452
1 2 % yield 
impure
449
schem e 2.40
A possible explanation for the poor results from solid phase is that the Lewis acidic nature 
of the Sm (III) by-products present in the cleavage step is promoting decomposition of the 
product oxindole 449. The carbonyl group of oxindole 449 is very electrophilic due to the 
electron withdrawing character of the aryl groups on nitrogen and is therefore succeptible 
to nucleophilic attack. The solid phase reaction time is longer than in solution, prolonged 
exposure to Lewis acid which may be resulting in decomposition of the product.
Although the solid phase route did not prove to be as effective as we had expected we 
believe that the problems can be attributed to the instability of the substrate. Some 
alternative oxindole kinase p38 inhibitor analogues could be made using this methodology 
by changing the dichlorophenyl group to a less electron withdrawing hydrophobic moiety 
such as cyclopropyl.
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2.8 Conclusions
In conclusion, we have described the first Pummerer cyclisations on solid phase. The 
cyclisation reactions are enabled by the sulfur atom linking the substrate to the resin. 
Crucially, the sulfur link remains intact during the cyclisation allowing further solid phase 
modification of the basic heterocyclic scaffold. The generality of the approach has been 
investigated by preparing a range of oxindoles. The sulfur linking atom has been used a 
second time in a different oxidation state to assist further elaboration of the oxindole. 
Attempts to build up the cyclisation step stepwise on solid-phase were not successful and 
this will require further investigation.
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Chapter 3: A Fluorous phase, Pummerer cyclative capture strategy for the synthesis 
of A-Heterocycles
3.0 Introduction to fluorous phase synthesis
Fluorous phase synthesis has become a useful tool for organic synthesis. ’ ’ The main 
advantage of using fluorous phase chemistry is in the ease with which fluorinated 
components of a reaction can be separated from non-fluorinated organic molecules or 
reagents.
3.0.1 Fluorous biphasic systems (FBS)
The earliest application of fluorous molecules was in fluorous biphasic catalytic systems. 
In a fluorous biphasic reaction the immiscibility of fluorous solvents with conventional 
organic solvents is exploited. For example, a fluorous catalyst is present in the fluorous 
phase and the organic phase contains the substrate to be involved in the reaction together 
with organic reagents. The reaction is heated and the two phases combine, becoming 
homogeneous and allowing the catalytic reaction to take place. After the reaction is 
complete, the mixture is allowed to cool and the two phases separate again. The fluorous 
catalyst is in the fluorous phase and can be recovered and re-used, while the desired 
product can be found in the organic phase. An example of a fluorous palladium-catalysed 
Suzuki reaction carried out by Bannwarth is shown in scheme 3.1.74 A fluorous bis- 
triphenylphosphane palladium complex was synthesised and employed in the Suzuki cross 
coupling of aryl bromide 453 with phenyl boronic acid to give biaryl 454. The reaction was 
carried out in a mixture of PFMC (perfluoromethylcyclohexane) and dimethoxyethane. 
The catalyst was recovered from the fluorous phase after the reaction and re-used several 
times. After recycling the catalyst six times the yield had not significantly diminished.
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schem e 3.1
3.0.2 Fluorous liquid-liquid extraction
Following on from the idea of fluorous biphasic reactions, the technique of fluorous liquid- 
liquid extraction (F-LLE) for the separation of fluorous from non-fluorous organic 
molecules was utilised. Fluorous solvents such as perfluoroalkanes, perfluoroethers and 
perfluoroamines are generally immiscible with organic solvents. Fluorous molecules are 
soluble in fluorous solvents due to favourable fluorine-fluorine interactions. This property 
of fluorous solvents can be used to extract fluorous molecules from an organic phase into a 
fluorous solvent phase.
Curran has employed this technique in the purification of allyl alcohols prepared by the 
allylation of aldehydes using a fluorous allylstannane reagent (scheme 3.2) . 75 Aldehyde
457 was heated with fluorous allylstannane 456. At the end of the reaction the crude 
mixture contains product alcohol 458 and fluorous tin products. The crude reaction mixture 
was partitioned between acetonitrile and perfluorohexanes (FC-72), fluorous tin products 
should partition into the fluorous layer whilst the desired alcohol 458 should remain in the 
acetonitrile layer. The layers were separated and the acetonitrile layer was extracted two 
more times with FC-72 to ensure that the fluorous tin products had been completely 
removed. After evaporation of the solvent from the acetonitrile layer, the desired product
458 was obtained in high purity.
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j^J£'ss / Sn(CH2CH2C6F 13)3
schem e 3.2
A limitation of fluorous liquid-liquid extraction is that a high partition co-efficient in 
fluorous solvent is necessary if the technique is to be effective. The molecule must have a 
very high fluorine content to be soluble in the fluorous liquid phase. It has been estimated 
that the fluorine content must be approximately 60 % of the molecular weight of the 
molecule for effective liquid-liquid extraction. In recent years attention has turned to the 
technique of fluorous solid phase extraction (FSPE) for the separation of fluorinated and 
non-fluorinated molecules.
3.0.3 Fluorous solid phase extraction (FSPE)
Fluorous solid phase extraction is a technique which allows simple, convenient separation
of fluorous tagged compounds from non-fluorous compounds using fluorous reverse phase
1(\silica gel (FRPSG). Fluorous reverse phase silica 460 is prepared by treatment of normal 
silica gel with a silyl chloride bearing a perfluoroalkyl chain as shown in scheme 3.3.
CISi(Me)2CH2CH2C6F13 
silica-OH , silica-OSi(Me)2CH2CH2C6F13
459  base 460
schem e 3.3
Several other fluorous reverse phase silica columns with branched fluorous chains have 
also been developed. Organic compounds are eluted from these columns in order of 
decreasing polarity. Fluorous silica was originally used by analytical chemists in standard 
reverse phase HPLC columns for the separation of organic compounds. Fluorous reverse 
phase silica gel was found to be superior to normal reverse phase silica columns in that 
they did not retain organic compounds as readily, and therefore gave better separation.
Fluorous reverse phase silica columns were found to show special separation properties 
with fluorous tagged molecules. It was found that these columns retained fluorous tagged
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molecules to a much greater degree than one would expect based on the polarity of the 
molecule. Fluorous-fluorous interactions between the tagged molecule and the fluorous 
column cause molecules with greater fluorine content to be retained on the column longer. 
Fluorous molecules are eluted from these columns based on fluorous tag length instead of 
polarity.
A typical fluorous solid phase extraction (FSPE) procedure involves loading a crude 
reaction mixture containing fluorous tagged and non-fluorous organic molecules onto a 
fluorous silica column. Elution with a fluorophobic solvent system such as 80 % MeOH / 
H2O removes non-fluorinated compounds from the column. The fluorous tagged molecules 
are retained due to their strong fluorous-fluorous interactions with the fluorous silica. The 
column is then eluted with a fluorophilic solvent system such as MeOH which removes the 
fluorous tagged molecule from the column in high purity.
A major advantage of FSPE over F-LLE is that a much lighter fluorous tag can be used. 
The fluorous tagged molecule can be 40 % or less by molecular weight and separation 
from non-tagged organic molecules is still highly effective. Since the development of 
FSPE the application of fluorous techniques in synthesis has rapidly increased in 
popularity. Within organic synthesis, the fluorous phase has been employed in several 
ways.
The utility of FSPE can be demonstrated by considering fluorous reagent systems. 
Fluorous versions of many reagents such as DEAD, triphenylphosphine, organotin and 
organoselenium reagents have been developed. Non-fluorous versions of these reagents 
and their by-products are often difficult to separate from the products of a reaction. 
Fluorous solid phase extraction (FSPE) can be used to remove these reagents at the end of 
a synthetic transformation. As with polymer bound reagents, an excess of fluorous reagents 
can be used to drive reactions to completion, these reagents can be separated easily from
the product molecules at the end of the reaction. In the example shown in scheme 3.4 a
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fluorous phosphine was employed in the Staudinger reaction. Azide 461 was treated with 
fluorous tagged phosphine 462 followed by water to give amine 463. Normally, the 
triphenylphosphine oxide generated in this reaction is difficult to remove. However, the 
fluorous tagged phosphine 463 employed here can easily be separated using FSPE to give 
the desired amine 463 in very high purity. This example highlights how a single “light”
103
fluorous tag is sufficient for FSPE to be successful. F-LLE would require higher fluorine 
content in the fluorous triphenylphosphine.
schem e 3.4
Fluorous reagents, fluorous scavengers, fluorous ligands, fluorous protecting groups and 
fluorous tags are just some of the ways in which fluorous technology has been employed 
since the development of the very useful FSPE technique.
3.0.4 Fluorous thiols
Several fluorous thiols with varying lengths of perfluoroalkyl chains are commercially 
available Fig 3.1.
Rf = C3F7 
C4F9 
6^^ 13
(CF2)4CF(CF3)2 
(CF2)6CF(CF3)2 
C8F17
c 10h 21
Fig 3.1
These fluorous thiols each contain a two carbon spacer unit between the perfluoroalkyl 
chain and the thiol functional group. This spacer unit minimizes the strong electron 
withdrawing effect of the perfluoroalkyl group such that nucleophilicity at the sulfur is 
maintained. Fluorous thiols such as these have been employed in several ways in organic 
synthesis.
Fluorous thiol 467 has been employed by Zhang as an alkyl halide scavenger in N-
no
alkylation reactions (scheme 3.5). Amine 464 was alkylated with an excess of a- 
bromoketone 465. After the alkylation is complete the crude reaction mixture contains a 
mixture of A-alkylated product 466 and excess a-bromoketone 465. IH, 1H, 2H, 2H-
R,-— SH
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Perfluorooctanethiol 467 was added in order to scavenge the excess alkyl halide 465 by the 
formation of fluorous tagged sulfide 468. The desired product 466 was then separated from 
sulfide 468 using FSPE. Eluting with 80 % MeOH / H2O gave the amine 466 in good yield 
and high purity. Fluorous sulfide 468 was obtained by eluting with MeOH. A range of 
tertiary amines were synthesised in this manner using FSPE to assist purification. Products 
were obtained in yields ranging from 75-95 % and HPLC purities from 80-95 % 
demonstrating that fluorous thiols can act as effective scavenging reagents for the removal 
of unreacted alkylating agents from reaction mixtures. It is interesting to note that the use 
of a fluorous thiol scavenger is superior to the use of a polymer supported thiol scavenger 
since the scavenging reaction takes place much faster under the homogeneous solution 
phase conditions involved.
CO™
464 
1 eq
OMe466
467OTHF
excess
MeO' 2.5 eq
465
MeO'
465 
2 eq FSPE
MeOH
MeO' 468466 OMe
93 % yield 
89 % HPLC purity
scheme 3.5
In similar work, Lindsley has employed the same fluorous thiol as a scavenger of excess
IQalkyl halide in A-alkylation of a primary amine (scheme 3.6). a-Bromoester 469 was 
treated with phenethylamine. Excess bromide 469 was scavenged using fluorous thiol and
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following FSPE, the desired A-alkylated product was obtained in excellent yield and 
purity.
1 .
4 1 ,  Ph— NH2 ,  eq  F.SPE H 94% y|e |d
^ > 9 8 % p u r i t y
PS-DIEA, THF, rt
1.3 eq  470
469 2’ C6F13' ^ SH
1 eq
schem e 3.6
Fluorous thiols have also been used as phase tags. As in solid phase synthesis where a 
polymer resin is used to immobilise a substrate during a multi-step synthetic sequence and 
to assist the purification throughout the synthesis; functionalised fluorous chains can be 
linked to substrates and act as a phase tag during a synthetic sequence. Zhang has 
employed fluorous phase tags in the synthesis of disubstituted pyrimidines (scheme 3.7 & 
3.8) . 80 2,4-Dichloro-6-methylpyrimidine 471 was treated with 1H, 1H, 2H, 2H- 
perfluorodecanethiol to give a mixture of fluorous tagged chloropyrimidines 472 and 473. 
Flash chromatography on normal silica gel was used to separate the isomers, the major of 
which was used in subsequent steps.
ci ,f , ^ sh c,f „ ^ sy y  ciw
N^N -------------------- ► N^N nY N
I DIPEA, T A
Cl THFDMF Cl
471 69%  23%  C8F17
472 473
schem e 3.7
Fluorous tagged pyrimidine 472 was treated with pyrazole 474 under basic conditions 
which resulted in nucleophilic substitution at chlorine to give 475. The sulfur atom in the 
fluorous tag was then activated by oxidation to the sulfone 476 using Oxone®. The 
fluorous tag then underwent nucleophilic displacement upon treatment with 3-amino 
pyridine to give disubstituted pyrimidine 477. An important feature of this synthetic 
sequence is that at each stage FSPE can be used to allow convenient, easy purification. In 
the final cleavage step, the crude reaction mixture containing the fluorous tag, the desired 
product, DIPEA and excess amine were loaded onto a fluorous silica column which
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contained a small amount of acidic ion-exchange resin (Amberlite CG-50) on top. Eluting 
with 80 % MeOH / H2O gave the desired product 477 in high purity. The fluorous tag was 
retained by the fluorous silica and the excess amines were retained by the ion-exchange 
resin. A range of different nucleophiles were used in the cleavage step to produce a small 
library of disubstituted pyrimidines in yields ranging from 74-93 % with HPLC purities of 
89-97 %.
F3 C ^N'nh
C8F17 !YV-
4 7 4  CsF!
472
N ^ n
Cl
DIPEA, K2C 0 3, 
DMF
FSPE
Oxone®, CsF17'
476
475
CF3
n h 2
DIPEA,
THF
FSPE
74 % yield 
93 % HPLC purity
schem e 3.8
3.0.5 Advantages of using fluorous phase tags
The use of fluorous phase tags in organic synthesis instead of polymer beads offers many 
advantages. Fluorous phase reactions are carried out in solution phase as “light” fluorous 
tagged molecules are very lipophilic and highly soluble in organic solvents. Since the 
tagged molecule and the reagents are homogeneous in organic solvent during the reaction, 
the kinetics of fluorous phase reactions are much faster than solid phase reactions. 
Reactions can be monitored by conventional methods such as NMR and TLC therefore a 
fluorous phase synthetic route can be developed and optimised much quicker and easier 
than an analogous solid phase route. Purification is made trivial by employing the FSPE 
technique. As with solid phase synthesis, an excess of reagents can be used to drive 
reactions to completion. These excess reagents can be easily removed using FSPE. The use
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of fluorous phase tags therefore offers the advantages of solution phase synthesis whilst 
retaining the advantages offered by solid phase synthesis.
3.1 Fluorous phase, Pummerer cyclative capture strategy for the synthesis of N- 
heterocycles
Although a successful route to oxindoles using the first Pummerer cyclisations on solid 
phase has been developed, our methodology has some limitations. As with all solid phase 
processes, due to the limited methods available for monitoring reactions on solid support, 
the synthetic route took a long time to develop and optimise. In addition, several steps on 
resin are necessary to access the basic heterocyclic framework (i.e. immobilisation, 
oxidation and cyclisation). We sought to address these limitations in two ways. Firstly, by 
using a fluorous phase tag instead of polystyrene resin; this would overcome some of the 
inherent limitations of solid phase synthesis. Secondly, we proposed to develop a novel 
method of carrying out the Pummerer cyclisation; using a cyclative capture strategy. Our 
strategy involves introducing the fluorous phase tag and constructing the heterocyclic 
framework in a single synthetic operation (scheme 3.9).
The approach is based upon the addition of fluorous thiols to a glyoxamide 478, generating 
a hemi-thioacetal intermediate 479, which is at the correct oxidation level for activation 
and Pummerer cyclisation. Therefore, in one-step, the substrate is captured by a fluorous 
thiol triggering cyclisation to give a heterocycle with the fluorous phase tag incorporated. 
The phase tag can then be used to assist in further elaboration of the heterocyclic 
framework. At the end of the synthesis the fluorous tag can be cleaved under mild, electron 
transfer conditions using Sml2 . The use of a fluorous phase tag allows reactions to be 
monitored conveniently and purification at each stage is simple using FSPE (scheme 3.9).
It should be noted that this is a novel approach to the Pummerer cyclisation in which the 
sulfonium ion intermediate is generated from readily accessible glyoxamide substrates via 
a hemi-thioacetal, in a single synthetic operation. This is in contrast to the more 
conventional approaches to the Pummerer reaction in which the sulfonium ion intermediate 
is usually accessed from a sulfoxide substrate. In this work, this novel reaction has been 
applied primarily to the construction of oxindoles, however it has the potential for 
application in the synthesis of a range of interesting targets.
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3.2 Results and discussion
3.2.1 Synthesis of glyoxamide substrates for cyclative capture
Glyoxamides can be synthesised in three steps from secondary amines. 81 An example is 
shown in scheme 3.10. Secondary amine 484 was coupled with acetoxyacetic acid using 
EDCI and HOBt to give a-acetoxyamide 485 in 74 % yield. Hydrolysis of the acetate 
group gave hydroxyamide 486 in 77 % yield. No purification was required after either of 
these steps. Oxidation of hydroxyamide 486 using Swem oxidation conditions gave the 
desired glyoxamide 487. The crude NMR of the glyoxamide is complex as the glyoxamide 
exists in equilibrium with the corresponding hydrate. It is therefore difficult to determine a 
yield for the oxidation. The crude product was therefore used without further purification.
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EDCI, HOBt, A c O ^ K
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K2 CO3 ,
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O
HO^A
484 485
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(COCI)2, 
NEt3, DMSO, 
CH2CI2
V-
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scheme 3.10
In practice, our Fluorous phase, Pummerer cyclative capture strategy was highly effective 
in the synthesis of oxindoles. As shown in scheme 3.11, addition of fluorous thiol 479 to 
glyoxamide 487, followed by successive treatment with TFAA and BF3 OEt2 gave the 
desired fluorous tagged oxindole 488 in 65 % yield after purification using FSPE. 
Cleavage of the fluorous tag with Sml2 followed by FSPE gave oxindole 489 in excellent 
yield.
TFAA, b f 3 OEt2,
c h 2c i2
65%
FSPE
scheme 3.11
Table 3.1 summarises the glyoxamides synthesised for use in our cyclative capture 
approach. All glyoxamides were prepared using an analogous 3 step route to that shown in 
scheme 3.10. Yields for a-acetoxy amides are based on the coupling of acetoxyacetic acid 
with the corresponding secondary amine.
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a-acetoxyamide glyoxamidea-hydroxamide
492491490 74% 95%
87% 99%
495494493
70%96%
498497496
77%74%
487486485
93% 96%
501500499
Table 3.1
3.2.2 Fluorous, Pummerer cyclative capture
The readily accessible glyoxamide substrates were treated with 1H, 1H, 2H, 2H- 
perfluorodecane-1-thiol (C8F 17CH2CH2SH) 479 which resulted in capture of the substrate 
and hemi-thioacetal formation. In the same reaction pot, activation with TFAA followed by 
treatment with BF3 OEt2 gave the product heterocycles in good isolated yield after rapid 
purification using fluorous solid-phase extraction. The N-heterocycles synthesised by 
fluorous phase, Pummerer cyclative capture of a range of glyoxamides are shown in table 
3.2. Yields are overall isolated yields for the 2 steps from the corresponding a- 
hydroxyamide.
I l l
glyoxamide tagged W-Heterocycle
59%
492 502
85%
495 503
80%
498 504
65%
487 488
45%
501 505
Table 3.2
Neutral and electron deficient fluorous tagged oxindoles were synthesised in good yield 
using this methodology. A tetrahydroisoquinolinone was also synthesised, demonstrating 
that it is possible to apply this strategy in the synthesis of heterocycles with larger ring- 
sizes.
It would be useful to synthesise heterocycles bearing ester functionality on the aromatic 
ring as this would be amenable to further modification. Glyoxamide 508 which bears an
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ethyl ester in the para position was synthesised with a minor modification to the normal 
route (scheme 3.12). The cyclative capture strategy was applied to glyoxamide 508, 
however, the desired oxindole 509 was not obtained. The crude NMR indicated that the 
fluorous thiol had not undergone addition to glyoxamide 508.
C 02Et
acetoxyacetic acid, aco  J l  
EDCI, HOBt, ^ N '
CH2CI2, rt, 
44%
506C 02Et
S
O
1. K2C 0 3, H C X - X
MeOH:H20 , ^
2 . TMSCH2N2, 
Tol:MeOH(5:1)
73%  
(2 steps)
TFAA, BF3 OEt2, 
CH2CI2
507 C 02Me
(COCI)2,
NEt3,
DMSO,
CH2CI2
H
509 508
scheme 3.12
A possible explanation for the lack of reactivity of the glyoxamide can be understood by 
considering the position of the equilibrium between the glyoxamide 508 and its hydrate
cyy
(scheme 3.13). Where the aromatic ring does not bear a strongly electron withdrawing 
group in conjugation with the nitrogen atom, the equilibrium should lie towards the 
glyoxamide, however, in this substrate the ester group lies para to the nitrogen and 
therefore the hydrate should predominate as the aldehyde group of the glyoxamide is more 
electron deficient. In this substrate, the hydrate appears not to react with the fluorous thiol 
and therefore Pummerer cyclisation does not take place. The NMR of the crude reaction 
mixture after the Swem oxidation of 507 suggests that the hydrate is formed exclusively 
since the usual aldehyde proton is not observed. A possible solution to this problem is to 
synthesise a glyoxamide with the ester functionality in the meta position, thus avoiding 
direct conjugation with the lone pair on nitrogen.
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3.3 Modification of the heterocyclic framework post cyclisation
3.3.1 Modifications at the a-position
After conveniently accessing fluorous-tagged heterocycles by the Pummerer cyclative 
capture process, the tagged-heterocycles can be modified in a variety of ways. The sulfur 
atom linkage to the fluorous phase tag can be used to facilitate elaboration at the a- 
position. Some a-alkylations are shown in scheme 3.14.
2. BrCH2C 02Et 
FSPE
89%
503
LDA, LiCI, 
Mel, -78 °C, THF,
FSPE
96%
511
scheme 3.14
Oxindole 512 was prepared by O-acylation followed by DMAP catalysed rearrangement to 
give the C-acylated product (scheme 3.15).83
s
504 F
1. CIC(0)0Me, 
NEt3, CH2CI2
2. DMAP, t o l , 70°C 
FSPE
58%
MeO'
512
s c h e m e  3 .15
114
The Michael addition of oxindole 503 to methyl acrylate was investigated. The use of LDA 
led to a mixture containing only 35 % yield of the desired product 513.
o
o o
LDA, LiCI
+ by-product
-78 °C, THF, 
35% + SM
Br Br503
513
schem e 3.16
The by-product(s) was thought to arise from the enolate generated after the first Michael 
addition (Fig 3.2), undergoing further reaction with methyl acrylate. The use of only one 
equivalent of base and methyl acrylate did not prevent by-product formation or the 
recovery of starting material. The use of LHMDS as a base gave similar results.
These results suggested that the enolate of the Michael adduct was more reactive than the 
enolate of the oxindole. The use of a protic solvent to protonate the enolate as soon as it 
was formed was felt to be necessary and the use of sodium methoxide in methanol gave 
the Michael adduct 513 in good yield. All the starting material was consumed and no by­
product was observed (scheme 3.17).
o
Fig 3.2
O O
Br
NaOMe, MeOH
methyl acrylate, 
rt
FSPE
71 %
Br
503 513
s c h e m e  3 .17
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Crucially, in all of these modification reactions, excess reagents can be used to drive the 
reactions to completion. Purification after each modification step can be carried out 
conveniently using FSPE.
Oxidation of the sulfur atom linkage to the sulfone oxidation state allows modifications at 
the a-position to be carried out under much milder conditions. As shown in scheme 3.18, 
mCPBA oxidation of the sulfide 514 to sulfone 515 enables a-alkylation to be carried out 
using mild bases such as K2CO3 . FSPE can again be used at each stage to assist 
purification.
503
/nCPBA,
CH2CI2i
79%
FSPE
Me
515
k 2c o 3,
Mel,
DMF,
40°C
K2C 0 3, 
Kl, BnBr, 
DMF, 
40°C,
514
FSPE FSPE
O
Bn
516
92% 94%
scheme 3.18
Similarly, sulfide 502 can be oxidised to the sulfone 517 in excellent yield. Sulfone 
assisted alkylation gave the desired modified oxindole 518 in quantitative yield (scheme 
3.19).
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3.3.2 Modifications using palladium-catalysed cross couplings
We aimed to diversify the fluorous tagged heterocycles through palladium catalysed cross 
couplings utilising halide functionality on the aromatic ring. Initially the Heck reaction of 
oxindole 503 was attempted (scheme 3.20). Unfortunately, no reaction occurred and 
starting material was recovered. It was considered that it might be necessary to block the 
enolisable a-position. Oxindole 511 bearing an a-methyl group was therefore prepared and 
subjected to the Heck reaction but again no palladium catalysis was observed.
503
Methyl acrylate, 
Pd(OAc)2, x -
NEt3
P(o-Tol)3,
xylene,
100 °C OMe 519
Methyl acrylate, 
Pd(OAc)2,
 ..................V -
NEt3
P(o-Tol)3,
xylene,
100 °C
scheme 3.20
Since no catalytic activity had been observed, it was postulated that the structure of 
fluorous tagged oxindoles such as 503 could be inhibiting catalysis. In the oxindole
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substrates the carbonyl oxygen atom and the sulfur atom are locked in a cis conformation, 
this makes them potentially excellent chelating ligands for palladium. Strong chelation to 
palladium would prevent the metal becoming involved in the catalytic cycle (Fig 3.3).
Fig 3.3
In order to further investigate this hypothesis an uncyclised a-alkylsulfanyl-Af-arylamide 
522 was synthesised (Scheme 3.21). In substrates such as 522 there is free rotation around 
the C-S bond and therefore it is likely to be a less effective metal chelator. The Heck 
reaction on 522 was indeed successful which lends support to the idea that the tagged 
oxindole structure itself is inhibiting palladium catalysis.
o
Br
521
NEt3l 
DMF, 
rt, 
75 %,
FSPE
Br
522
methyl acrylate, 
Pd(OAc)2, 
NEt3 
P(oTol)3, 
xylene, 
100°C, 
43%
MeO.
523
scheme 3.21
Palladium catalysed reactions on a compound such as 510 may be more successful if the 
sulfide is oxidised to the sulfone 514. In the sulfone the sulfur lone pairs are no longer
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available for chelation to palladium. The Heck reaction of sulfone 514 with methyl acrylate 
was attempted (scheme 3.22). On this occasion some catalysis was observed. Heck 
reaction on the aryl ring took place, however, the increased acidity of the a-proton in the 
sulfone resulted in Michael addition to methyl acrylate. The major product of this reaction 
was 524 (impure, yield not obtained), suggesting that blocking the a-position would be 
necessary to prevent competing reaction occurring.
Methyl acrylate, 
Pd(OAc)2, 
NEt3
MeO.
P(oTol)3f 
xylene, 
100 °C 524MeO.
scheme 3.22
514
The Heck reaction of a-blocked sulfone 515 was sluggish and gave only a trace of product 
after 24 h. Since substrates which showed some activity in palladium catalysed reactions 
had been identified, we decided to test them in other palladium catalysed transformations 
such as Sonogashira reactions (Scheme 3.23). These reactions proved very successful and 
coupled products were obtained in excellent yields. FSPE proved very useful in the 
purification of these modified oxindole products.
Me
515
Pd(PPh3)4, 
propargyl alcohol, 
NEt3, 80°C
FSPE
Pd(PPh3)4, Cul 
NEt3, 80°C
TMS—^
FSPE
Me
HO 525
60%
V/
Me
526TMS
82%
s c h e m e  3 .23
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Suzuki couplings (scheme 3.24) of tagged 5-bromo-oxindoles also proved very successful. 
In each case excess boronic acid could be used to drive the reactions to completion. At the 
end of the reaction FSPE effectively removed the excess acid together with by-products 
from the palladium tetrakis(triphenylphosphine), to give modified fluorous tagged 
oxindoles in high purity.
Me"
515
Bn"
516
Pd(PPh3)4, 
Na2C 0 3 (aq),
4-methylbenzene 
boronic acid, 
H20
1,4-dioxane, 80 °C 
FSPE
Pd(PPh3)4l 
Na2C 0 3 (aq),
2 -thiopheneboronic acid 
H20
1,4-dioxane, 80 °C
FSPE
527
O
Bn"
528
87%
92%
Bn"
516
Pd(PPh3)4, 
Na2C 0 3 (aq),
3-pyridine boronic acid 
H20
1,4-dioxane, 80 °C 
FSPE
scheme 3.24
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Bn"
529
72%
3.4 Traceless cleavage of the fluorous tag
At the end of the synthetic sequence, the fluorous phase tag can be removed in a traceless 
manner by reduction with Sml2 . No additives were required to activate Sml2 regardless of 
whether the sulfur atom was in the sulfide or the sulfone oxidation state. Treatment of a 
fluorous tagged heterocycle with the linking sulfur atom in the sulfide oxidation state with 
Sml2 at room temperature, gave the desired heterocycle after cleavage. FSPE can again be 
used to assist purification, the desired product eluting in the non-fluorous fraction, thereby 
separating it from the fluorous thiol tag. Fig 3.4 summarizes the heterocycles produced by 
Sml2 cleavage of the fluorous phase tags at the sulfide oxidation state.
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Fig 3.4
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For cleavage of fluorous sulfones, treatment of the fluorous tagged heterocycles with Sml2 
at room temperature gave the desired product. No further purification was required as the 
fluorous component was lost to the aqueous layer during work up.
Fig 3.5 shows the heterocycles obtained by Sml2 cleavage of the fluorous phase tag in the 
sulfone oxidation state.
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3.5 Conclusions
In conclusion, we have developed a new strategy for the fluorous phase synthesis of N- 
heterocycles libraries. The sequence involves several key features; a fluorous phase, 
Pummerer cyclative capture strategy for rapid access to tagged, heterocyclic frameworks; 
modification of the fluorous heterocyclic scaffolds using a variety of approaches including 
palladium catalysed cross couplings; traceless, reductive removal of the fluorous phase tag. 
The use of a fluorous phase tag has enabled us to overcome some of the limitations 
associated with our solid phase Pummerer sequence, allowing us to expand some of its 
generality.
3.6 Future work
There are several areas in which our fluorous phase Pummerer cyclative capture strategy 
can be further developed and applied for the high throughput synthesis of heterocycles.
3.6.1 Cyclative capture of glyoxamides bearing nitrogen protecting groups
Many biologically active nitrogen heterocycles contain a free NH group (see fig 2.1). The 
preparation of heterocycles by Pummerer reaction has been shown to require a substituent 
on nitrogen for successful cyclisation. 84 In order to apply our Pummerer, cyclative capture 
approach to the synthesis of these heterocycles it is necessary to develop a protecting group 
strategy to temporarily mask the nitrogen atom and thus enable cyclative capture. We 
therefore need to identify a suitable protecting group and to find a route to a glyoxamide 
substrate such as 544 (scheme 3.25). Following cyclative capture to give fluorous tagged 
heterocycle 545, removal of the A-protecting group and cleavage of the tag will yield the 
desired heterocycle 547 with a free NH group. The protecting group used must be stable 
under the Lewis acidic conditions used in the cyclisation reaction.
)n
Y-H
544
SH
545
removal of 
protecting group
cleavage ofNH
1= protecting group p hase  tag
Y—r!
547
schem e 3.25
This approach will also allow us to synthesise libraries of compounds with different 
substituents on nitrogen.
3.6.2 Intermolecular Pummerer reactions
It would be interesting to investigate whether our one-pot approach to the Pummerer 
reaction could be applied in an intermolecular sense85 (scheme 3.26). Addition of fluorous
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thiol to glyoxylates such as 548 (or glyoxamides) would generate an intermediate hemi- 
thioacetal 549 from which a sulfonium ion 550 can form. Nucleophiles such as 551 should 
undergo addition to sulfonium ion 550 to give 552. The fluorous tag can be used to assist 
in purification after further modifications. It is necessary to explore the scope of the 
nucleophiles which can be used in this intermolecular Pummerer reaction. For example, the 
use of silyl enol ethers, allyl silanes and electron rich aromatics would be examined 
initially.
•SH
0<^ ^ O E t
548
‘OEt
OH 550549
O
OEtModificationremoval
of tag
553 552
554 o ^ J
schem e 3.26
3.6.4 Sequential Sml2 cleavage-diversification
Sml2 cleavage of the phase tag may present an opportunity to introduce further 
diversification into the product heterocycle. Treatment of the fluorous tagged heterocycle 
555 with Sml2 results in reductive cleavage of the tag and the formation of a samarium 
enolate 556. If an electrophile such as an aldehyde or ketone is present in the cleavage 
reaction then it may be possible to trap the enolate to give modified heterocycles such as 
557.
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schem e 3.27
3.6.3 Fluorous mixture synthesis
To further explore the utility of our methodology in high throughput synthesis we aim to 
undertake the construction of a small library of heterocycles using fluorous mixture 
synthesis. Fluorous mixture synthesis relies upon the principal that molecules bearing 
fluorous tags of varying fluorine content can be separated using fluorous HPLC (F-HPLC). 
Curran has applied fluorous mixture synthesis in the synthesis of analogues of
OiT
discodermolide and in the production of a 560-member library of Mappicine analogues 
559 (Fig 3.6) . 87
HO
(S)-mappicine 558
Fig 3.6
HO
mappicine analogues 559
The basic outline for construction of the library is shown in scheme 3.28. Seven different 
pyridinyl alcohols each bearing a different Rj group were attached to seven different 
fluorous phase tags of varying fluorine content. After conversion to pyridones 561 these 
compounds were mixed and split into eight portions. Each of these portions was TV- 
alkylated in parallel with eight different propargyl bromides. After alkylation, each portion 
was further split into ten portions and each portion was reacted in parallel with a ten 
different isonitriles. This gave eighty mixtures each containing seven different tagged 
heterocycles. The seven different tagged heterocycles in each mixture were separated from 
each other on the basis of the length of their fluorous phase tag using F-HPLC. Following 
separation by F-HPLC, de-tagging gave 560 different mappacine analogues in high purity.
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As shown in scheme 3.29, fluorous thiols of varying fluorine content can be added to 
different glyoxamides to give a range heterocycles with different fluorous tags 
incorporated. [Note that a range of fluorous thiols are commercially available.] The tagged 
heterocycles can be mixed together and split and each mixture exposed to different 
modification reactions. Each mixture of tagged products can then be de-mixed by F-HPLC 
and finally de-tagged to give a library of modified heterocycles.
It is easy to see how the simple fluorous mixture using our Pummerer cyclative capture 
approach shown in scheme 3.28 could be extended to make large libraries of N- 
heterocycles.
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Chapter 4: Experimental Section
General considerations
All experiments were performed under an atmosphere of Ar or N2 , using anhydrous 
solvents unless otherwise stated. Reactions were carried out using oven dried glassware. 
THF was distilled from sodium/benzophenone, CH2CI2 and 'PrNH2 was distilled from 
CaH2 , NEt3 was distilled from CaH2 and stored over KOH under Ar/N2 . DMSO was 
distilled from CaH2 and stored over molecular sieves and under Ar/N2 .
!H NMR and 13C NMR were recorded on a Fourier transform spectrometer, with chemical 
shift values being reported in ppm relative to residual chloroform ( 8 h  = 7.27 or 8 c = 77.2) 
as an internal standard unless otherwise stated. NMR signals were assigned using DEPT - 
135, HMQC and COSY spectra. All coupling constants are reported in Hertz (Hz). Mass 
spectra were recorded at the University of Glasgow using a JEOL JMS-700. IR spectra 
were recorded using a JASCO FT/IR 410 spectrometer. Melting points were measured on a 
Kofler hot stage apparatus and are uncorrected.
Column chromatography was carried out using Fischer Matrex silica gel 60 and 
Fluoroflash silica. Macherey-Nagel aluminium backed plates, precoated with silica gel 60 
(UV2 5 4) were used for thin layer chromatography and were visualised by UV or staining 
with alkali KMn0 4 .
Solid phase reactions were carried out in round bottom flasks and were performed with 
gentle stirring. Commercially available Merrifield resin with a loading of 1.1 mmol/g 
[copoly(styrene-l% DVB), 200-400 mesh] was used. Solvents and soluble reagents were 
removed by water suction after transference of the reaction suspension into polypropylene 
bond elute® cartridges (25 ml or 50 ml fitted with a polyethylene porous disk). THF used 
for washing resin was distilled prior to use in order to remove the BHT stabiliser.
Calculation of the theoretical loading of resins was carried out according to the equation 
reported in the Advanced ChemTech catalogue 1998 plOl as shown below:
128
S (s)
S (th) = ------- ----------------------
/  S (s) x Wt (add) 
\ 1000
S (th) - Theoretical substitution mmol / g 
S (s) - Starting substitution mmol / g 
Wt (add) - g/mol added to resin
General procedure for washing resin
After transferring the resin to a bond elute® cartridge, the resin was washed with the 
following solvents: H20 , THF, THF: H20  (3:1), THF: H20  (3:1), THF: H20  (1:3), THF, 
MeOH, CH2C12j MeOH and THF.
O-Merrifield bound 1,4-butanediol (343)21
Merrifield resin (1.00 g, 1.10 mmol, 1 eq) was swollen in DMF (15 ml) for 15 min. 1,4- 
Butanediol (0.97 ml, 11.0 mmol, 10 eq) and NaH (132 mg, 5.50 mmol, 5 eq) were added 
to the suspension of resin and the reaction was allowed to stir overnight at room 
temperature. The resin was then washed using our standard washing protocol.
IR tw /lc r r f1) 3436 (OH)
01O-Merrifield bound methanesulfonic acid 4-hydroxy-butyl ester (344)
(9-Merrifield bound 1,4-butanediol (300 mg, 0.32 mmol, 1 eq) was swollen in CH2C12 (4 
ml) for 15 min. Methane sulfonyl chloride (0.12 ml, 1.59 mmol, 5 eq ) and triethylamine 
(0.22 ml, 1.59 mmol, 5 eq) was added and the reaction allowed to stir at room temperature 
for 4 h. The resin was then washed using our standard washing protocol.
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IR iW (c m  ') 1355 (S02-0), 1172 (S02-0)
O-Merrifield bound S-(4-hydroxybutyI) thioacetate (345)
q T " 0'
O-Menifield bound methanesulfonic acid 4-hydroxy-butyl ester (300 mg, 0.294 mmol, 1 
eq) was swollen in DMF ( 6  ml) for 15 min. Potassium thioacetate (67.2 mg, 0.59 mmol) 
was then added and the reaction was allowed to stir overnight at room temperature. The 
resin was then washed using our standard washing protocol.
IR tw /Ccrrf1) 1689 (C=0)
O-Merrifield bound 4-mercaptobutanoI (341)
O-Merrifield bound S-(4-hydroxybutyl) thioacetate (300 mg, 0.30 mmol, 1 eq) was 
swollen in THF for 15 min. LiBFLj (0.3 ml of 2 M soln in THF, 0.60 mmol, 2 eq) was then 
added. The reaction was allowed to stir overnight at room temperature. The resin was then 
washed using our standard washing protocol.
2-Bromo-iV-methyl-iV-phenylacetamide (348)88
To a solution of N-methyl aniline (0.33 ml, 3.00 mmol, 1 eq) and NEt3 (0.42 ml, 3.00 
mmol, 1 eq) in CH2CI2 (3.5 ml) at 0 °C was added by cannula, a solution of bromoacetyl 
bromide (0.26 ml, 3.00 mmol, 1 eq) in CH2CI2 (5 ml). The reaction was allowed to stir at 
room temperature for 16 h. CH2CI2 ( 1 0  ml) was then added to the reaction, the organic 
layer was washed with 0.5 M HC1 (3 x 20 ml) and brine (3 x 20 ml). The combined 
organic layers were dried (MgS0 4 ) and concentrated in vacuo, to give 2-bromo-7V-methyl-
o
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A-phenylacetamide 348 (0.60 g, 2.63 mmol, 8 8 %) as a brown solid which was used 
without further purification.
*H NMR (400 MHz, CDC13) 6  3.24 (3H, s, NCH3), 3.65 (2H, s, 7.22 (2H, d, J =
7.3 Hz, 2 x ArH) and 7.31-7.41 (3H, m, 3 x ArH).
13C NMR (100 MHz, CDC13) 6  27.2 (CH2Br), 38.5 (NCH3), 127.4 (2 x ArCH), 128.9 
(ArCH), 130.4 (2 x ArCH), 143.5 (ArQ and 166.9 (C=0).
IR Dnax/^m'1) 3060, 2969, 1662 (C=0), 1594, 1496, 1382, 1226, 1118 and 701 (C-Br).
MS m/z (FAB mode) 228 ((M+H)+, 100%), 227 (20), 199 (5), 148 (17), 106 (11), 92 (3) 
and 69 (3).
CgHnNOBr requires 228.0024, found 228.0023. 
2-Ethylsulfanyl-A-methyl-A-phenylacetamide (349)
o
To a solution of 2-bromo-A-methyl-A-phenylacetamide 348 (70 mg, 0.31 mmol, 1 eq) in 
DMF (4 ml) was added NEt3 (52 pi, 0.37 mmol, 1.2 eq) and ethanethiol (27 pi, 0.37 mmol,
1.2 eq). The reaction was allowed to stir at rt for 2 h. CH2CI2 was added and the reaction 
was washed with water. The organic layer was then dried (MgSCU), and concentrated in 
vacuo to give 2-ethylsulfanyl-A-methyl-A-phenyl-acetamide 349 as a yellow/orange oil 
(54 mg, 0.26 mmol, 84%) which was used without further purification.
*H NMR (400 MHz, CDC13) 5 1.13 (3H, t, J = 7.4 Hz, CH3CH2), 2.60 (2H, q, J = 7.4 Hz, 
CH3CH2), 2.99 (2H, s, CH2CO), 3.22 (3H, s, NCH3) and 7.18-7.29 (5H, m, 5  x ArH).
13C NMR (100 MHz, CDC13) 6  14.7 (CH3), 27.0 (CH2), 33.2 (CH2CO), 38.0 (NCH3),
127.8 (2 x ArCH), 128.4 (ArCH), 130.2 (2 x ArCH), 144.1 (ArQ  and 170.2 (C=O).
IR Dmax^cm'1) 3060, 2965, 2927, 1655 (C=0), 1595 and 1117.
MS m/z (EC mode) 209 (M+, 11%), 149(100), 148(48), 134(22), 107(42), 77(37) and 
58(13).
CnHisNOS requires 209.0874, found 209.0873.
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(±)-2-Ethylsulfinyl-A-methyl-A-phenylacetamide (350)
To a solution of 2-ethylsulfanyl-A-methyl-iV-phenylacetamide 349 (40 mg, 0.19 mmol, 1 
eq) in HFIP (2 ml) and CH2CI2 (1ml) was added 30 % aqueous H2O2 (43 ini* 0.38 mmol, 2 
eq). The reaction was allowed to stir at room temperature for 15 min- The reaction was 
then quenched with aqueous saturated Na2SC>3 solution. The aqueous and organic layers 
were separated and the aqueous layer was extracted with CH2CI2 . The combined organic 
layers were dried (MgSCU) and concentrated in vacuo to give (±)-2-ethylsulfinyl-/V- 
methyl-jV-phenylacetamide 350 as an orange oil (39 mg, 0.18 mmol, 93%) which was used 
without further purification.
]H NMR (400 MHz, CDC13) 8  1.26 (3H, t, J = 7.5 Hz, C //3CH2), 2.7l (1H, m, 1H from 
CH3CH2) , 2.95 (1H, m, 1 H from CH3C//2), 3.44 (1H, d, AB system, J = 13.9Hz, 1H from 
CH2CO), 3.52 (1H, d, AB system, J = 13.9 Hz, 1H from CH2CO), 3.24 (3H, s, NCH3), 
7.16-7.19 (2H, m, 3 x Ar//) and 7.30-7.41 (3H, m, 3 x Ar//).
13C NMR (100 MHz, CDC13) 8  6 . 8  (CH3), 37.9 (NCH3), 46.7 (CH3 CH2) 55.6 (CH2CO),
127.7 (2 x ArCH), 129.1 (ArCH), 130.6 (2 x ArCH), 143.1 (ArC) and 164,7 (C=0).
IR tw A c m 1) 3060, 2965, 2973, 2934, 2360, 1655 (C=0), 1594, 1117, 1020 (S=0).
MS m/z (CI+ mode) 226 ((M+H)+, 57%), 200 (10), 169 (14), 149 (100), 148 (28), 120(25), 
79 (39), 77 (17).
C11H 15NO2S requires 225.0823, found 225.0824 (calculated for M+in EI+ mode).
(±)-l-Methyl-3-ethylsulfanyl-l,3-dihydro-indol-2-one (355)
o
B
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To a solution of (±)-2-ethylsulfinyl-./V-methyl-iV-phenylacetamide 350 (50 mg, 0.22 mmol, 
1 eq) in CCI4 (3 ml) was added anhydrous /?-TsOH (76 mg, 0.44 mmol, 2 eq). The reaction 
mixture was heated at reflux for 2  h. After cooling, CH2CI2 (10 ml) was added and the 
organic layer was washed with water (3 x 10 ml), dried (MgS0 4 ) and concentrated in 
vacuo. The crude product was purified using flash chromatography on silica gel using 40% 
ethyl acetate in petroleum ether as eluant to give (±)-l-methyl-3-ethylsulfanyl-l,3-dihydro- 
indol-2-one 355 (33 mg, 0.16 mmol, 71 %) as a clear oil.
lR  NMR (400 MHz, CDC13) 6  1.57 (3H, t, J = 7.4 Hz, C # 3CH2), 2.50 (1H, m, 1H from 
CH3CH2 ) , 2.67 (1H, m, 1H from CH3C #2), 3.15 (3H, s, N C#3), 4.23 (1H, s, C#CO), 6.75 
(1H, d, J = 7.7 Hz, Ar#), 7.02 (1H, t, J = 7.4Hz, Ar#), 7.23 (1H, t, J = 7.7 Hz, Ar#), 7.31 
(1H, d, J = 7.4 Hz, Ar#).
13C NMR (100 MHz, CDC13) 6  14.6 (CH3), 24.3 (CH3 CH2) 26.8 (NCH3), 45.0 (CHCO),
108.5 (ArCH), 123.2 (ArCH), 125.4 (ArCH), 126.5 (ArQ, 129.3 (ArCH), 144.4 (ArQ and 
175.9 (C=0).
IR iw /tc m '1) 3055, 2964, 2927, 2871, 1718 (C=0), 1611, 1469, 1491 and 1371.
MS m/z (EI+ mode) 207 (M+, 23%), 206 (23), 178 (18), 147 (100), 146 (55), 118 (15), 104 
(15), 91(21), 83 (18), 65 (16) and 44 (21).
ChH13NOS requires 207.0718, found 207.0717.
(±)-3-Hydroxy-l-methyI-l,3-dihydro-indol-2-one (356)89
*H NMR (400 MHz, CDC13) 5 3.12 (3H, s, NC#3), 4.99 (1H, s, C#OH), 6.76 (1H, d, J =
7.8 Hz, Ar#), 7.04 (1H, t, J = 7.6 Hz, Ar#), 7.27 (1H, t, J = 7.8 Hz, Ar#) and 7.39 (1H, d, 
J = 7.3 Hz, Ar#).
13C NMR (100 MHz, CDC13) 6  26.6 (NCH3), 70.2 (CHOH), 108.9 (ArCH), 123.5 (ArCH),
125.5 (ArCH), 127.1 (ArC), 130.3 (ArCH), 144.3 (ArQ and 177.0 (C=0).
MS m/z (EI+ mode) 163 (M+, 82%), 161(19), 146 (13), 134 (17), 118 (20), 106 (100), 77 
(41), 63 (12), 77 (40) and 51 (21).
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(±)-2-EthyIsulfanyI-2-hydroxy-A-methyl-(V-phenylacetamide (357)
o
*H NMR (400 MHz, CDCI3) 5 1.07 (3H, t, J = 7.4 Hz, CH3) 2.51-2.66 (2H, m, Ctf2 S) 3.21 
(3H, s, NCH3), 4.24 (1H, s, CHOH) and 7.25-7.45 (5H, m, 5 x AiH).
13C NMR (100 MHz, CDC13) 6  14.6 (CH3), 24.7 (CH3 CH2), 38.1 (NCH3), 49.3 (CHOH),
127.8 (2 x ArCH), 128.7 (ArCH), 130.2 (2 x ArCH), 143.7 (ArC) and 169 (C=0).
MS m/z (EI+ mode) 209 (M+, 96%), 206 (21), 178 (10), 146 (80), 135 (100), 106 (18), 77 
(20) and 45 (7).
l-Methyl-l,3-dihydro-indoI-2-one (358)65
To a solution of l-methyl-3-ethylsulfanyl-l,3-dihydro-indol-2-one 355 (26 mg, 0.13 mmol, 
1 eq) in THF (1 ml) was added DMPU (0.32 ml, 2.64 mmol, 3 eq) and Sml2 (0.1 M in 
THF, 6.7 ml, 0.67 mmol, 3 eq). The reaction was allowed to stir at room temperature for 1 
h. The reaction was then quenched with H20  (5 ml) and NaHC03 (5 ml) then extracted 
with ethyl acetate (3 x 10 ml). The organic layers were dried (Mg2SC>4 ) and concentrated in 
vacuo. The crude product was purified using flash chromatography on silica gel using 30% 
ethyl acetate in petroleum ether as eluant to give l-methyl-l,3-dihydro-indole-2-one 358 
(24.6 mg, 0.17 mmol, 77%) as a clear oil.
'H  NMR (400 MHz, CDC13) 8  3.14 (3H, s, NCH3), 3.46 (2H, s, CH2CO), 6.75 (1H, d, J =
7.8 Hz, ArH), 6.97 (1H, t, J = 7.5 Hz, AiH) and 7.17-7.24 (2H, m, 2  x ArH).
13C NMR (100 MHz, CDC13) 8  25.1 (NCH3), 34.7 (CH2CO), 107.1 (ArCH), 121.3 (ArCH),
123.3 (ArCH), 123.5 (ArQ, 126.9 (ArCH) 144.2 (ArQ and 174.0 (C=0).
IR iW (c m '')  3058,2942, 2919,1700 (C=0), 1612,1463, 1348 and 754
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MS m/z (EI+ mode) 147 (M+, 90%), 132 (10), 118 (100), 104 (7), 91 (20), 85 (24), 82 (38), 
78 (16), 57 (12) and 47(11)
C9H9NO requires 147.0684, found 147.0684.
4-Benzyloxy-butan-l-oI (365) 90
To a solution of butane-1,2-diol (2 ml, 22.6 mmol, 1 eq) in DMF (45 ml) at 0°C was added 
NaH (434 mg, 18.1 mmol, 0.8 eq). The mixture was allowed to stir at rt for 1 h. Benzyl 
bromide (2.15 ml, 18.1 mmol, 0.8 eq) was added and the reaction allowed to stir at rt for 
2 2  h. H2O ( 1 0  ml) was added to the reaction mixture and the aqueous layer was extracted 
with CH2CI2 (3 x 2 0  ml). The combined organic layers were washed with NaHCC>3 (3 x 20 
ml), dried (MgS0 4 ) and concentrated in vacuo to give a crude yellow oil. The crude 
product was purified by flash chromatography using 50% ethyl acetate in petroleum ether 
as eluant to give 4-benzyloxy-butan-l-ol 365 as a clear oil (1.52 g, 7.96 mmol, 44%).
‘H NMR (400 MHz, CDC13) 8  1.63-1.76 (4H, m, 2 x CH2), 2.22 (1H, s, OH), 3.54 (2H, t, J 
= 6.0 Hz, CH2O), 4.14 (2H, m, CH2OH), 4.55 (2H, s, PhCH2) and 7.28-7.36 (5H, m, 5 x 
AiH).
13C NMR (100 MHz, CDCI3) 8  27.1 (CH2), 30.6 (CH2), 63.2 (Ctf2OH), 70.7 (CH20), 73.5 
(CH2Ph), 128.1 (2 x ArCH), 128.8 (3 x ArCH) and 138.5 (ArC).
MS m/z (EI+ mode): 180 (M+, 6 %), 107 (65), 91 (100), 83 (21), 65 (17) and 43 (6 ).
Ci 1H 16O2 requires 180.1150, found 180.1152.
Methanesulfonic acid 4-benzyloxy-butyl ester (366)91
To a solution of 4-benzyloxy-butan-l-ol 365(183 mg, 0.95 mmol, 1 eq) in CH2CI2 (5 ml) 
was added NEt3 (0.2 ml, 1.43 mmol, 1.5 eq) and methane sulfonyl chloride (0.11ml, 1.43 
mmol, 1.5 eq). The reaction was allowed to stir at rt overnight. The reaction was then 
quenched with NaHCC>3 (5 ml) and the aqueous layer extracted with CH2CI2 ( 3 x 5  ml). 
The combined organic layers were dried (MgSO^ and concentrated in vacuo to give
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methanesulfonic acid 4-benzyloxy-butyl ester 366 as a yellow oil (245 mg, 0.95 mmol, 
1 0 0 %) which was used without further purification.
‘H NMR (400 MHz, CDCI3 ) 5 1.63-1.69 (2H, m, CH2), 1.77-1.84 (2H, m, CH2) 2.90 (3H, 
s, CH3SO2), 3.45 (2H, t, J 6.1 Hz, CH2OMs), 4.19 (2H, t, J 6.4 Hz, CH20), 4.43 (2H, s, 
PhCtf2) and 7.20-7.31 (5H, m, 5 x AiH).
13C NMR (100 MHz, CDCI3) 5 26.1 (CH2), 26.6 (CH2), 37.7 (CH3S 02), 69.7 (CH2OMs),
70.3 (CH20), 73.4 (CH2Ph), 128.1 (3 x ArCH), 128.8 (2 x ArCH) and 138.7 (ArC).
IR W ( c m '')  3029,2938, 2859,1454, 1353 (S0 20), 1174 (S0 20), 941,740.
MS m/z (EI+ mode) 258 (M+, 6 %), 161 (20), 91 (100), 84 (17) and 55 (11).
C 12H 18O4S requires 258.0926, found 258.0927.
Thioacetic acid-S-(4-benzyloxybutyl) ester (367)
O
To a solution of methanesulfonic acid 4-benzyloxy-butyl ester 366 (245 mg, 0.95 mmol, 1 
eq) in DMF (10 ml) was added potassium thioacetate (163 mg, 1.43 mmol, 1.5 eq). The 
reaction was allowed to stir at rt for 2 0  h. H2O ( 8  ml) was added to the reaction mixture 
and the reaction mixture was extracted with ethyl acetate (3 x 10 ml). The combined 
organic layers were washed with NaHCC>3 ( 3 x 5  ml), dried (MgSCU) and concentrated in 
vacuo to give a brown oil. The crude product was purified by filtration through a pad of 
silica gel using 30 % ethyl acetate in petroleum ether as eluant to give thioacetic acid-S-(4- 
benzyloxybutyl) ester 367 (210 mg, 0.88 mmol, 93 %) as a yellow oil.
'H  NMR (400 MHz, CDC13) 8  1.57-1.65 (4H, m, 2 x CH2), 2.25 (3H, s, CH3CO), 2.81 
(2H, t, J = 5.9 Hz, CH2), 3.40 (2H, t, J = 5.9 Hz, CH2), 4.42 (2H, s, PhC//2), 7.20-7.29 (5H, 
m, 5 x Ar//).
13C NMR (100 MHz, CDCI3) 8  26.76 (CH2), 29.2 (CH2), 29.3 (CH2), 31.0 (CH3CO), 70.0 
(CH2), 73.2 (PhCH2), 127.9 (ArCH), 128.0 (2 x ArCH), 128.8 (2 x ArCH), 138.9 (ArC),
196.3 (C=0).
IR rW (c m  ') 3029, 2856,1691 (C=0), 1454,1355,1105, 1027,956.
MS (EC mode): 238 (M+, 24 %), 195 (13), 132 (30), 91 (100).
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C 13H 18O2S requires 238.1028, found 238.1028.
2-(4-Benzyloxy-butylsulfanyl)-A^-methyl-A^-phenylacetamide (368)
o
To a solution of thioacetic acid-S-(4-benzyloxybutyl) ester 367 (153 mg, 0.64 mmol, 1 eq) 
in THF (7.5 ml) was added UA IH 4 (49 mg, 0.32 mmol, 2 eq). The reaction was allowed to 
stir at rt overnight then quenched with acetone (5 ml). The organic layer was washed with 
water ( 3 x 8  ml), dried (MgS0 4 ) and concentrated in vacuo. The crude product was 
immediately placed under an argon atmosphere then dissolved in DMF (14 ml) and NEt3 
(90 j l l I ,  0.64 mmol, 1 eq). 2-Bromo-N-methyl-iV-phenylacetamide (160 mg, 0.70 mmol, 1.1 
eq) was added and the reaction was allowed to stir at rt for 1 2  h. CH2CI2 was added and the 
reaction mixture was then washed with water (3 x 10 ml), dried (MgSCU) and concentrated 
in vacuo. The crude product was purified by flash chromatography using 5% ethyl acetate 
in dichloroethane as eluant to give 2-(4-benzyloxy-butylsulfanyl)-iV-methyl-N-phenyl- 
acetamide 368 (137 mg, 0.40 mmol, 63%) as a clear oil.
'H  NMR (400 MHz, CDCI3) 5 1.52-1.62 (4H, m, 2 x CH2), 2.58 (2H, t, J = 6 . 8  Hz, CH2S), 
2.97 (2H, s, C # 2CO), 3.21 (3H, s, NC#3), 3.38 (2H, t, J = 6.0, CH2O), 4.41 (2H, s, 
PhC#20), 7.06-7.39 (10H, m, Ar#).
I3C NMR (100 MHz, CDCI3) 8  26.3 (CH2), 29.2 (CH2), 32.7 (CH2S), 33.5 (CH2CO), 38.0 
(NC#3), 70.1 (CH20), 73.3 (CH2Ph), 127.6 (ArCH), 127.8 (2 x ArC#), 127.9 (2 x ArCH),
128.7 (2 x ArCH), 130.1 (2 x ArCH), 130.6 (ArCH), 139.0 (ArQ, 144.1 (ArCN), 160.6 
(C=0).
IR iW (c m '')  2935,2856, 1654 (C=0), 1594,1373,1114.
MS m/z (EI+ mode) 343 (M+, 25%), 252 (15), 195 (13), 149 (100), 148 (85), 134 (35), 120 
(24), 107 (52), 92 (100), 91 (100), 77 (38), 65 (12).
C20H25NO2S requires 343.1606, found 343.1603 .
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(±)-2-(4-Benzyloxy-butyIsulfinyl)-Ar-methyl-A/-phenyl-acetamide (369)
BnO
To a solution of 2-(4-benzyloxy-butylsulfanyl)-iV-methyl-A/r-phenylacetamide 368 (27 mg, 
0.08 mmol, 1 eq) in HFIP (2 ml) and CH2CI2 (1 ml) was added 30 % aqueous H2O2 (16.5 
pi, 0.16 mmol, 2 eq). The reaction was allowed to stir at rt for 2 h. The reaction was then 
quenched with saturated aqueous Na2 SC>3 and the aqueous layer was extracted with CH2CI2 
( 3 x 5  ml). The combined organic layers were washed with brine, dried (MgSCU) and 
concentrated in vacuo to give (±)-2-(4-benzyloxybutylsulfinyl)-./V-methyl-Af- 
phenylacetamide 369 (22 mg, 0.06 mmol, 75 %) as a clear oil which was used without 
further purification.
‘H NMR (400 MHz, CDCI3) 8  1.64-1.75 (2H, m, CH2), 1.75-1.83 (2H, m, CH2), 2.69-2.76 
(1 H, m, 1 H from CH2SO), 2.89-2.98 (1H, m, 1H from CH2SO), 3.23 (3H, s, NC//3), 3.34- 
3.53 (4H, m, CH2CO and CH20 )  4.42 (2H, s, PhC//2), 7.14-7.40 (10H, m, ArH).
13C NMR (100 MHz, CDCI3) 5 18.5 (CH2), 27.8 (CH2), 36.5 (NCH3), 51.9 (CH2S), 55.0 
(CH2CO), 68.5 (CH20), 72.0 (PhCH2), 126.3 (2 x ArCH), 126.6 (ArCH), 126.6 (2 x 
ArCH), 127.4 (2 x ArCH), 127.7 (ArCH), 129.2 (2 x ArCH), 137.3 (ArC), 141.7 (ArC),
163.3 (C=0).
IR U m a x A cm '1)  2 9 3 5 ,  2 8 6 1 ,  1 6 5 0  ( C = 0 ) ,  1 5 9 4 ,  1 3 7 6 ,  1 1 1 2 , 1 0 2 7  ( S = 0 ) .
MS m/z (FAB+/NOBA mode): 360 ((M+H)+, 19%), 281 (9), 147 (36), 73 (100). 
C20H2 6NO3S requires 360.1633, found 360.1632.
(±)-3-(4-Benzyloxy-butylsulfanyl)- l-methyI-l,3-dihydro-indol-2-one (370)
o
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To a solution of (±)-2-(4-benzyloxy-butylsulfinyl)-A-methyl-iV-phenylacetamide 369 (63.3 
mg, 0.18 mmol, 1 eq) in 1,2-dichloroethane (4 ml) was added TFAA (0.15 ml, 1.08 m m ol, 
6  eq). The reaction was allowed to stir at room temperature for 10 min. BF3 Et2 0  (0.19 ml,
1.52 mmol, 4 eq) was then added and the reaction was allowed to stir for 1 h. The reaction 
was then quenched with 1 M NaOH solution. The aqueous layer was extracted with 
CH2CI2 . The combined organic layers were dried (MgSC>4 ) and concentrated in vacuo. The 
crude product was purified using flash chromatography on silica gel using 40% ethyl 
acetate in petroleum ether as eluant to give (±)-3-(4-benzyloxybutylsulfanyl)-l-methyl-1,3- 
dihydro-indol-2-one 370 (46 mg, 0.14 mmol, 75%) as a clear oil.
*H NMR (400 MHz, CDC13) 5 1.43-1.65 (4H, m, 2 x CH2), 2.44-2.50 (1H, m, 1H from 
C //2S), 2.66-2.73 (1H, m, 1H from CH2S), 3.14 (3H, s, NCH3), 3.37 (2H, t, J = 5.2 Hz, 
CH20), 4.22 (1H, s, CHS), 4.40 (2H, s, PhCH2), 6.74 (1H, d, J = 7.8 Hz, ArH), 7.00 (1H, t, 
J = 7.5 Hz, ArH), 7.20-7.31 (7H, m, ArH).
13C NMR (100 MHz, CDC13) 8  26.2 (CH2), 26.8 (NCH3), 29.2 (CH2), 29.9 (CH2S), 45.0 
(CHS), 70.1 (CH20), 73.2 (PhCH2), 108.6 (ArCH), 123.3 (ArCH), 125.4 (ArCH) 126.4 
(ArC), 127.9 (ArCH), 128.0 (2 x ArCH), 128.7 (2 x ArCH), 129.4 (ArCH), 139.0 (ArC),
144.0 (ArC), 176.0 (C=0).
IR tW tc m '1) 2935, 2857, 1716 (C=0), 1612, 1371, 1087.
MS m/z (EI+ mode) 341 (M+, 24%), 250 (9), 178 (29), 162 (33), 147 (100), 146 (85), 118 
(14), 91 (89), 89 (14), 65 (10).
C20H23O2S requires 341.1449, found 341.1451.
Preparation of benzyl thiol resin 
Method 1: Thioacetate route
S-Merrifield bound thioacetic acid (371)13
Merrifield resin (1.00 g, 1.1 mmol/g, 1.1 mmol, 1 eq) was swollen in DMF (10 ml) for 15 
min. Potassium thioacetate (377 mg, 3.3 mmol, 3 eq) was added and the reaction was
o
139
allowed to stir at rt for 24 h. The resin was then washed using our standard washing 
protocol. The product resin 371 was then dried in vacuo.
IR iW C cm '1) 1687 (C=0).
Benzyl thiol resin (342)13
S-Menifield bound thioacetic acid 371(1.05 g, 1.06 mmol / g, 1.11 mmol, 1 eq) was 
swollen in THF (10 ml). LiBFLi (120 mg, 5.55 mmol, 5 eq) was added. The reaction was 
allowed to stir at rt for 20 h. The resin was then washed using our standard washing 
protocol. The product resin 342 was then dried in vacuo. Disappearance of the IR C=0 
stretch at 1687 cm ' 1 was observed.
Method 2: thiourea route 
S-Merrifield bound isothiouronium chloride (372)
0 ^ s ^ N H 2 c i -  
+ nh2
Merrifield resin (1.00 g, 1.1 mmol / g, 1.1 mmol, 1 eq) was swollen in DMF (10 ml) for 15 
min. Thiourea (419 mg, 5.5 mmol, 5 eq) was added and the reaction was heated at 60 °C 
for 24 h. The resin was then washed using our standard washing protocol. The product 
resin 372 was then dried in vacuo.
IR Dmax/(cin'') 1648(C=N).
Benzyl thiol resin (342)
S-Merrifield bound isothiouronium chloride 372 (1.07 g, 1.02 mmol / g, 1.09 mmol, 1 eq) 
was swollen in DMF (10 ml). rc-Butylamine (0.28 ml, 5.45 mmol, 5 eq) was added and the
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reaction was heated at 60 °C for 18 h. The resin was then washed using our standard 
washing protocol. The product resin 342 was then dried in vacuo.
Upon IR analysis, disappearance of the C=N stretch was observed.
S-Merrifield bound 2-mercapto-/V-methyl-iV-phenyIacetamide (373)
Benzyl thiol resin 342 (410 mg, 1.11 mmol/g theoretical loading based on loading of 
Merrifield resin, 0.46 mmol, 1 eq) was swollen in DMF (5 ml) for 15 min. NEt3 (0.14 ml, 
1.40 mmol, 3 eq) and 2-bromo-/V-methyl-/V-phenyl acetamide 348 (319 mg, 1.40 mmol, 3 
eq) were then added and the reaction was allowed to stir at rt for 18 h. The resin was then 
washed using our standard washing protocol. The product resin 373 was then dried in 
vacuo.
IR Umax/tern'1) (C=0) 1654 cm ' 1
Determination of the loading of benzyl thiol resin prepared via method 1
S-Merrifield bound 2-mercapto-ALmethyl-/V-phenylacetamide 373 (420 mg, 0.97 mmol/g 
(theoretical loading), 0.41 mmol, 1 eq) which was derived from benzyl thiol resin 342 
prepared using the thioacetate method was swollen in THF (4 ml). DMPU (0.40 ml, 3.30 
mmol, 8  eq) and a solution of SmU ( 8  ml, 0.1 M sol in THF, 0.8 mmol, 2 eq) was added 
and the reaction allowed to stir at rt for 18 h. The resin was filtered and the solution phase 
was collected and concentrated, before filtration through a short plug of silica washing 
with 40 % ethyl acetate in petroleum ether to give iV-methyl-ZV-phenyl acetamide 362 (33 
mg, 0.22 mmol, 53 %)
Loading of the ^-Merrifield bound 2-mercapto-ALmethyl-jV-phenylacetamide was therefore 
approximately 0.52 mmol /g. Loading of the benzyl thiol resin prepared via the thioacetate 
route was 0.56 mmol / g.
Determination of the loading of benzyl thiol resin prepared via method 2
Cleavage of S-Merrifield bound 2-mercapto-/V-methyl-iV-phenylacetamide 373 which was 
derived from benzyl thiol resin prepared using the thiourea method was carried out 
according to the previous procedure. Loading of S'-Merrifield bound 2-mercapto-iV-methyl-
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A-phenylacetamide 362 was approximatley 0.56 mmol / g. Loading of benzyl thiol resin 
prepared via the thiourea route was therefore 0.61 mmol / g.
A-BenzyI-3-methoxyaniline (376)92
To a neat mixture of m-methoxy aniline 374 (0.70 ml, 6.20 mmol, 1 eq) and benzaldehyde 
375 (0.75 ml, 7.4 mmol, 1.2 eq) was added Ti(OfPr) 4  (2.7 ml, 9.3 mmol, 1.5 eq). The 
reaction was heated at 80 °C for 18 h. The reaction was allowed to cool to rt, MeOH ( 6  ml) 
was added and the reaction was further cooled to 0 °C. NaBfLt (235 mg, 6.2 mmol, 1 eq) 
was then added and the reaction was allowed to stir at rt for 5 h. Water was added and the 
organic layer was extracted with CH2CI2 (x 3). The combined organic layers were dried 
(MgS0 4 ) and concentrated in vacuo to give A-benzyl-3-methoxyaniline 376 (1.23 g, 5.77 
mmol, 93 %) as an orange oil which was used without further purification.
'H  NMR (400 MHz, CDCI3) 6  3.67 (3H, s, C //3O), 4.04 (1H, s, NH), 4.24 (2H, s, PhC//2), 
6.12 (1H, m, ArH), 6.20 (2H, m, 2 x Ar//), 7.00 (1H, t, J = 8.1 Hz, Ar//), 7.18-7.34 (5H, 
m, 5 x ArH).
13C NMR (100 MHz, CDC13) 5 48.7 (PhCH2), 55.5 (CH30), 99.3 (ArCH), 103.1 (ArCH),
106.4 (ArCH), 128.1 (ArCH), 128.3 (2 x ArCH), 129.0 (2 x ArCH), 130.4 (ArCH), 139.7 
(ArC), 150.0 (ArC), 161.2 (ArC).
IR rw /(c m  ') 3409 (NH), 3025,2931,2832,1612, 1509,1494,1452.
MS m/z (EI+ mode) 213 (M+, 95%), 136 (21), 91 (100), 84 (25), 65 (14).
C 14H,5NO requires 213.1154, found 213.1153.
A-Benzyl-2-bromo-A-(3-methoxy-phenyI) acetamide (377)
o
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To a solution of A-benzyl-3-methoxyaniline 376 (878 mg, 4.12 mmol, 1 eq) and NEt3 (0.87 
ml, 6.20 mmol, 1.5 eq) in CH2CI2 (30 ml) at 0°C was added bromoacetyl bromide (0.54 ml, 
6.20 mmol, 1.5 eq). The reaction was allowed to stir at rt for 7 h. The reaction mixture was 
then washed with 0.5 M HC1 (3 x 20 ml) and brine (3 x 20 ml). The organic layer was 
dried (MgSCU) and concentrated in vacuo to give A-benzyl-2-bromo-iV-(3-methoxy- 
phenyl) acetamide 377 (1.34 g, 4.09 mmol, 99 %) as a brown oil which was used without 
further purification.
‘H NMR (400 MHz, CDCI3) 5 3.64 (2H, s, CH2CO), 3.65 (3H, s, Ctf30), 4.81 (2H, s, 
PI1C//2), 6.49 (1H, apparent triplet, J = 2.1 Hz, AiH), 6.57 (1H, d, J= 7.8 Hz, Ar//), 6.81 
(1H, dd, J= 8.3, 2.2 Hz, Ar//), 7.12- 7.23 (6 H, m, Ar//).
I3C NMR (100 MHz, CDC13) S 27.7 (CH2CO), 54.0 (PhCH2), 55.7 (CH3O), 114.1 (ArCH),
114.8 (ArCH), 120.6 (ArCH), 128.1 (ArCH), 128.8 (2 x ArCH), 129.3 (2 x ArCH), 130.8 
(ArCH), 137.1 (ArC), 142.6 (ArC), 160.7 (ArCO), 166.8 (C=0).
IR iW (c rr r ')  3029,1662 (C=0), 1600,148,1286.
MS m/z (EH mode) 333 (M+, 5%), 254 (82), 212 (12), 150 (80), 91 (100), 65 (12). 
C^H^NC^Br requires 333.0364, found 333.0361.
A-Benzyl-2-benzylsulfanyl-A-(3-methoxy-phenyl)-acetamide (379)
OMe
To a solution of A-benzyl-2-bromo-A-(3-methoxyphenyl) acetamide 377 (300 mg, 0.90 
mmol, 1 eq) in DMF (4ml) was added NEt3 (0.13 ml, 0.90 mmol, 1 eq) and benzyl thiol 
378 (0.11 ml, 0.90 mmol, 1 eq). The reaction was allowed to stir at rt for 4.5 h. CH2CI2 (10 
ml) was added and the organic layer was washed with water (3 x 1 0  ml) and NaHCC>3 (3 x 
10ml). The organic layer was dried (MgS0 4 ) and concentrated in vacuo. The crude product 
was purified using flash chromatography on silica gel using 30% ethyl acetate in petroleum 
ether as eluant to give A-benzyl-2-benzyl sulfanyl-A-(3 -methoxyphenyl)-acetamide 379 
(160 mg, 0.44 mmol, 49%) as a yellow oil.
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'H  NMR (400 MHz, CDC13) 5 2.S6 (2H, s, CH2CO), 3.60 (3H, s, CH3O), 3.82 (2H, s, 
PhCH2S), 4.80 (2H, s, PhCH2), 6.43 (1H, d, J = 2.3 Hz, ArH), 6.49 (1H, d, J = 7.8 Hz, 
ArH), 6.73 (1H, dd, J = 8.3, 2.3 Hz, ArH), 7.09-7.25 (11H, m, 11 x ArH)
,3C NMR (100 MHz, CDCI3) 8  32.5 (CH2), 36.7 (CH2), 53.5 (PhCH2), 55.7 (CH30), 114.4 
(ArCH), 120.9 (ArCH), 127.4 (AiCH), 127.8 (ArCH), 128.8 (4 x ArCH), 129.1 (2 x 
ArCH), 129.6 (2 x ArCH), 130.5 (ArCH), 137.7 (ArC), 138.1 (ArC), 143.3 (ArC), 160.6 
(ArCO), 169.7 (C=0).
IR t>max/(cm ') 3060, 3027,2937,1650 (C=0), 1600,1488,1390.
MS m/z (EI+ mode) 377 (M \ 8 %), 255 (62), 213 (16), 164 (5), 122 (10), 91 (100), 65 (10). 
C23H23N 0 2S requires 377.1449, found 377.1451.
(±)-A/-BenzyI-2-benzylsulfinyl-/V-(3-methoxyphenyI) acetamide (380)
■QMe
To a solution of A-benzyl-2-benzylsulfanyl-iV-(3-methoxy-phenyl) acetamide 379 (126 
mg, 0.34 mmol, 1 eq) in HFIP:CH2Cl2 (4ml:2ml) was added 30 % aqueous H2O2 (0.15 ml, 
1.36 mmol, 4 eq) and the reaction allowed to stir at rt for 1 h. The reaction was then 
quenched with aqueous saturated Na2SC>3 solution. The aqueous and organic layers were 
separated and the aqueous layer was extracted with CH2CI2 . The combined organic layers 
were dried (MgS0 4 ) and concentrated in vacuo to give (±)-iV-benzyl-2-benzylsulfinyl-./V- 
(3-methoxyphenyl) acetamide 380 as a yellow oil (122 mg, 0.31 mmol, 92 %) which was 
used without further purification.
‘H NMR (400 MHz, CDC13) 8  3.26 (1H, d, AB system, J = 14.6 Hz, 1H from PhCH2S), 
3.35 (1H, d, AB system, J = 14.6 Hz, 1H from PhCH2S), 3.59 (3H, s, OCH3), 4.05 ( 1H, d, 
AB system, 13.0 Hz, 1H from CHiCO), 4.24 ( 1H, d, AB system, 13.0 Hz, 1H from 
CH2CO), 4.75 (1H, d, AB system, J = 14.2 Hz, 1H from PhC//2N), 4.85 (1H, d, AB 
system, J = 14.2 Hz, 1H from PhC/^N), 6.33 (1H, apparent triplet, J = 2.2 Hz, ArH), 6.43 
(1H, dd, J= 7.8, 1.0 Hz, ArH), 6.73-6.76 (1H, multiplet, ArH), 7.08 -  7.30 (11H, m, 11 x 
ArH).
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13C NMR (100 MHz, CDCI3) S 52.0 (PhCH2S), 52.7 (CH2CO), 54.4 (OCH3), 56.4 
(PhCH2N), 112.9 (ArCH), 113.5 (ArCH), 119.3 (ArCH), 126.7 (ArCH), 127.3 (ArCH),
127.5 (2 x ArCH), 127.7 (2 x ArCH), 127.9 (2 x ArCH), 128.5 (ArC), 129.5 (3 x ArCH),
135.5 (ArC), 140.8 (ArC), 159.5 (ArCO), 163.4 (C=0).
IR rW (c m  ‘) 3060,3029,2919,1644 (C=0), 1587,1488,1402, 1164.
MS m/z (El* mode) 393 (M+, 10%), 255 (16), 212 (6 ), 91 (100), 83 (24), 65 (7). 
C23H23NO3S requires 393.1399, found 393.1400.
(±)-l-Benzyl-3-benzylsulfanyI-6-methoxy-1,3-dihydro-indol-2-one (381)
OMe
To a solution of (±)-A-benzyl-2-benzylsulfinyl-iV-(3-methoxyphenyl) acetamide 380 (41.2 
mg, 0.11 mmol, 1 eq) in 1,2-dichloroethane (4ml) was added TFAA (93 pi, 0.66 ml, 6  eq) 
and the reaction allowed to stir at rt for 2 h. The reaction was quenched with 5 % NaOH 
solution (5 ml) and the aqueous and organic layers were separated. The aqueous layer was 
extracted with CH2CI2 (x 2) and the combined organic layers were dried (MgSCU) and 
concentrated in vacuo. The crude product was purified using flash chromatography on 
silica gel (20% ethyl acetate in petroleum ether) to give (±)-l-benzyl-3-benzylsulfanyl-6- 
methoxy-l,3-dihydro-indol-2-one 381 (26 mg, 0.07 mmol, 63%) as a yellow oil.
‘H NMR (400 MHz, CDC13) 5 3.64 (3H, s, CH/0), 3.68-3.72 ( 1H, m, 1H from PhCH2),
4.04 -4.16 (2H, m, 1H from PhC/ / 2 and CHS), 4.75 (2H, s, PhCH2N), 6.19 (1H, d, J = 2.2 
Hz, ArH), 6.42 (1H, dd, J = 2.2, 8.2 Hz, ArH), 7.08 (1H, d, J = 8.2 Hz, ArH), 7.14-7.32 ( 
10H, m, 10 x ArH).
13C NMR (100 MHz, CDCI3) 8  34.7 (PhCH2S), 43.2 (CHS), 44.3 (PhCH2N), 55.8 (CH3O),
97.7 (ArCH), 106.9 (ArCH), 117.5 (ArC), 126.2 (ArCH), 127.6 (ArCH), 127.7 (2 x 
ArCH), 128.1 (ArCH), 128.7 (2 x ArCH), 129.2 (2 x ArCH), 129.7 (2 x ArCH), 136.0 
(ArC), 137.8 (ArC), 144.9 (ArC), 161.0 (ArCO), 176.8 (C=0).
IR rw A cm -1) 2915,2838, 1720 (C=0), 1621,1496, 1373,1164.
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MS m/z (El* mode) 375 (M+, 5%), 253 (100), 252 (82), 162 (5), 91 (85), 65 (7). 
C23H21NO2S requires 375.1293, found 375.1292.
General procedure A: The immobilisation of a-bromo acetamides onto benzyl thiol 
resin
5-Merrifield bound /V-benzyl-2-mercapto-A-(3-methoxyphenyI) acetamide (383)
Benzyl thiol resin 342 (617 mg, 0.56 mmol / g, 0.35 mmol, 1 eq) was swollen in DMF (5 
ml) for 15 mins and NEt3 (0.22 ml, 1.56 mmol, 4.6 eq) added. A solution of A-benzyl-2- 
bromo-A-(3-methoxyphenyl) acetamide 377 (520 mg, 1.56 mmol, 4.6 eq) in DMF (3 ml) 
was then added by cannula. The reaction was allowed to stir at rt for 18 h. The resin was 
then washed using our standard washing protocol. The product resin 383 was then dried in 
vacuo.
IR tw /(c m ‘‘) 1650 (C=0).
General procedure B: Oxidation of resin bound sulfides to sulfoxides 
5-Merrifield bound A-benzyl-/V-(3-methoxyphenyl)-2-sulfinyl acetamide (384)
S-Merrifield bound /V-benzyl-2-mercapto-/V-(3-methoxyphenyl) acetamide 383 (716 mg, 
0.49 mmol/g, 0.35 mmol, 1 eq) was swollen in HFIP (4 ml) and CH2CI2 (2ml). 30% 
aqueous H2O2 (0.26 ml, 2.28 mmol, 6.5 eq) was then added and the reaction allowed to stir 
at rt overnight. The resin was then washed using our standard washing protocol. The 
product resin 384 was then dried in vacuo.
o
IR Umax/ (cm 1) 1 6 7 0  ( C = 0 ) .
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General procedure C: Pummerer cyclisation of electron rich aromatic systems
5-MerrifieId bound l-benzyl-3-mercapto-6-methoxy-l,3-dihydro-indol-2-one and 5- 
Merrifield bound l-benzyl-3-mercapto-4-methoxy-l,3-dihydro-indol-2-one (385)
5-Merrifield bound /V-benzyl-/V-(3-methoxyphenyl)-2-sulfinyl acetamide (384) (671 mg, 
0.49 mmol/g, 0.33 mmol, 1 eq) was swollen in 1,2-dichloroethane ( 6  ml) for 15 mins. 
Trifluoroacetic anhydride (0.75 ml, 5.3 mmol, 16 eq) was then added and the reaction was 
allowed to stir at rt for 18 h. The resin was then washed using our standard washing 
protocol. The product resin 385 was then dried in vacuo.
IR 1714 (C=0).
l-Benzyl-6-methoxy-l,3-dihydro-indol-2-one (382) and l-Benzyl-4-methoxy-l,3- 
dihydro-indol-2-one (414)
O n
5-Merrifield bound l-benzyl-3-mercapto-6-methoxy-l,3-dihydro-indol-2-one and 5- 
Merrifield bound l-benzyl-3-mercapto-4-methoxy-l,3-dihydro-indol-2-one 385 (598 mg, 
0.49 mmol /g, 0.29 mmol, 1 eq) were swollen in THF (5 ml) for 15 min. DMPU (0.58 ml,
4.8 mmol, 16.5 eq) and a solution of Sml2 (12.0 ml of 0.1 M, 1.20 mmol, 4.1 eq) were 
added and the reaction was allowed to stir at rt for 15 h. The resin was filtered and the 
solution phase was collected and concentrated before filtration through a short plug of 
silica washing with 30 % ethyl acetate in petroleum ether to give l-benzyl-6-methoxy-l,3- 
dihydro-indol-2-one 382 and 1-benzyl-4-methoxy-l,3-dihydro-indol-2-one 414 (27.7 mg,
OMe
OMe
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0.11 mmol, 38 % as a 9:1 mixture of regioisomers (by NMR). (Yield is calculated over 4 
solid phase steps based on thiol resin loading of 0.48 mmol/g) as a clear oil.
The regioisomers were separated by flash chromatography using 20 % ethyl acetate in 
petroleum ether as eluant. l-Benzyl-6-methoxy-l,3-dihydro-indol-2-one 382 was the 
major regioisomer.
For major isomer 382:
*H NMR (400 MHz, CDC13) 5 3.48 (2H, s, CH2CO), 3.65 (3H, s, CH3O), 4.82 (2H, s, 
PhCH2) 6.25 (1H, d, J= 2.3 Hz, ArH), 6.43 (1H, dd, J= 8.2, 2.3 Hz, ArH), 7.05 (1H, d, J = 
8.2 Hz, ArH), 7.16-7.26 (5H, m, 5 x ArH).
13C NMR (100 MHz, CDC13) 5 35.5 (CH2CO) 44.2 (PhCH2), 55.8 (CH30), 97.7 (ArCH),
106.4 (ArCH), 116.8 (ArC), 125.2 (ArCH), 127.8 (2 x ArCH), 128.0 (ArCH), 129.2 (2 x 
ArCH), 136.2 (ArC), 145.9 (ArC), 160.2 (ArCO), 176.3 (C=0).
IR OmaxAcm'1) 3002, 2937, 1700 (C=0), 1623, 1594,1496.
MS m/z (EF mode) 253 (M+, 97%), 224 (8 ), 162 (144), 149 (13), 91 (100), 83 (18), 57 
(10).
Ci6Hi5N 0 2 requires 253.1103, found 253.1103.
For minor isomer 414:
'H  NMR (400 MHz, CDCI3) 8  3.48 (2H, s, C7/2CO), 3.78 (3H, s, C //3O), 4.82 (2H, s, 
PhCH2), 6.32 (1H, d, J= 7.8 Hz, ArH), 6.51 (1H, d, J = 8.1 Hz, ArH), 7.07 (1H, apparent t, 
J = 8.1 Hz, ArH), 7.16-7.26 (5H, m, 5 x ArH).
I3C NMR (100 MHz, CDC13) 8  33.9 (CH2CO) 44.3 (PhCH2), 55.8 (CH3 0), 102.9 (ArCH),
105.8 (ArCH), 111.4 (ArC), 127.8 (2 x ArCH), 127.9 (ArCH), 129.1 (2 x ArCH), 129.5 
(ArCH) 136.5 (ArC), 145.9 (ArC), 155.8 (ArCO), 175.9 (C=0).
Benzo[l,3]dioxol-5-yl-(3-cyclopentyl-propyl)-amine (388)
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To a solution of 3,4-(methylenedioxy) aniline 386 (1.72 g, 12.5 mmol, 1 eq) in CH2CI2 
(20ml) was added NEt3 (1.94 ml, 13.8 mmol, 1.1 eq) and 3-cyclopentyl propionyl chloride 
(1.94 ml, 13.8 mmol, 1.1 eq). The reaction was allowed to stir at room temperature for 3 h 
before EtOAc was added to the reaction mixture. After separation, The organic layer was 
washed with NaHCC>3 , dried (MgS0 4 ) and concentrated to give a white solid. To a solution 
of the crude amide (3.20 g, 12.2 mmol, 1 eq) in THF (45 ml) at 0 °C was added LiAOT* 
(972 mg, 25.6 mmol, 2.1 eq). The reaction was allowed to stir at room temperature for 18 
h. The reaction was quenched with H2O. The aqueous and organic layers were separated 
and the aqueous layer was washed with NaHCC>3 , dried (MgSCU) and concentrated in 
vacuo. The crude reaction mixture was purified by flash chromatography using 50 % 
petroleum ether in CH2CI2 as eluant to give benzo[l,3 ]dioxol-5 -yl-(3 -cyclopentyl-propyl)- 
amine 388 (1.07 g, 4.38 mmol, 35 %) as a brown oil.
'H  NMR (400 MHz, CDC13) 8  1.07-1.12 (2H, m, 2H from 2 x CH2), 1.37-1.49 (2H, m, 
CH2), 1.50-1.67 (6 H, m, 3 x CH2), 1.73-1.87 (3H, m, CH and 2H from 2 x CH2), 3.07 (2H, 
t, J = 7.3 Hz, C //2N), 5.89 (2H, s, C //20 2), 6.18 (1H, dd, J = 2.3, 8.3 Hz, Ar//), 6.36 (1H, d, 
J = 2.3 Hz, Ar//), 6.69 (1H, d, J = 8.3 Hz, Ar//).
13C NMR (100 MHz, CDCI3) 5 25.5 (2 x CH2), 28.7 (CH2), 33.1 (2 x CH2), 33.9 (CH2),
40.3 (CH), 46.6 (CH2), 97.2 (ArCH), 101.1 (CH20 2), 106.1 (ArCH), 109.0 (ArCH), 141.0 
(ArCO), 143.0 (ArCO), 148.7 (C=0).
IR r W lc in '1) 3399 (NH), 2857,1633,1504,1199.
MS m/z (E r  mode) 247 (M+, 6 8 %), 150 (100), 137 (8 ), 65(5).
C 15H21NO2 requires 247.1572, found 247.1572.
4-Iodo-A-propyl aniline (391)
i
To a solution of 4-iodoaniline 389 (3.00 g, 13.7 mmol, 1 eq) in CH2CI2 (60 ml) was added 
and NEt3 (5.78 ml, 41.1 mmol, 3 eq) and propionic anhydride (3.51 ml, 27.4 mmol, 3 eq). 
The reaction was allowed to stir at room temperature for 3 h. The reaction mixture was
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washed with NaHCC>3 , and 1 M HC1, dried (MgS0 4 ) and concentrated in vacuo to give a 
white solid. THF (100ml) was added the solution cooled to 0 °C. LiAlHi (1.09 g, 28.8 
mmol, 2.1 eq) was added slowly. The reaction was allowed to stir at room temperature for 
18 h. The reaction was quenched with H2O. The aqueous and organic layers were separated 
and the aqueous layer was washed with NaHCC>3 , dried (MgSC^) and concentrated in 
vacuo to give a yellow oil. The crude reaction mixture was purified by flash 
chromatography using 50 % petroleum ether in CH2CI2 as eluant to give 4-iodo-A^-propyl 
aniline 391 (1.31 g, 4.93 mmol, 36 %) as a yellow oil.
'H  NMR (400 MHz, CDC13) 8  1.01 (3H, t, J = 7.4 Hz, CH3), 1.60-1.69 (2H, m, Ctf2CH3),
3.07 (2H, t, J = 7.1 Hz, CH2N), 3.75 (1H, broad s, Nfl), 6.34-6.40 (2H, apparent dt, J= 3.0,
9.8 Hz, 2 x ArH), 7.41-7.45 (2H, apparent dt, J = 3.0,9.8 Hz, 2 x Ar//).
13C NMR (100 MHz, CDCI3) 8  11.9 (CH3), 22.9 (CH2), 46.1 (CH2N), 77.9 (ArCI), 115.3 
(2 x ArCH), 138.1 (2 x ArCH), 148.3 (ArC).
IR W ( c m '')  2962, 1604,1506,1321.
MS m/z (EI+ mode) 261 (M \ 62%), 232 (92), 105 (36), 84 (100), 47 (17).
C9H 12NI requires 261.0015, found 261.0014.
4-Chloro-A-propyl-aniline (394)93
ci
To a solution of 4-chloroaniline 392 (1.18 g, 14.2 mmol, 1 eq) in CH2 CI2 (40ml) was added 
NEt3 (4.00 ml, 28.4 mmol, 2 eq) and propionic anhydride (2.00 ml, 15.6 mmol, 1.1 eq). 
The reaction was allowed to stir at room temperature for 3 h. The reaction mixture was 
washed with NaHC0 3  and 1 M HC1, dried (MgS0 4 ), filtered and concentrated in vacuo to 
give a white solid. THF (100 ml) was added and the solution was cooled to 0 °C before the 
addition of LiAlFLi. (1.02 g, 26.8 mmol, 2 eq). The reaction was then allowed to stir at room 
temperature for 18 h before being quenched with H2O. The aqueous and organic layers 
were separated and the aqueous layer was washed with NaHCC>3 , dried (MgS0 4 ) and
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concentrated in vacuo to give 4-chloro-N-propyl aniline 394 (2.12 g, 24.9 mmol, 93 %) as 
a yellow oil which was used without further purification.
'H  NMR (400 MHz, CDC13) 8  1.05 (3H, t, J = 7.4 Hz, C //3CH2), 1.62-1.72 (2H, m, CH2),
3.08 (2H, t, J= 7.1 Hz, CH2N), 3.67 (1H, broad singlet, Nfl), 6.55 (2H, apparent doublet, J 
= 8 . 8  Hz, 2 x Ar//), 7.14 (2H, apparent doublet, J = 8.9 Hz, 2 x Ar//).
13C NMR (100 MHz, CDC13) 8  12.01 (CH3), 23.0 (CH2), 46.3 (CH2N), 114.1 (2 x ArCH),
121.9 (ArCCl), 129.6 (2 x ArCH), 147.5 (ArCN)
IR Umax/(cm'') 3413 (NH), 1598,1496,1317,1176.
MS m/z (EI+ mode) 169 (M+, 70%), 143 (25), 140 (100), 111 (26), 82 (45), 77 (14), 46 (7). 
C9H 12NCI requires 169.0658, found 169.0657.
2-Bromo-Af-methyl-./V-(3-methylphenyI)-acetamide (395)
To a solution of N-methyl toluidine (1 ml, 7.80 mmol, 1 eq) and NEt3 (1.20 ml, 8.60 mmol,
1.1 eq) in CH2CI2 (30 ml) at 0 °C was added bromoacetyl bromide (0.74 ml, 8.60 mmol,
1.1 eq), the reaction was allowed to stir at rt for 1.5 h. The reaction mixture was then 
washed with 0.5 M HC1 (3 x 20 ml) and brine (3 x 20 ml). The organic layer was dried 
(MgS0 4 ) and concentrated in vacuo to give 2-bromo-A^-methyl-N-(3-methylphenyl) 
acetamide 395 (660 mg, 2.73 mmol, 35 %) as a red/brown solid which was used without 
further purification.
‘H NMR (400 MHz, CDC13) 8  2.33 (3H, s, CH3-Ar), 3.22 (3H, s, NCH3), 3.60 (2H, s, 
C/^Br), 7.00 (2H, overlapping singlet and doublet, 2 x Ar//), 7.13 (1H, d, J= 8.0 Hz, 
Ar//), 7.25 (1H apparent t, J= 7.6 Hz, Ar//).
I3C NMR (100 MHz, CDC13) 8  21.7 (CH3Ar), 27.3 (CH2Br), 38.4 (CH3N), 124.3 (ArCH),
127.9 (ArCH), 129.7 (ArCH), 130.1 (ArCH), 140.6 (ArC), 143.4 (ArC), 166.9 (C=0).
IR tw A c m '1): 3045,2962, 1664 (C=0), 1376,1114.
MS m/z (EH mode) 241 (M*. 7%), 162 (9), 1 2 1  (13), 83 (100), 47 (17).
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CioH^BrNO requires 241.0102, found 241.0104. 
2-Bromo-iV-allyl-Af-phenylacetamide (396)
o
To a solution of iV-allylaniline (1.0 g, 7.50 mmol, 1 eq) and NEt3 (1.05 ml, 7.50 mmol, 1 
eq) in CH2CI2 (15 ml) at 0 °C was added a solution of bromoacetyl bromide (1.96 ml, 22.5 
mmol, 3 eq) in CH2CI2 (5 ml) and the reaction allowed to stir at rt for 18 h. The reaction 
mixture was then washed with 0.5 M HC1 (3 x 20 ml) and brine (3 x 20 ml). The organic 
layer was dried (MgSCU), and concentrated in vacuo. The crude reaction was purified by 
flash chromatography on alumina using 40 % ethyl acetate in petroleum ether as eluant to 
give 2-bromo-7V-allyl-iV-phenylacetarnide 396 ( 8 6 8  mg, 3.38 mmol, 45%) as a clear oil.
'H  NMR (400 MHz, CDCI3) 8  3.67 (2H, s, C //2Br), 4.32 (2H, d, J = 6.1 Hz, C //2N), 5.15 
(2H, apparent t J = 7.5 Hz, CH2=CH), 5.83-5.93 (1H, m, C//=CH2), 7.22-7.28 (2H, m, 
ArH), 7.39-7.48 (3H, m, Ar//).
13C NMR (100 MHz, CDCI3) 5 27.6 (CH2Br), 53.3 (CH2N), 119.0 (CH2 =CH), 128.5 (2 x 
ArCH), 129.1 (ArCH), 130.2 (2 x ArCH), 132.5 (CH=CH2), 141.8 (ArC), 166.5 (C=0). 
IR rW O tin 1) 1666 (C=0), 1594,1494,1394, 1276.
MS m/z (E f  mode) 253 (Mf, 8 %), 212 (7), 174 (100), 132 (25), 106 (28), 83 (65), 77 (35), 
41 (19).
CnH^BrNO requires 253.0102, found 253.0107.
2-Bromo-AyV-diphenyIacetamide (397)94
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To a solution of A,ACdiphenylamine (0.68 g, 4.00 mmol, 1 eq) and NEt3 (0.56 ml, 4.00 
mmol, 1 eq) in CH2CI2 (10 ml) at 0 °C was added by cannula, a solution of bromoacetyl 
bromide (1.05 ml, 12.0 mmol, 3.0 eq) in CH2CI2 (5 ml) and the reaction was allowed to 
stir at room temperature for 16 h. CH2CI2 ( 1 0  ml) was added to the reaction, the organic 
layer was washed with 0.5 M HC1 (3 x 20 ml) and brine (3 x 20 ml). The organic layer was 
dried (MgSCU) and concentrated in vacuo. The crude product was purified by 
recrystallisation from petroleum ether / methanol to give 2-bromo-AC/V-diphenylacetamide 
397 (0.49 g, 1.68 mmol, 42%) as a white solid.
‘H NMR (400 MHz, CDC13) 8  3.87 (2H, s, CHiCO), 7.18-7.59 (10H, broad signal, Arfl).
13C NMR (100 MHz, CDCI3) 8  28.3 (CH2Br), 125-131 (10 x ArCH).
MS m/z (E f  mode) 289 (M+, 32%), 222 (4), 196 (14)), 169 (100), 167 (53), 8 6  (30), 84
(48), 49 (25)
Cj4Hi2BrNO requires 289.0102, found 289.0103. 
2-Bromo-A-(4-chlorophenyl)-,/V-propylacetamide (398)
o
Cl
To a solution of A-propyl-4-chloroaniline (1.18 g, 10.7 mmol, 1 eq) and NEt3 (4.5 ml, 32.1 
mmol, 3 eq) in CH2CI2 (40 ml) at 0 °C was added bromoacetyl bromide (1.23 ml, 13.9 
mmol, 1.3 eq) and the reaction allowed to stir at rt for 16 h. The reaction mixture was 
washed with 0.5 M HC1 and 1 M NaOH. The organic layer was dried (MgS04) and 
concentrated in vacuo to give 2-bromo-./V-(4-chlorophenyl)-./V-propylacetamide 398 (3.11 
g, 10.7 mmol, 100 %) as a brown oil which was used without further purification.
'H  NMR (400 MHz, CDC13) 8  0.83 (3H, t, J = 7.4 Hz, CHi), 1.36-1.51 (2H, m, CH2), 3.51- 
3.61 (4H, m, C//2N and C //2 CO), 7.16 (2H, apparent d, J =8.7 Hz, 2 x Ar//), 7.39 (2H, 
apparent d, J = 8.7 Hz, 2 x ArH).
,3C NMR (100 MHz, CDC13) 5 11.5 (CH3), 21.1 (CH2), 27.4 (CH2CO), 51.9 (CH2N),
129.8 (2 x ArCH), 130.9 (2 x ArCH), 134.9 (ArC), 140.4 (ArC), 166.6 (C=0).
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IR tW C cm '1) 2962,2931,1658 (C=0), 1488.
MS m/z (E f  mode) 289 (M+, 7%), 249 (11), 140 (52), 84 (100), 47 (15). 
CnHnNOClBr requires 288.9869, found 288.9875.
iV-Benzo[l,3]dioxol-5-yl-2-bromo-Ar-(3-cyclopentyl-propyl)acetamide (399)
To a solution of benzo[l,3]dioxol-5-yl-(3-cyclopentyl-propyl)amine (1.07 g, 4.30 mmol, 1 
eq) in CH2CI2 (50 ml) at 0 °C was added NEt3 (1.20 ml, 8.60 mmol, 2 eq) and bromoacetyl 
bromide (0.45 ml, 5.20 mmol, 1.2 eq) and the reaction was allowed to stir at room 
temperature for 14 h. The reaction mixture was washed with 0.5 M HC1, NaHCC>3 , dried 
(MgSC>4 ) and concentrated to give iV-benzo[l,3]dioxol-5-yl-2-bromo-iV-(3-cyclopentyl- 
propyl) acetamide 399 as a brown oil (1.53 g, 4.13 mmol, 96 %) which was used without 
further purification.
‘H NMR (400 MHz, CDC13) 8  0.97-.099 (2H, m, 2H from 2 x CH2), 1.19-1.28 (2H, m, 
CH2), 1.35-1.52 (6 H, m, 3 x CH2), 1.62-1.65 (3H, m, CH and 2H from 2 x CH2), 3.56 (2H, 
t, I = 7.7 Hz, C //2N), 3.60 (2H, s, C //2Br), 5.98 (2H, s, C //20 2), 6.65 (2H, m, 2 x Ar//),
6.76 (1H, d, J = 8.7 Hz, Ar//).
I3C NMR (100 MHz, CDC13) 5 25.5 (CH2), 27.0 (CH2), 27.8 (CH2CO), 33.0 (2 x CH2),
33.4 (2 x CH2), 40.3 (CH), 50.6 (CH2N), 102.4 (CH20 2), 209.0 (ArCH), 109.1 (ArCH),
122.0 (ArCH), 135.64 (ArCN), 148.1 (ArCO), 148.9 (ArCO), 166.8 (C=0).
IR tW (c m '')  1661 (C=0), 1623,1504, 1484,1228.
MS m/z (E f  mode) 367 (M+, 57%), 288 (23), 257 (25), 192 (14), 150 (100), 111(29), 69 
(30), 41 (15).
CnH^NC^Br requires 367.0783, found 367.0788.
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2-Bromo-Af-(4-iodophenyl)-./V-propyIacetamide (400)
o
To a solution of 4-iodo-A-propyl aniline (813 mg, 3.11 mmol, 1 eq) and NEt3 (0.87 ml, 
6.22 mmol, 2 eq) in CH2CI2 (20 ml) at 0 °C was added bromoacetyl bromide (0.35 ml, 4.04 
mmol, 1.3 eq) and the reaction allowed to stir at rt for 1.5 h. The reaction mixture was then 
washed with 0.5 M HC1 (3 x 20 ml) and brine (3 x 20 ml). The organic layer was then 
dried (MgSO^) and concentrated in vacuo to give 2-bromo-iV-(4-iodophenyl)-./V- 
propylacetamide 400 (1.02 g, 2.67 mmol, 8 6 %) as a brown oil which was used without 
further purification.
‘H NMR (400 MHz, CDCI3) 5 0.85 (3H, t, J = 7.2 Hz, CH3), 1.41-1.51 (2H, m, CH2), 3.53 
(2H, s, CH2CO), 3.57 (2H, t, J = 7.6 Hz, CH2N), 6.95 (2H, apparent d, J = 8.4 Hz, 2 x 
ArH), 1.11 (2H, apparent d, J = 8.4 Hz, 2 x Ar//).
13C NMR (100 MHz, CDCI3) 6  11.2 (CH3), 20.7 (CH2), 27.2 (CH2), 51.5 (CH2N), 94.1 
(ArCI), 130.1 (2 x ArCH), 139.5 (2 x ArCH), 141.3 (ArC), 165.7 (C=0).
IR tW tc m '1) 2961, 2930,1655 (C=0), 1481,1211.
MS m/z (CI+ mode) 384 ((M+H)+, 43%), 382 ((M+H)+, 43%), 302 (45), 256 (40), 218 (27), 
176 (100), 136 (20).
CnHuNOBrl requires 381.9304, found 381.9305. 
2-BenzylsuIfanyl-iV-(4-iodophenyl)-iV-propylacetamide (401)
i
To a solution of 2-bromo-AL(4-iodophenyl)-A-propylacetamide 400 (386 mg, 1.01 mmol, 1 
eq) and NEt3 (0.21 ml, 1.52 mmol, 1.5 eq) in DMF (10 ml) was added benzyl thiol (0.12
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ml, 1.01 mmol, 1 eq) and the reaction allowed to stir at rt for 2 h. 40 % EtOAc in 
petroleum ether was added to the reaction mixture and the organic layer separated and 
washed with NaHCC>3 and H2O. The organic layer was then dried (MgS0 4 ) and 
concentrated in vacuo. The crude reaction mixture was purified by flash chromatography 
using 20 % EtOAc in petroleum ether as eluant to give 2-benzylsulfanyl-A-(4-iodophenyl)- 
A-propyl acetamide 401 (268 mg, 0.63 mmol, 62 %) as a clear oil.
'H  NMR (400 MHz, CDC13) 8  0.9 (3H, t, J = 7.4 Hz, Ctf3), 1.58-1.49 (2H, m, Ctf2CH3), 
2.86 (2H, s, CH2CO), 3.65 (2 H, t, 7.6 Hz, CH2N), 3.86 (2H, s, PhCtf2S), 6.92 (2H, 
apparent d, J = 8.5 Hz, 2 x Ar//), 7.25-7.93 (5H, m, 5 x Ar//), 7.71 (2H, apparent d, J = 8.5 
Hz, 2 x Ar//).
13C NMR (100 MHz, CDCI3) 5 11.5 (CH3), 21.3 (CH2), 32.5 (CH2), 36.6 (CH2), 51.4 
(CH2), 93.7 (ArCI), 127.4 (ArCH), 128.8 (2 x ArCH), 129.6 (2 x ArCH), 130.7 (2 x 
ArCH), 138.0 (ArC), 139.3 (2 x ArCH), 142.3 (ArC), 169.3 (C=0)
IR rW (c m  ') 1643 (C=0), 1481,1396, 1305.
MS m/z (EC mode) 425 (M+, 15%), 303 (73), 260 (100), 219 (19), 91 (79).
C18H20NOSI requires 425.0310, found 425.0311.
(±)-2-(BenzyIsuIfinyl)-A^-(4-iodophenyl)-Ar-propylacetamide (403)
i
To a solution of 2-benzylsulfanyl-A-(4-iodophenyl)-A-propyl acetamide 401 (290 mg, 0.68 
mmol, 1 eq) in HFIP: CH2CI2 (4 ml: 2 ml) was added 30 % aqueous H2O2 (0.31 ml, 2.72 
mmol, 4 eq) and the reaction allowed to stir at rt for 1 h. The reaction was then quenched 
with aqueous saturated Na2SC>3 solution. The aqueous and organic layers were separated 
and the aqueous layer was extracted with CH2CI2 . The combined organic layers were dried 
(MgS04) and concentrated in vacuo to give (±)-2-(benzylsulfinyl)-/V-(4-iodophenyl)-A- 
propylacetamide 403 (300 mg, 0.68 mmol, 100 %) as a yellow oil. The crude product was 
used without further purification.
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lH NMR (400 MHz, CDC13) 8  0,83 (3H, t, J = 7,4 Hz, Ctf3), 1.39-1,50 (2H, m, CH2), 3.18 
(1H, d, AB system, J = 14.3 Hz, 1H from CH2CO), 3.23 (1H, d, AB system, J = 14.3 Hz, 
1H from CH2CO), 3.52-3.63 (2H, m, CH2N), 3.99 (1H, d, AB system, J = 13.1 Hz, 1H 
from PhCtf2S), 4.18 (1H, d, AB system, J = 13.1 Hz, 1H from PhCtf2S), 6.77 (2H, 
apparent doublet, J = 8 . 6  Hz, 2 x AiH), 7.19-7.22 (2H, m, 2 x ArH), 7.27-7.31 (3H, m, 3 x 
Ar//), 7.61 (2H, apparent doublet, J = 9.3 Hz, 2 x Ar//).
I3C NMR (100 MHz, CDCI3) 8  10.1 (CH3), 19.8 (Cff2CH3), 50.0 (CH2), 52.2 (CH2), 56.3 
(CH2), 93.1 (ArQ), 127.5 (ArCH), 127.8 (2 x ArCH), 128.3 (ArC), 129.1 (2 x ArCH),
129.4 (2 x ArCH), 138.2 (2 x ArCH), 139.8 (ArCN), 162.9 (C=0).
IR tw /(c m  ‘) 2965, 2875,1644 (C=0), 1482, 1410, 1129.
MS m/z (E f  mode) 441 (M+, 10%), 303 (6 ), 91 (100), 43 (8 ).
C 18H20O2NSI requires 441.0260, found 441.0258.
(±)-3-Benzylsulfanyl-5-iodo-1 -propyl-1,3-dihydro-indol-2-one (405)
To a solution of (±)-2-(benzylsulfinyl)-iV-(4-iodophenyl)-/V-propylacetamide 403 (166.5 
mg, 0.38 mmol, 1 eq) in 1,2-dichloroethane (4 ml) was added TFAA (0.43 ml, 3.04 mmol, 
8  eq), and the reaction allowed to stir at room temperature for 10 min. BF3 Et2 0  (0.19 ml,
1.52 mmol, 4 eq) was then added and the reaction was allowed to stir for a further hour. 
The reaction was then quenched with 1 M NaOH solution and the aqueous layer extracted 
with CH2CI2 . The combined organic layers were dried (MgS04) and concentrated in vacuo. 
The crude reaction mixture was purified by flash chromatography using 40 % EtOAc in 
petroleum ether as eluant to give (±)-3-benzylsulfanyl-5-iodo-l-propyl-1,3-dihydro-indol- 
2-one 405 (117 mg, 0.28 mmol, 73 %) as an orange oil.
!H NMR (400 MHz, CDC13) 6  0.88 (3H, t, J = 7.4 Hz, CH3), 1.54 -1.64 (2H, m, CH2), 3.50 
(2H, t, J = 7.3 Hz, CH2N), 3.68 (1H, d, J = 13.2 Hz, 1H from PhC//2S), 4.04 (1H, s, CHS),
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4.11 (1H, d, J = 13.2 Hz, 1H from PhC//2S), 6.49 (1H, d, J = 8.2 Hz, Ar//), 7.14-7.29 (5H, 
m, 5 x Ar//), 7.43 (1H, s, Ar//), 7.49 (1H, dd, J = 8.2,1.1 Hz, Ar//).
13C NMR (100 MHz, CDC13) 8  11.7 (CH3), 21.0 (CH2), 34.8 (CH2), 42.2 (PhCH2S), 43.1 
(CHS), 85.1 (A rd), 110.8 (ArCH), 127.8 (ArCH), 128.4 (ArC), 128.9 (2 x ArCH), 129.6 
(2 x ArCH), 134.4 (ArCH), 137.4 (ArC), 138.1 (ArCH), 143.7 (ArC), 175.2 (C=0)
IR t>m ax/(cm "1)  1 7 0 4 ( C = O ) ,  1 6 0 0 ,  1 4 7 7 , 1 3 3 2 ,  1 1 0 3 .
MS m/z (EC mode) 423 (M \ 19%), 301 (100), 272 (30), 258 (25), 116 (24), 91 (61). 
CigHisNOIS requires 423.0154, found 423.0155.
2-BenzylsuIfanyl-iV-(4-chlorophenyl)-./V-propyIacetamide (402)
ci
To a solution of 2-bromo-iV-(4-chlorophenyl)-./V-propylacetamide 398 (249 mg, 0.86 mmol,
1 eq) in DMF (5 ml) were added NEt3 (0.18 ml, 1.29 mmol, 1.5 eq) and benzyl thiol (0.11 
ml, 0.95 mmol, 1.1 eq) and the reaction was allowed to stir at rt for 45 min. H2O was added 
and the reaction mixture was extracted with 40 % ethyl acetate in petroleum ether. The 
organic layer was dried (MgSCU) and concentrated in vacuo. The crude reaction mixture 
was purified by flash chromatography using 2 0  % ethyl acetate in petroleum ether as eluant 
to give 2-benzylsulfanyl-A^-(4-chlorophenyl)-A^-propylacetamide 402 (158 mg, 0.47 mmol, 
55 %) as a clear oil.
'H  NMR (400 MHz, CDC13) 8  0.83 (3H, t, J = 7.4 Hz, C //3CH2), 1.40-1.55 (2H, m, C//2),
2.76 (2H, s s, C/Z2CO), 3.55 (2H, t, J = 7.6 Hz, CZ72N), 3.77 (2H, s, PhC//2S), 7.0 (2H, m,
2 x Ar//), 7.08-7.31 (7H, m, 7 x ArH)
13C NMR (100 MHz, CDC13) 8  11.5 (CH3), 21.3 (CH2), 32.5 (CH2), 36.6 (CH2), 51.4 
(CH2), 127.4 (ArCH), 128.8 (2 x ArCH), 129.6 (2 x ArCH), 130.2 (4 x ArCH), 134.3 
(ArC), 138.0 (ArC), 141.0 (ArC), 169.4 (C=0).
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3-BenzylsuIfanyl-5-ChIoro-l-propyl-l,3-dihydro-indol-2-one (406)
To a solution of 2-benzylsulfanyl-A-(4-chloro phenyl)-A^-propylacetamide 402 (46.8 mg, 
0.14 mmol, 1 eq) in HFIP (3 ml) was added 30 % aqueous H2 O2 (0.06 ml, 0.56 mmol, 4 eq) 
and the reaction allowed to stir at rt for 15 min. The reaction was then quenched with 
aqueous saturated Na2SC>3 solution. The aqueous and organic layers were separated and the 
aqueous layer was extracted with CH2CI2 . The combined organic layers were dried 
(MgSC>4 ) and concentrated in vacuo to give (±)-2-benzylsulfinyl-./V-(4-chlorophenyl)-./V- 
propylacetamide 404 (39 mg, 0.11 mmol, 80 %).
To a solution of (±)-2-benzylsulfinyl-A-(4-chlorophenyl)-iV-propylacetamide 404 (39 mg, 
0.11 mmol, 1 eq) in 1,2-dichloroethane (5 ml) was added TFAA (0.13 ml, 0.90 mmol, 8  
eq) and the reaction was allowed to stir for 1 h. BF3 OEt2 (0.06 ml, 0.45 mmol, 4 eq) was 
then added and the reaction was allowed to stir for a further 1 h. The reaction was then 
quenched with 1 M NaOH solution. The aqueous layer was extracted with CH2CI2 . The 
combined organic layers were dried (MgSCU) and concentrated in vacuo. The crude 
reaction mixture was purified by flash chromatography using 20 % EtOAc in petroleum 
ether as eluant to give (±)-3-benzylsulfanyl-5-chloro-l-propyl-l,3-dihydro-indol-2-one 406 
(26 mg, 0.28 mmol, 72%) as a clear oil.
'H  NMR (400 MHz, CDCI3) 5 0.90 (3H, t, J = 6 . 6  Hz, CH3), 1.55-1.65 (2H, m, C //2), 3.53 
(2H, t, J = 7.3 Hz, CH2N), 3.89 (1H, d, J = 15.9 Hz, 1H from PhCH2S), 4.06 (1H, s, CHS),
4.11 (1H, d, J= 13.2 Hz, 1H from PhCH2S), 6.63 (1H, dd, J = 3.4, 5.4 Hz, ArH), 7.06-7.44 
(7H, m, 7 x A tH ) .
13C NMR (100 MHz, CDC13) 8  10.3 (CH3), 19.7 (CH2), 33.4 (PhCH2S), 40.9 (CH2N), 42.0 
(CHS), 108.3 (ArCH), 124.6 (ArCH), 126.3 (ArC), 126.4 (ArCH), 126.8 (ArC), 127.5 (2 x 
ArCH), 127.8 (ArCH), 128.2 (2 x ArCH), 135.9 (ArC), 141.1 (ArC), 174.0 (C=0).
IR iW fc m '1) 1708 (C=0), 1608,1481,1334,1106.
MS (EI+ mode) 331 (M+, 3 %), 209 (100), 108 (15), 91 (25).
C 18Hi8NOC1S requires 331.0798, found 331.0793.
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Solid phase route to oxindoles
S-Merrifield bound 2-mercapto-A-methyl-A-(3-methylphenyl)acetamide
Q ^sJlN.o
As for general procedure A. Thiol resin 342, on treatment with 2-bromo-7V-methyl-7V-(3- 
methylphenyl) acetamide 395 gave S'-Merrifield bound 2-mercapto-iV-methyl-7V-(3- 
methylphenyl)acetamide.
IR (cm 1) 1650 (C=0).
S-Merrifield bound 2-mercapto-AVV-diphenyIacetamide
As for general procedure A. Thiol resin 342, on treatment with 2 -bromo-A,A-diphenyl 
acetamide 397 gave S-Merrifield bound 2-mercapto-vVv/V-diphenylacetamide.
IR Umax/ (cm-1) 1664 (C=0).
S-Merrifield bound 2-mercapto-A-methyl-A-phenylacetamide
As for general procedure A. Thiol resin 342, on treatment with 2-bromo-A-methyl-A- 
phenyl acetamide 348 gave S-Merrifield bound 2-mercapto-A-methyl-7V-phenylacetamide. 
IR Umax/ (cm'1) 1654 (C=0).
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S-Merrifield bound jV-allyl-2-mercapto-A-phenylacetamide
o
As for general procedure A. Thiol resin 342, on treatment with 2 -bromo-A-allyl-A-phenyl 
acetamide 396 gave S-Merrifield bound A-allyl-2-mercapto-A-phenylacetamide.
IR W C c m '1) 1652 (C=0).
S-Merrifield bound A-(benzo[d][l,3]dioxol-5-yI)-A-(3-cyclopentylpropyl)-2- 
mercaptoacetamide
As for general procedure A. Thiol resin 342, on treatment with A-benzo[l,3]dioxol-5-yl-2- 
bromo-A-(3-cyclopentyl-propyl) acetamide 399 gave S-Merrifield bound N- 
(benzo[d][l,3]dioxol-5-yl)-iV-(3-cyclopentylpropyl)-2- mercaptoacetamide.
IR i)max/(cm') 1650 (C=0 ).
S-Merrifield bound A-(4-chlorophenyl)-2-mercapto-A-propylacetamide
As for general procedure A. Thiol resin 342, on treatment with 2-bromo-A-(4- 
chlorophenyl)-A-propylacetamide 398 gave product resin S-Merrifield bound A-(4- 
chlorophenyl)-2 -mercapto-A-propylacetamide.
IR D m a x /C c m "1)  1652 (C=0).
o
Cl
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S-Merrifield bound A-(4-iodophenyl)-2-mercapto-,/V-propylacetamide
o
As for general procedure A. Thiol resin 342, on treatment with 2-bromo-iV-(4-iodophenyl)- 
A-propylacetamide 400 gave S-Merrifield bound A-(4-iodophenyl)-2-mercapto-A^- 
propylacetamide.
IR tW C cm '1) 1650 (C=0).
S-Merrifield bound A-methyl-A-(3-methylphenyl)-2-(suIfinyl) acetamide
As for general procedure B. Upon oxidation, S-Merrifield bound 2-mercapto-A-methyl-A- 
(3-methylphenyl)acetamide gave S-Merrifield bound A-methyl-7V-(3-methylphenyl)-2- 
(sulfinyl) acetamide.
IR x>mJ  (cm 1) 1650 (C=0).
S-Merrifield A^V-diphenyl 2-(sulfinyl) acetamide
As for general procedure B. Upon oxidation, S-Merrifield bound 2-mercapto-7V,7V- 
diphenylacetamide gave product resin S-Merrifield A,A-diphenyl 2-(sulfinyl) acetamide.
IR Umax/ (cm'1) 1660 (C=0 ).
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S-Merrifield bound A-methyl-A-phenyl 2-(suIfinyl) acetamide
-  o o
As for general procedure B. Upon oxidation, S-Merrifield bound 2 -mercapto-A-methyl-Ar- 
phenylacetamide gave S-Merrifield bound A-methyl-A-phenyl 2-(sulfinyl) acetamide.
IR Umax/ (cm'1) 1650 (C=0).
S-Merrifield bound A-allyI-A-Phenyl-2-suIfinyI acetamide
As for general procedure B. Upon oxidation, S-Merrifield bound A-allyl-2-mercapto-A- 
phenylacetamide gave S-Merrifield bound A-allyl-A-Phenyl-2-sulfinyl acetamide.
IR umax/(cm'1) 1648 (C=0).
S-Merrifield bound A-(benzo[d][l,3]dioxol-5-yl)-A-(3-cyclopentyIpropyl)-2-sulfinyl 
acetamide
As for general procedure B. Upon oxidation, S-Merrifield bound A-(benzo[d][l,3]dioxol-5- 
yl)-A-(3-cyclopentylpropyl)-2- mercaptoacetamide gave S-Merrifield bound N- 
(benzo[d][l,3]dioxol-5-yl)-A-(3-cyclopentylpropyl)-2-sulfinyl acetamide.
IR Umax/ (cm 1) 1648 (C=0)
" O  o
- O  o
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S-Merrifield bound A-(4-chlorophenyl)-./V-propyl-2-suIfinyl acetamide
ci
As for general procedure B. Upon oxidation, S-Merrifield bound A-(4-chlorophenyl)-2- 
mercapto-A-propylacetamide gave S-Merrifield bound A-(4-chlorophenyl)-iV-propyl-2- 
sulfinyl acetamide.
IR W ( c m ’') 1644 (C=0).
S-Merrifield bound A-(4-iodophenyl)-A-propyl-2-sulfinyl acetamide
As for general procedure B. Upon oxidation, S-Merrifield bound A-(4-iodophenyl)-2- 
mercapto-A-propylacetamide gave S-Merrifield bound 7V-(4-iodophenyl)-A-propyl-2- 
sulfinyl acetamide.
IR t>max/(cm l) 1648 (C=0).
o o
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General procedure D: Pummerer cyclisation of neutral and electron deficient 
aromatic systems
S-Merrifield bound 3-mercapto-l,6-dimethyl-l,3-dihydro-indoI-2-one and S-
Merrifield bound 3-mercapto-l,4-dimethyl-l,3-dihydro-indol-2-one
S-Merrifield bound A-methyl-./V-(3-methylphenyl)-2-(sulfinyl) acetamide and S-Merrifield 
bound jV-methyl-iV-(5-methylphenyl)-2-(sulfinyl) acetamide (647 mg, 0.55 mmol/g, 0.36 
mmol, 1 eq) was swollen in 1,2-dichloroethane ( 6  ml) for 15 min. Trifluoroacetic 
anhydride (0.85 ml, 0.60 mmol, 17 eq) was added and the reaction allowed to stir at rt for 3 
h. BF3 OEt2 (1.14 ml, 9 mmol, 25 eq) was added and the reaction was allowed to stir at rt 
for a further 18h. The resin was then washed using our standard washing protocol.The 
product resin was then dried in vacuo.
IR umax/ (cm'1) 1714 (C=0).
S-Merrifield bound 3-mercapto-l-phenyl-l,3-dihydro-indol-2-one
As for general procedure D. Upon cyclisation, S-Merrifield A,iV-diphenyl 2-(sulfinyl) 
acetamide gave S-Merrifield bound 3-mercapto-l -phenyl- l,3-dihydro-indol-2-one.
IR v max/ (cm’1) 1722 (C=0).
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S-Merrifield bound 3-mercapto-l-methyl-l,2-dihydro-indol-2-one
o
As for general procedure D. Upon cyclisation, S-Merrifield bound TV-methyl-TV-phenyl 2- 
(sulfinyl) acetamide gave S-Merrifield bound 3-mercapto-l-methyl-l,2-dihydro-indol-2- 
one.
IR Umax/ (cm 1) 1716 (C=0 ).
S-Merrifield bound l-allyI-3-mercapto-l,3-dihydro-indol-2-one
As for general procedure D. Upon cyclisation, S-Merrifield bound A-allyl-A-Phenyl-2- 
sulfinyl acetamide gave product resin S-Merrifield bound l-allyl-3-mercapto-l,3-dihydro- 
indol-2 -one.
IR o W (cm  ') 1714 (C=0).
S-Merrifield bound 5-(3-cyclopentylpropyl)-7-mercapto-5H-[l,3]dioxolo[4,5-f]indol- 
6(7H)-one
As for general procedure C. Upon cyclisation, S-Merrifield bound 7V-(benzo[d][l,3]dioxol-
5-yl)-iV-(3-cyclopentylpropyl)-2-sulfinyl acetamide gave S-Merrifield bound 5-(3- 
cyclopentylpropyl)-7-mercapto-5H-[l,3]dioxolo[4,5-f]indol-6(7H)-one.
o
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IR (cm 1) 1710 (C=0)
S-Merrifield bound 5-chloro-3-mercapto-l-propyl-l,3-dihydro-indol-2-one
o
ci
As for general procedure D. Upon cyclisation, S-Merrifield bound A-(4-chlorophenyl)-A- 
propyl-2-sulfinyl acetamide gave S-Merrifield bound 5-chloro-3-mercapto-l-propyl-1,3- 
dihydro-indol-2 -one.
IR U m a x ^ c m '1)  1716 (C=0).
S-Merrifield bound 5-iodo-3-mercapto-l-propyl-l,3-dihydro-indol-2-one
As for general procedure D. Upon cyclisation, S-Merrifield bound iV-(4-iodophenyl)-./V- 
propyl-2-sulfinyl acetamide gave S-Merrifield bound 5-iodo-3-mercapto-l-propyl-1,3- 
dihydro-indol-2 -one.
IR iw/Ccm'1) 1714 (C=0).
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S111I2 cleavage of oxindoles from resin
l,6-Dimethyl-l,3-dihydro-indol-2-one (408) and l,4-Dimethyl-l,3-dihydro-indoI-2-one 
(409)
S-Merrifield bound 3-mercapto-l,6 -dimethyl-l,3-dihydro-indol-2-one and S-Merrifield 
bound 3-mercapto-l,4-dimethyl-l,3-dihydro-indol-2-one (584 mg, 0.55 mmol / g, 0.32 
mmol, 1 eq) was swollen in THF (7 ml) for 15 min. DMPU (0.51 ml, 4.20 mmol, 13 eq) 
and a solution of Sml2 (10.4 ml of 0.1 M sol in THF, 1.04 mmol, 3.3 eq) were then added 
and the reaction allowed to stir at rt for 18 h. The resin was filtered and the solution phase 
was collected and concentrated in vacuo. Filtration through a short plug of silica washing 
with 30 % ethyl acetate in petroleum ether to gave l,6-dimethyl-l,3-dihydro-indol-2-one 
408 and 1,4-dimethyl-l,3-dihydro-indol-2-one 409 (32.4 mg, 0.20 mmol, 63 %) as a 2:1 
mixture by NMR and as a clear oil. (yield over 4 solid phase steps based on thiol resin of 
loading 0.61 mmol/g).
For the major isomer 40895:
'H  NMR (400 MHz, CDC13) 8  2.31 (3H, s, Ctf3Ar), 3.11 (3H, s, NCH3), 3.40 (2H, s, CH2),
6.57 (1H, s, ArH), 6.77 (1H, d, J = 8.2 Hz, AiH), 6.79 (1H, d, J = 8.2 Hz, Arfl),
13C NMR (100 MHz, CDC13) 8  20.7 (CH3Ar), 25.1 (NCH3), 34.5 (CH2CO), 108.0 (ArCH),
120.4 (ArQ, 121.7 (ArCH), 123.0 (ArCH), 136.9 (ArC), 144.3 (ArC), 174.5 (C=0).
IR ■omax/(cm1) 3052,2937,1695 (C=0), 1619,1606,1467, 1097,948.
MS m/z (E f  mode) 161 (M+, 100%), 132 (83), 117 (24), 91 (19), 83 (34), 57 (18), 55 (10). 
CioHnNO requires 161.0841, found 161.0840.
For the minor isomer 40996:
*H NMR (400 MHz, CDC13) 6  2.26 (3H, s, C //3Ar), 3.12 (3H, s, NC//3), 3.33 (2H, s, CH2),
6.57 (1H, d, J = 9.8 Hz, Ar//), 7.03 (1H, d, J = 7.5 Hz, Ar//), 7.13 (1H, apparent t, J = 7.8 
Hz, Ar//).
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13C NMR (100 MHz, CDCI3) 8  17.5 (CH3Ar), 25.3 (NCH3), 33.7 (CH2CO), 104.6 (ArCH),
122.2 (ArC), 122.7 (ArCH), 126.8 (ArCH), 133.0 (ArC), 143.9 (ArC), 174.1 (C=0).
l-Phenyl-l,3-dihydro-indol-2-one (410)65
S-Merrifield bound 3-mercapto-l-phenyl-l,3-dihydro-indol-2-one (577 mg, 0.50 mmol /g, 
0.29 mmol, 1 eq) was swollen in THF ( 6  ml) for 15 min. DMPU (0.51 ml, 4.2 mmol, 8.4 
eq) and a solution of Sm h  (10.6 ml of 0.1 M solution in THF, 1.06 mmol, 3.7 eq) were 
added and the reaction allowed to stir at rt for 18 h. The resin was filtered and the solution 
phase was collected and concentrated in vacuo. Filtration through a short plug of silica 
washing with 40 % ethyl acetate in petroleum ether to gave 1 -phenyl-l,3-dihydro-indol-2- 
one 410 (24 mg, 0.11 mmol, 39 %) as a clear oil. (Yield over 4 solid phase steps based on 
thiol resin of loading 0.56 mmol/g).
'H  NMR (400 MHz, CDC13) 8  3.65 (2H, s, CH2), 6.71 (1H, d, J = 7.9 Hz, ArH), 7.0 (1H, t, 
J = 7.3 Hz, ArH), 7.13 (1H, t, J = 7.5 Hz, ArH), 7.24 (1H, d, J = 7.4 Hz, ArH), 7.32-7.36 
(3H, m, 3 x ArH), 7.44-7.57 (2H, m, 2 x ArH).
13C NMR (100 MHz, CDC13) 8  36.5 (CH2CO), 109.8 (ArCH), 123.2 (ArCH), 124.7 (ArC),
125.0 (ArCH), 127.0 (2 x ArCH), 128.2 (ArCH), 128.5 (ArCH), 130.1 (2 x ArCH), 134.9 
(ArC), 145.6 (ArC), 174.8 (C=0).
IR iW C c m 1) 3056,2948,2919,1706 (C=0), 1610,1590,1500, 1479,1365.
MS m/z (EC mode) 209 (M+, 50%), 209 (54), 180 (100), 82 (25), 77 (11), 46 (8 )/
C 14H 14NO requires 209.0841, found 209.0840.
l-Methyl-l,3-dihydro-indole-2-one (411)65
o
S-Merrifield bound 3-mercapto-l-methyl-l,2-dihydro-indol-2-one (315 mg, 0.52 mmol /g, 
0.16 mmol, 1 eq) was swollen in THF (4 ml) for 15 min. DMPU (0.30 ml, 2.48 mmol, 15.5 
eq) and a solution of Sml2 (6.20 ml of 0.1 M solution in THF, 0.62 mmol, 3.9 eq) were 
added and the reaction allowed to stir at rt for 18 h. The resin was filtered and the solution 
phase was collected and concentrated in vacuo. Filtration through a short plug of silica 
washing with 50 % ethyl acetate in petroleum ether to gave 1 -methyl-l,3 -dihydro-indole-2 - 
one 411 (10 mg, 0.07 mmol, 43 %) as a clear oil. (Yield over 4 solid phase steps based on 
thiol resin of loading 0.56 mmol/g ).
'H  NMR (400 MHz, C D C I 3 )  8  3.14 (3H, s, NCH3), 3.46 (2H, s, CH2CO), 6.75 (1H, d, J =
7.8 Hz, ArH), 6.97 (1H, t, J = 7.5 Hz, ArH) and 7.17-7.24 (2H, m, 2 x ArH).
13C NMR (100 MHz, CDC13) 8  25.1 (NCH3), 34.7 (CH2CO), 107.1 (ArCH), 121.3 
(ArCH), 123.3 (ArCH), 123.5 (ArC), 126.9 (ArCH) 144.2 (ArC) and 174.0 (C=0).
IR iw A c m '1) 3058, 2942, 2919, 1700 (C=0), 1612, 1463, 1348 and 754.
MS m/z (EC mode) 147 (M+, 90%), 132 (10), 118 (100), 104 (7), 91 (20), 85 (24), 82 (38), 
78(16), 57 (12) and 47(11).
C9H9NO requires 147.0684, found 147.0684.
l-Allyl-l,3-dihydro-indol-2-one (412)97
S-Merrifield bound l-allyl-3-mercapto-l,3-dihydro-indol-2-one (641 mg, 0.55 mmol /g, 
0.35 mmol, 1 eq) was swollen in THF ( 6  ml) for 15 min. DMPU (0.57 ml, 4.70 mmol, 13.4 
eq) and a solution of SmU (11.8 ml of 0.1 M solution in THF, 1.18 mmol, 3.4 eq) were 
added and the reaction allowed to stir at rt for 18 h. The resin was filtered and the solution 
phase was collected and concentrated. It was then filtered through a short plug of silica 
washing with 40 % ethyl acetate in petroleum ether to give l-allyl-l,3-dihydro-indol-2-one 
412 (18 mg, 0.10 mmol, 30 %) as a clear oil. (Yield over 4 solid phase steps based on thiol 
resin of loading 0.61 mmol/g).
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'H  NMR (400 MHz, CDC13) 5 3.5 (2H, s, CH2 CO), 4.27-4.29 (2H, m, CH2N), 5.14-5.19 
(2H, m, CH2=CH), 5.73-5.82 (1H, m, CH=CH2), 6.75 (1H, d, J = 7.8 Hz, ArH), 6.96 (1H, 
t, J = 7.3 Hz, ArH), 7.15 -  7.19 (2H, m, 2 x ArH).
13C NMR (100 MHz, CDCI3) 8  36.1 (CH2 CO), 42.7 (CH2N), 109.3 (CH=CH2), 117.9 
(CH2=), 122.7 (ArCH), 124.8 (ArCH), 124.9 (ArC), 128.2 (ArCH), 131.8 (ArCH), 144.8 
(ArC), 175.2 (C=0).
IR iW /(cm ‘l) 3054,2917, 1702 (C=0), 1612,1486,1465,1349, 1197.
MS m/z (E f  mode) 173 (M+, 85%), 144 (31), 130 (51), 118 (26), 84 (100), 77 (17), 47 
(20).
CjiHuNO requires 173.0841, found 173.0841. 
5-(3-cyclopentylpropyl)-5H-[l,3]dioxoIo[4,5-f]indol-6(7H)-one (413)
S-Merrifield bound 5-(3-cyclopentylpropyl)-7-mercapto-5H-[ 1,3]dioxolo[4,5-f]indol- 
6(7H)-one (620 mg, 0.48 mmol/g, 0.30 mmol, 1 eq) was swollen in THF (5 ml) for 15 min. 
DMPU (0.46 ml, 3.8 mmol, 12.7 eq) and a solution of Sml2 (9.6 ml of 0.1 M solution in 
THF, 0.96 mmol, 3.2 eq) were added and the reaction was allowed to stir at rt for 18 h. The 
resin was filtered and the solution phase was collected and concentrated in vacuo. 
Filtration through a short plug of silica washing with 30 % ethyl acetate in petroleum ether 
to give 5-(3-cyclopentylpropyl)-5H-[l,3]dioxolo[4,5-f]indol-6(7H)-one 413 (31 mg, 0.11 
mmol, 36 %) as a clear oil. (Yield over 4 solid phase steps based on thiol resin of loading 
0.56 mmol/g).
]H NMR (400 MHz, CDC13) 6  0.98-1.02 (2H, m, 2H from 2 x CH2), 1.26-1.32 (2H, m, 
CH2), 1.42-1.60 (6 H, m, 3 x CH2), 1.65-1.70 (3H, m, CH and 2H from 2 x CH2), 3.37 (2H, 
s, CH2 CO), 3.56 (2H, t, J = 7.5 Hz, C //2N), 5.86 (2H, s, CH2 0 2), 6.37 (1H, s, AiH ), 6.7 
(1H, s, ArH).
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,3C NMR (100 MHz, CDC13) 5 25.5 (2 x CH2), 27.1 (CH2), 33.0 (2 x CH2), 33.7 (CH2),
36.5 (CH2CO), 40.2 (CH), 40.7 (CH2N), 92.7 (ArCH), 101.4 (CH20 2), 106.5 (ArCH),
116.5 (ArC), 139.2 (ArCN), 143.2 (ArCO), 147.5 (ArCO), 175.6 (C=0).
IR W f r m '1) 1687 (C=0 ), 1616,1500,1473,1328.
MS m/z (E f  mode) 287(M+, 100%), 177 (20), 162 (45), 132 (28), 104 (5), 77 (7), 41 (14). 
C17H21NO3 requires 287.1521, found 287.1520.
5-Chloro-l-propyI-l,3-dihydro-indol-2-one (415)98
o
Cl
S-Merrifield bound 5-chloro-3-mercapto-l-propyl-l,3-dihydro-indol-2-one (0.99 g, 0.50 
mmol/g, 0.50 mmol, 1 eq) was swollen in THF (10 ml) for 15 min. DMPU (0.99 ml, 8.20 
mmol, 16.4 eq) and a solution of SmU (20.5 ml of 0.1 M solution in THF, 2.05 mmol, 4.1 
eq) were added and the reaction was allowed to stir at rt for 18 h. The resin was filtered 
and the solution phase was collected and concentrated in vacuo. Filtration through a short 
plug of silica washing with 30 % ethyl acetate in petroleum ether to give 5-chloro-l- 
propyl-l,3-dihydro-indol-2-one 415 (39.7 mg, 0.19 mmol, 38 %) as a clear oil. (Yield over 
4 solid phase steps based on thiol resin of loading 0.56 mmol/g).
'H NMR (400 MHz, CDC13) 6  0.89 (3H, t, J = 7.4 Hz, CH3), 1.57-1.67 (2H, m, CH2), 3.45 
(2H, s, CH2 CO), 3.59 (2H, t, J = 7.4 Hz, Ctf2N), 6.76 (1H, d, J = 7.9 Hz, ArH), 7.15-7.18 
(2H, m, 2 x ArH).
I3C NMR (100 MHz, CDCI3) 6  10.4 (CH3), 19.7 (CH2), 34.6 (CH2CO), 40.7 (CH2N),
108.1 (ArCH), 123.9 (ArCH), 125.2 (ArC), 126.4 (ArC), 126.7 (ArCH), 142.3 (ArC), 
173.4 (C=0).
IR rW (c m -‘) 1695 (C=0), 1610,1486,1342.
MS m/z (EI+ mode) 209 (M \ 64%), 180 (36), 152 (58), 117 (32), 85 (65), 84 (100), 47 
(17).
C 11H 12NOCI requires 209.0607, found 209.0605.
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5-Iodo-l-propyl-l,3-dihydro-indol-2-one (407)
o
S-Merrifield bound 5-iodo-3-mercapto-l-propyl-l,3-dihydro-indol-2-one (845 mg, 0.48 
mmol/g, 0.41 mmol, 1 eq) was swollen in THF (7 ml) for 15 min. DMPU (0.44 ml, 3.65 
mmol, 8.9 eq) and a solution of Sml2 (9.10 ml of 0.1 M solution in THF, 0.91 mmol, 2.2 
eq) were added and the reaction allowed to stir at rt for 18 h. The resin was filtered and the 
solution phase was collected and concentrated in vacuo. Filtration through a short plug of 
silica washing with 30 % ethyl acetate in petroleum ether to give 5-iodo-l-propyl-1,3- 
dihydro-indol-2-one 407 (24 mg, 0.08 mmol, 20 %) as a clear oil. (Yield over 4 solid phase 
steps based on thiol resin of loading 0.56 mmol/g).
'H NMR (400 MHz, CDCls) 5 0.88 (3H, t, J = 7.4 Hz, Ctf3), 1.56 -1.66 (2H, m, CH2), 3.43 
(2H, s, CH2CO), 3.57 (2H, t, J = 7.3 Hz, C/7 2N), 6.44 (1H, d, J = 8.2 Hz, ArH), 1A1 (1H, s, 
Artf), 7.52 (1H, d, J = 8.2 Hz, ArH).
13C NMR (100 MHz, CDC13) 8  10.3 (CH3), 19.6 (CH2), 34.3 (CH2CO), 40.6 (CH2N), 83.4 
(ArCI), 109.3 (ArCH), 126.0 (ArC), 132.2 (ArCH), 135.6 (ArCH), 143.5(ArC), 173.1 
(C=0).
IR (Vmax/(cm ') 2960,2917, 2848, 1698 (C=0), 1600, 1481.
MS m/z (E f  mode) 301 (M1-, 100%), 272 (36), 259 (19), 244 (19), 177 (70), 83 (29). 
C 11H 12NOI requires 300.9964, found 300.9964.
5-Merrifield bound l-benzyI-6-methoxy-3-sulfonyl-l,3-dihydro-indol-2-one (416)
OMe
S-Merrifield bound l-benzyl-3-mercapto-6-methoxy-l,3-dihydro-indol-2-one 384 (2.51 g, 
0.49 mmol/g, 1.23 mmol, 1 eq) was swollen in DMF:H2 0  (20 ml: 5 ml) for 15 min.
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Oxone® (11.4 g, 18.6 mmol, 15.1 eq) was then added and the reaction allowed to stir at rt 
for 18 h. The resin was then washed using our standard washing protocol and the product 
resin, S- Merrifield bound l-benzyl-6-methoxy-3-sulfonyl-l,3-dihydro-indol-2-one 416 
was then dried in vacuo.
IR iW (c m  ‘) 1712 (C=0), 1166 (S=0).
S-Merrifield bound 3-allyl-1 -benzyl-6-methoxy-3-sulfonyl-1,3-dihydro-indol-2-one 
(417)
OMe
S-Merrifield bound l-benzyl-6-methoxy-3-sulfonyl-l,2-dihydro-indol-2-one 416 (2.06 g, 
0.48 mmol/g, 0.98 mmol, 1 eq) was swollen in DMF (20 ml) for 15 min. K2CO3 (2.56 g,
18.5 mmol, 18.9 eq), KI (123 mg, 0.74 mmol, 0.76 eq) and allyl bromide (1.28 ml, 14.8 
mmol, 15.1 eq) were then added and the reaction was heated at 60 °C for 16 h. The resin 
was then washed using our standard washing protocol and the product resin, S-Merrifield 
bound 3-allyl-l-benzyl-6-methoxy-3-sulfonyl-l,3-dihydro-indol-2-one 417 was then dried 
in vacuo.
IR iW C cm '1) 1714 (C=0), 1180 (S=0).
3-Allyl-l-benzyl-6-methoxy-l,3-dihydro-indoI-2-one (418)
OMe
S Merrifield bound 3-allyl-l-benzyl-6-methoxy-3-sulfonyl-l,3-dihydro-indol-2-one 417 
(1.0 g, 0.47 mmol/g, 0.47 mmol, 1 eq) was swollen in THF (10 ml) for 15 min. DMPU 
(1.68 ml, 13.9 mmol, 30 eq) and a solution of Sml2 (34.7 ml of 0.1 M solution in THF, 
3.47 mmol, 7.4 eq) were added and the reaction was allowed to stir at rt for 18 h. The resin
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was filtered and the solution phase was collected and concentrated in vacuo. Filtration 
through a short plug of silica washing with 20% ethyl acetate in petroleum ether to gave 3- 
allyl-l-benzyl-6-methoxy-l,3-dihydro-indol-2-one 418 (38.7 mg, 0.13 mmol, 28 %) as a 
clear oil. (Yield over 4 solid phase steps based on thiol resin of loading 0.56 mmol/g ).
'H  NMR (400 MHz, CDCI3) 8  2.48-2.56 (1H, m, 1H from C //2CH=CH2), 2.71-2.81 (1H, 
m, 1H from CH2CH=CH2), 3.47 (1H, t, J = 6.1 Hz, CH), 3.65 (3H, s, C //3O), 4.72 (1H, d, J 
= 15.6 Hz, 1H from C //2N), 4.88 (1H, d, J = 15.6 Hz, 1H from C/f2N), 4.98 (1H, d, J =
10.1 Hz, 1H from C/72=CH), 5.05 (1H, dd, J = 17.0 Hz, 1.1 Hz, 1H from CH2 =CH), 5.62- 
5.72 (1H, m, C/7=CH2), 6.22 (1H, d„ J = 2.2 Hz, Ar//), 6.44 (1H, dd, J = 8.1, 2.2 Hz, 
Ar//), 7.10 (1H, d, J = 8.1 Hz, ArH), 7.16-7.27 (5H, m, 5 x Ar//).
13C NMR (100 MHz, CDC13) 8  35.3 (CH2CH=CH2), 43.8 (NCH2Ph), 44.7 (CH), 55.4 
(CH3O), 97.2 (ArCH), 105.9 (ArCH), 118.1 (CH2=CH), 120.5 (ArC), 124.7 (ArCH), 127.3 
(2 x ArCH), 127.6 (ArCH), 128.6 (2 x ArCH), 134.1 (CH=CH2), 135.9 (ArC), 144.7 
(ArC), 159.9 (ArC), 178.0 (C=0).
IR Dmax/frm1) 1710 (C=0 ), 1624, 1503, 1382, 1165.
MS m/z (EC mode) 293 (M+, 28%), 252 (100), 91 (75), 83 (39), 47 (8 ).
C 19H 19NO2 requires 293.1416, found 293.1415.
Ethyl-4-(2-chloroacetamido) benzoate (442)
COoEt
To a solution of 4-ethylamino benzoic acid 441 (6.04 g, 36.6 mmol, 1 eq) in CH2CI2 (100 
ml) was added NEt3 (10.2 ml, 73.2 mmol, 2 eq). The reaction was cooled to 0 °C and 
chloroacetyl chloride (3.2 ml, 40.3 mmol, 1.1 eq) was slowly added. The reaction was 
allowed to stir at rt for 3 h. The reaction mixture was then washed with 0.5M HC1, 
saturated aqueous NaHC03 then dried (MgS0 4 ) and concentrated in vacuo to give ethyl 4- 
(2-chloroacetamido)benzoate 442 (8.42 g, 34.8 mmol, 95 %) as a brown solid.
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'H  NMR (400 MHz, CDC13) 8  1.53 (3H, t, J = 7.1 Hz, CH3), 4.34 (2H, s, CH2CI), 4.49 
(2H, q, J = 7.1 Hz, CH2CH3), 7.77 (2H, m, 2 x ArH), 8.17 (2H, m, 2  x ArH), 8.50 (1H, s, 
NH).
13C NMR (100 MHz, CDC13) 8  13.3 (CH3), 41.9 (CH2), 60.0 (CH2), 118.3 (2 x ArCH),
125.7 (ArC), 129.7 ( 2  x ArCH), 140.0 (ArC), 163.5 (C=0), 165.0 (C=0).
IR tw A c m '1) 3389 (NH), 2359, 2340, 1716 (C=0, ester), 1682 (C=0, amide), 1599, 
1530,1408,1173,1107.
MS m/z (E f  mode) 241 (63), 213 (20), 196 (70), 165 918), 137 (24), 120 (500), 83 (100), 
65 (16), 47 (20).
Cn Hi2N 0 3Cl requires 241.0506, found 241.0504 
Ethyl 4-(2,6-dichlorophenyIamino)benzoate (440)
C 0 2Et
To a solution of ethyl 4-(2-chloroacetamido) benzoate 442 (7.69 g, 31.8 mmol, 1 eq) in 
DMF (140 ml) was added K2CO3 (17.6 g, 127.4 mmol, 4 eq) and 2,6-dichlorophenol (5.18 
g, 31.8 mmol, 1 eq) and the reaction was heated at 85 °C for 16 h. The reaction was 
allowed to cool and a solution of NaOEt (21.6 g, 318 mmol, 10 eq) in ethanol (80 ml) was 
added. The reaction was heated at 80 °C for 4 h. After cooling, water (150 ml) was added 
to the reaction. The water / DMF layer was extracted with CH2CI2 and the combined 
CH2CI2 layers were dried (MgSCU) and concentrated in vacuo to give a brown solid. The 
crude product mixture was purified by flash chromatography using 10 % EtOAc in 
petroleum ether as eluant to give ethyl 4-(2,6-dichlorophenylamino)benzoate 440 (3.03 g, 
9.45 mmol, 30 %) as a yellow solid.
'H  NMR (400 MHz, CDC13) 8  1.38 (3H, t, J = 7.1 Hz, CH3), 4.35 (2H, q, J = 7.1 Hz, 
CH2CH3), 5.98 (1H, s, NH), 6.67 (2H, apparent dt, J = 9.3, 2.2 Hz, 2  x ArH), 7.16 (1H, 
t, J = 8 .1 Hz, ArH), 7.43 (2H, d, J = 8.1 Hz, 2 x ArH), 7.94 (2H, d, J = 9.3 Hz, 2 x ArH).
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13C NMR (100 MHz, CDCI3 ) 8  14,8 (CH3), 60,8 (CH2), 114.8 (2 x ArCH), 122.6 (ArC),
127.1 (ArCH), 129.3 (2 x ArCH), 131.5 (2 x ArCH), 132.9 (2 x ArC), 135.6 (ArC), 148.0 
(ArC), 166.8 (C=0).
IR iw A cm '1) 3317 (NH), 2357,1667 (C=0), 1602,1515, 1287,1171.
MS m/z (EH mode) 309 (100), 264 (93), 201 (39), 167 (22), 132 (10), 83 (20), 65 (10). 
C 15H 13NO2CI2 requires 309.0323, found 309.0321.
Ethyl 4-(2-bromo-yV-(2,6-dichIorophenyl)acetamido)benzoate (439)
C 02Et
Ethyl 4-(2,6-dichlorophenylamino)benzoate 440 (1.18 g, 3.8 mmol, 1 eq) was heated in 
neat bromoacetyl bromide ( 6  ml) at 90 °C for 1 h. The reaction was allowed to cool and 
CH2CI2 (100 ml) was added. The CH2CI2 layer was washed with 0.5 M NaOH, dried 
(MgS0 4 ) and concentrated in vacuo to give ethyl 4-(2-bromo-N-(2,6- 
dichlorophenyl)acetamido)benzoate 439 (1.63 g, 3.80 mmol, 100 %) as a brown solid 
which was used without further purification ( - 2 : 1  mixture of rotamers).
‘H NMR (400 MHz, CDC13) 5 1.39 (6 H, t, J = 7.1 Hz, CH3 of both rotamers), 3.83 (2H, s, 
CH2 CO of one rotamer), 4.03 (2H, s, CH2CO of one rotamer), 4.38 (4H, q, J = 7.0 Hz, 
CH20  of both rotamers), 7.38 (6 H, broad signal, 3 x ArH of both rotamers), 7.38 (4H, 
broad signal, 2 x ArH of both rotamers), 7.75 (4H, broad signal, 2 x ArH of both 
rotamers).
13C NMR (100 MHz, CDC13) 8  14.7 (CH3), 28.6 (CH2CO), 61.5 (CH20), 124.7 (2 x 
ArCH), 130.2 (2 x ArCH), 130.6 (2 x ArCH), 131.5 (ArCH), 166.2 (C=0), signals for 
quaternary aromatic carbons not observed.
IR tW (c m  ') 2953, 1686 (C=0), 1602,1271, 1107.
MS m/z (EC mode) 431 (M+, 36%), 429 (M+, 26%), 396 (72), 309 (100), 264 (45), 201 
(35).
Ci7Hi4NC>3BrCl2 requires 428.9534, found 428.9532.
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Ethyl 4-(2-(benzylthio)-J/V-(2,6-dichlorophenyl)acetamido)benzoate (446)
C 0 2Et
To a solution of ethyl 4-(2-bromo-A^-(2,6-dichlorophenyl)acetamido)benzoate 439 (260 
mg, 0.6 mmol, 1 eq) in DMF (10 ml) was added NEt3 (0.16 ml, 1.2 mmol, 2 eq) and benzyl 
thiol (0.07 ml, 0.6 mmol, 1 eq) and the reaction allowed to stir at rt for 1 h. 30 % Ethyl 
acetate in petroleum ether was added to the reaction mixture and the mixture was washed 
with water, dried (MgS0 4 ) and concentrated in vacuo. The crude reaction mixture was 
purified by by flash chromatography using 10 % EtOAc in petroleum ether as eluant to 
give ethyl 4-(2-(benzylthio)-AL(2,6-dichlorophenyl)acetamido)benzoate 446 (212 mg, 0.44 
mmol, 74 %) as a clear oil.
'H NMR (400 MHz, CDC13) 5 1.39 (3H, t, J = 7.1 Hz, CH3), 3.06 (2H, s, one rotamer of 
CH2CO), 3.27 (2H, s, one rotamer of CH2CO), 3.94 (2H, s, PhCH2), 4.39 (2H, q, J = 7.1 
Hz, CH2O), 7.16-7.37 (10H, m, 10 x ArH), 7.55 (2H, d, J = 7.2 Hz, 2 x ArH).
13C NMR (100 MHz, CDCI3) 6  14.7 (CH3), 34.3 (CH2CO), 36.7 (PhCH2), 61.4 (CH20),
124.7 (2 x ArCH), 127.6 (2 x ArCH), 128.9 (2 x ArCH), 129.7 (2 x ArCH), 130.0 (2 x 
ArCH), 130.5 (ArCH), 131.1 (ArCH), 166.3 (C=0), 169.3 (C=0), quaternary aromatic 
carbons not detected.
IR tw /(c m '’) 2981,1714 (C=0), 1681 (C=0), 1604,1274, 1105.
MS m/z (EI+ mode) 473 (5), 351 (50), 316 (95), 309 (15), 264 (11), 91 (100), 65 (12). 
C24H2 iN0 3 BrCl2S requires 473.0619, found 473.0620.
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Ethyl 3-(benzyIthio)-l-(2,6-dichlorophenyl)-2-oxo-2,3-dihydro-lH-indol-5-yl
carboxylate (448)
BnS.
E t02C
To a solution of ethyl 4-(2-(benzylthio)-A-(2,6-dichlorophenyl)acetamido)benzoate 446 
(165 mg, 0.35 mmol, 1 eq) in hexafluoroisopropanol (5 ml) and CH2CI2 (2.5 ml). H2O2 
(0.14 ml of 35 % aq sol, 1.4 mmol, 4 eq) was added and the reaction was allowed to stir at 
room temperature for 20 min. The reaction was quenched with NaHCC>3 . CH2CI2 was 
added and the organic layer washed with water, dried (MgS0 4 ) and concentrated to give 
ethyl 4-(2-(benzylsulfinyl)-Ar-(2,6-dichlorophenyl)acetamido)benzoate 447 (172 mg, 0.35 
mmol, 100 %) as a clear oil which was used without further purification. To a solution of 
ethyl 4-(2-(benzylsulfinyl)-J/V-(2,6-dichlorophenyl)acetamido)benzoate 447 (61 mg, 0.12 
mmol, 1 eq) in 1,2-dichloroethane ( 8  ml) was added TFAA (70 pi, 0.5 mmol, 4 eq) and the 
reaction allowed to stir at room temperature for 15 min. BF3 OEt2 (0.13 ml, 1.0 mmol, 8  
eq) was added and the reaction was allowed to stir at room temperature for a further 2 0  
min. The reaction was quenched with 0.1 M NaOH. The aqueous and organic layers were 
separated and the organic layer was washed with NaHC0 3 , dried (MgS0 4 ) and 
concentrated in vacuo. The crude product mixture was purified by flash chromatography 
using 10 % ethyl acetate in petroleum ether as eluant to give Ethyl 3-(benzylthio)-l-(2,6- 
dichlorophenyl)-2-oxo-2,3-dihydro-lH-indol-5-yl carboxylate 448 47 mg, 0.29 mmol, 82 
%) as a clear oil.
'H  NMR (400 MHz, CDC13) 5 1.30 (3H, t, J = 7.1 Hz, CH3), 3.75 (1H, d, J = 12.9 Hz, 1H 
from PhCH2), 4.22-4.34 (3H, m, CH20  and 1H from PhCH2), 4.36 (1H, s, CH), 6.37 (1H, 
d, J = 8.2 Hz, ArH), 7.17-7.47 (8 H, m, 8  x ArH), 7.88 (1H, d, J = 8.2 Hz, ArH), 7.95 (1H, 
s, ArH).
13C NMR (100 MHz, CDC13) 5 14.7 (CH3), 34.9 (PhCH2), 43.4 (OH), 61.4 (CH20), 109.2 
(ArCH), 125.7 (ArC), 126.4 (ArC), 127.4 (ArCH), 127.8 (ArCH), 129.0 (2 x ArCH), 129.5
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(ArCH), 129.6 (2 x ArCH), 129.7 (2 x ArCH), 131.6 (ArCH), 131.9 (ArCH), 135.8 (2 x 
ArC), 137.3 (ArC), 146.4 (ArC), 166.3 (0=0), 174.5 (C=0).
MS m/z (FAB+ mode) 472 (M+, 64%), 349 (100), 348 (8 8 ), 91 (70).
Ethyl (l-(2,6-dichIorophenyl)-2-oxo-l,3-dihydro-indol-5-yl) carboxylate (449)
To a solution of ethyl 3-(benzylthio)-l-(2,6-dichlorophenyl)-2-oxo-2,3-dihydro-l//-indol- 
5-yl carboxylate 448 (70.3 mg, 0.14 mmol, 1 eq) in THF (5 ml) was added DMPU (0.14 
ml, 1.12 mmol, 8  eq) and a solution of Sml2 (2.97 ml of 0.1 M soln in THF, 0.30 mmol, 2 
eq) and the reaction allowed to stir at rt for 2.5 h. CHCI3 was added and the organic layer 
was washed with water, dried (MgSCU) and concentrated. The crude product mixture was 
purified by flash chromatography using 1 0  % ethyl acetate in petroleum ether as eluant to 
give ethyl (l-(2,6-dichlorophenyl)-2-oxo-l,3-dihydro-indol-5-yl) carboxylate 449 (19 mg, 
0.05 mmol, 49 % based on 20 % recovered starting material).
'H  NMR (400 MHz, CDC13) 8  1.32 (3H, t, J= 7.1 Hz, CH3), 3.75 (2H, s, CH2CO), 4.29 
(2H, q, J= 7.1Hz, CH20), 6.26 (1H, d, J = 8.3 Hz, ArH), 7.33 (1H, t, J = 7.5 Hz, ArH), 7.44 
(2H, m, 2 x ArH), 7.88 (1H, d, J= 8.3 Hz, ArH), 7.97 (1H, s, ArH).
13C NMR (100 MHz, CDC13) 8  14.7 (CH3), 34.7 (CH2CO), 61.4 (CH20), 109.5 (ArCH),
124.5 (ArC), 125.9 (ArC), 126.6 (ArCH), 129.5 (ArCH), 129.7 (2 x ArCH), 130.4 (2 x 
ArC), 131.1 (ArCH), 137.4 (ArC), 147.6 (ArC), 166.6 (C=0), 173.9 (C=0).
IR rW (c m  ‘) 2959, 2916, 1730 (C=0), 1711 (C=0), 1613,1492,1262,1162.
MS m/z (El* mode) 349 (M*, 45 %), 304 (27), 286 (15), 214 (20), 120 (24), 84 (100), 47 
(27).
C17H13NO3CI2 requires 349.0272, found 349.0270.
IR tw A cnV 1) 3062,2981,1735 (C=Q), 1710 (C=0), 1616,1494,1263,1166,1108.
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iY-ethyI-2-acetoxy-yV-phenyIacetamide (490)
o
AcO^ 1
To a solution of acetoxy acetic acid (1.29 g, 10.9 mmol, 1 eq), iV-ethyl aniline (1.65 ml,
13.1 mmol, 1.2 eq) and 1-hydroxybenzotriazole (283 mg, 2.20 mmol, 0.2 eq) in CH2CI2 
(40 ml) was added EDCI (2.50 g, 13.1 mmol, 1.2 eq) and the reaction was allowed to stir at 
room temperature for 18 h. The reaction mixture was washed with 1M HC1 and water then 
dried (MgSCU) and concentrated in vacuo to give a crude yellow oil. The crude product 
mixture was purified by flash chromatography using 50 % ethyl acetate in petroleum ether 
as eluant to give Af-ethyl-2-acetoxy-iV-phenylacetamide 490 (1.79 g, 8.01 mmol, 74 %) as a 
clear oil.
‘H NMR (400 MHz, C D C I 3 )  8  1.06 (3H, t, J = 7.1 Hz, CH3), 2.04 (3H, s, CH,), 3.69 (2H, t, 
J = 7.2 Hz, CH2), 4.26 (2H, s, C //2CO), 7.18 (2H, apparent d, J = 9.1 Hz, 2 x ArH), 7.27-
7.41 (3H, m, 3 x ArH).
I3C NMR (100 MHz, CDCI3 ) 8  13.2 (CH3), 20.6 (CH3), 44.6 (CH2N), 62.7 (CH2CO),
128.6 (2 x ArCH), 129.1 (ArCH), 130.4 (2 x ArCH), 143.2 (ArC), 165.4 (C=0, amide),
170.8 (C=0, ester).
IR tW (c m  ') 2973,2937, 1745 (C=0), 1671 (C=0), 1594,1494,1224.
MS m/z (E f  mode) 221 (M+, 20%), 148 (62), 121 (100), 83 (58), 43 (55).
C12H 15NO3 requires 221.1052, found 221.1058.
A^-Ethyl-2-hydroxy-iV-phenylacetamide (491)
To a solution of TV-ethyl-2-acetoxy-./V-phenylacetamide 490 (1.78 g, 8.05 mmol, 1 eq) in 
MeOH (30 ml) and water (15 ml) was added K2CO3 (4.45 g, 32.2 mmol, 4 eq) and the
o
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reaction was allowed to stir at room temperature for 24 h. H2O (30 ml) was added to the 
reaction and the aqueous layer was extracted with EtOAc. The combined organic layers 
were dried (MgSCU) and concentrated in vacuo to give A-ethyl-2-hydroxy-A- 
phenylacetamide 491 (1.37 g, 7.65 mmol, 95 %) as a clear oil which was used without 
further purification.
'H  NMR (400 MHz, CDC13) 5 1.05 (3H, t, J= 7.2 Hz, Ctf3), 3.45 (1H, s, OH), 3.63 (2H, s, 
CH2 CO), 3.70 (2H, q, J = 7.2 Hz, CH2), 7.07 (2H, dd, J= 8.4, 0.84 Hz, 2 x ArH), 7.23-7.37 
(3H, m, 3 x ArH).
13C NMR (100 MHz, CDC13) 5 13.3 (CH3), 44.8 (CH2), 60.9 (CH2), 128.6 (2 x ArCH),
129.1 (ArCH), 130.3 (2 x ArCH), 139.7 (ArC), 171.7 (C=0).
IR rw A c m 1) 3444 (OH), 1658 (C=0), 1594, 1496,1386.
MS m/z (EI+ mode) 179 (M+, 72%), 148 (64), 120 (100), 106 (75), 77 (52).
C10H 13NO2 requires 179.0946, found 179.0944.
4-Bromo-A-propyl aniline
Br
To a solution of 4-bromoaniline (6.00 g, 35.0 mmol, 1 eq) in CH2CI2 (150 ml) was added 
NEt3 (7.38 ml, 52.5 mmol, 1.5 eq) and propionic anhydride (9.0 ml, 70.0 mmol, 2 eq) and 
the reaction allowed to stir at room temperature for 3 h. The reaction mixture was then 
washed with aqueous saturated NaHCC>3 , dried (MgS0 4 ) and concentrated in vacuo. THF 
(120 ml) was then added and the reaction was cooled to 0 °C. LiAlHU (3.05g, 80.5 mmol, 
2.3 eq) was added slowly and the reaction was allowed to stir at room temperature for 16 h. 
The reaction was cooled to 0 °C and quenched slowly with H2O. CH2CI2 was added and 
the aqueous and organic layers were separated. The aqueous layer was extracted with 
CH2CI2 and the combined organic layers were dried (MgSCU) concentrated in vacuo. The 
crude product was purified by flash chromatography using 20 % EtOAc in petroleum ether 
to give 4-bromo-A-propyl aniline (4.97 g, 23.1 mmol, 6 6  % over 2 steps) as a dark orange 
oil.
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‘H NMR (400 MHz, CDC13) 8  1.01 (3H, t, J = 7.4 Hz, CH3), 1.66 (2H, m, CH2), 3.07 (2H, 
t, J = 7.1 Hz, CH2N), 3.87 (1H, broad singlet, NH), 6.49-6.53 (2H, m, 2 x ArH), 7.24-7.28 
(2H, m, 2 x ArH).
13C NMR (100 MHz, CDCI3) 8  12.0 (CH3), 22.9 (CH2), 46.2 (CH2N), 109.1 (ArC), 114.7 
(2 x ArCH), 132.3 (2 x ArCH), 147.7 (ArQ-
MS m/z (E f  mode) 213 (M \ 32%), 184 (100), 105 (22), 84 (34), 47 (7).
CQH^NBr requires 213.0153, found 213.0151.
Af-(4-Bromophenyl)-Af-propyl 2-acetoxyacetamide (493)
o
Br
To a solution of acetoxy acetic acid (2.64 g, 22.4 mmol, 1 eq), 4-bromo-Af-propyl aniline 
(4.97, 22.4 mmol, 1.2 eq) and 1-hydroxybenzotriazole (605 mg, 4.48 mmol, 0.2 eq) in 
CH2CI2 (40 ml) was added EDCI (5.14g, 26.9 mmol, 1.2 eq) and the reaction allowed to 
stir at room temperature for 18 h. The reaction mixture was washed with 1M HC1 and 
water then dried (MgS0 4 ) and concentrated in vacuo to give a crude yellow oil. The crude 
product mixture was purified by flash chromatography using 30 % ethyl acetate in 
petroleum ether as eluant to give 7/-(4-bromophenyl)-7V-propyl 2-acetoxyacetamide 493 
(6.16 g, 19.5 mmol, 87 %) as an orange oil.
‘H NMR (400 MHz, CDC13) 8  0.82 (3H, t, J = 7.4 Hz, CH3), 1.40-1.49 (2H, m CH2), 2.06 
(3H, s, CH3CO), 3.56 (2H, t, J = 8.2 Hz, CH2N), 4.24 (2H, s, CH2CO), 7.04- 7.08 (2H, m, 
2 x ArH), 7.47-7.52 (2H, m, 2 x ArH).
,3C NMR (100 MHz, CDC13) 8  11.5 (CH3), 20.9 (CH3CO), 21.2 (CH2), 51.4 (CH2N), 62.1 
(CH2CO), 123.0 (ArC), 130.3 (2 x ArCH), 133.7 (2 x ArCH), 140.0 (ArC), 166.4 (C=0 
amide), 170.1 (C=O, ester).
IR iW (c m '')  2962, 2933, 2873,1747 (C=0), 1679,1486, 1423, 1224.
MS m/z (E r  mode) 315 (M+, 35%), 213 (50), 184 (56), 8 6  (65), 84 (100), 43 (67). 
CoH^OaNBr requires 313.0314, found 313.0318.
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AK4-Bromophenyl)-A-propyl-2-hydroxyacetamide (494)
To a solution of iV-(4-bromophenyl)-iV-propyl 2-acetoxyacetamide 493 (748 mg, 2.38 
mmol, 1 eq) in MeOH (20 ml) and water (10 ml) was added K2CO3 (1.31g, 9.52 mmol, 4 
eq) and the reaction allowed to stir at room temperature for 24 h. H2O (20ml) was added to 
the reaction and the aqueous layer was extracted with EtOAc. Combined organic layers 
were dried (MgS0 4 ) and concentrated in vacuo to give Af-(4-bromophenyl)-iV-propyl-2- 
hydroxyacetamide 494 (646 mg, 2.36 mmol, 99 %) as an orange oil which was used 
without further purification.
'H  NMR (400 MHz, CDCI3 ) 8  0.82 (3H, t, J = 7.4 Hz, CH,), 1.40-1.51 (2H, m, CH,), 3.23 
(1H, t, J = 4.5 Hz, OH), 3.61 (2H, t, J = 7.6 Hz, CH2 N), 3.67 (2H, d, J = 4.5 Hz, CH,CO), 
6.98 (2H, d, J = 8.5 Hz, 2 x ArH), 7.50 (2H, d, J = 8.5 Hz, 2 x ArH).
I3C NMR (100 MHz, CDCI3) 5 11.5 (CH3), 21.2 (CH2), 51.6 (CH2N), 60.9 (CH2CO),
123.2 (ArC), 130.2 (2 x ArCH), 133.7 (2 x ArCH), 139.0 (ArC), 171.7 (C=0).
IR rW (c m  ') 3436 (OH), 2962, 2931,2873,1658 (C=0), 1488,1384, 1286,1097.
MS m/z (EH mode) 271 (M+, 35%), 229 (35), 184 (100), 155 (15), 105 (27), 84 (64), 43 
(68).
C n H i^ N B r requires 271.0208, found 271.0207.
iV-(4-FluorophenyO-iV-methyl 2-acetoxyacetamide (496)
o
F
To a solution of acetoxy acetic acid (2.64 g, 22.1 mmol, 1 eq), 4-fluoro-A-methyl aniline 
(2.5 ml, 22.1 mmol, 1 eq) and 1-hydroxybenzotriazole (597 mg, 4.48 mmol, 0.2 eq) in 
CH2CI2 (40 ml) was added EDCI (5.06 g , 26.5 mmol, 1.2 eq) and the reaction allowed to
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stir at room temperature for 18 h. The reaction mixture was washed with 1M HC1 and 
water then dried (MgS0 4 ) and concentrated in vacuo to give A^-(4-fluorophenyl)-//-methyl
2-acetoxyacetamide 496 (4.79 g, 21.2 mmol, 96 %) as a brown solid which was used 
without further purification.
'H  NMR (400 MHz, CDCI3) 8  2.06 (3H, s, CH3CO), 3.19 (3H, s, CH3N), 4.28 (2H, s, 
CH20), 7.05-7.20 (5H, m, 5 x ArH).
I3C NMR (100 MHz, CDCI3) 8  20.9 (CH3CO), 38.0 (CH3N), 61.9 (CH2 0), 117.5 (d, J =
22.7 Hz, 2 x ArCH), 129.5 (d, J = 8.7 Hz, 2 x ArCH), 138.4 (ArCN), 163.1 (d, J = 247.8 
Hz, ArCF), 167.0 (C=0), 171.0 (C=O).
IR rw A c m 1) 2952, 1745 (C=0, ester), 1666 (C=0, amide), 1508, 1423, 1218,1079.
MS (CC mode) 226 ((M+H)+, 100%),184 (9), 174 (8 ).
C 11H 13NO3F requires 226.0879 found 226.0855.
M pt: 65-67 °C
A-(4-FluorophenyI)-/V-methyI-2-hydroxyacetamide (497)
o
HO^A,
To a solution of A-(4-fluorophenyl)-7V-methyl 2-acetoxyacetamide 496 (4.73g, 21.0 mmol, 
1 eq) in MeOH (60 ml) and H2O (30 ml) was added K2CO3 (11.6 g, 84.0 mmol, 4 eq) and 
the reaction allowed to stir at room temperature for 24 h. H2O (20 ml) was added to the 
reaction and the aqueous layer was extracted with EtOAc. The combined organic layers 
were dried (MgS0 4 ) and concentrated in vacuo to give AL(4-fluorophenyl)-ALmethyl-2- 
hydroxyacetamide 497 (2.68 g, 14.7 mmol, 70 %) as a brown solid which was used 
without further purification.
'H  NMR (400 MHz, CDC13) 8  3.24 (3H, s, CH3N), 3.72 (2H, s, CH2CO), 7.01-7.16 (5H, 
m, 5 x ArH).
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13C NMR (100 MHz, CDC13) 5 38.0 (CH3N), 60.8 (CH2 0), 117.5 (d, J = 22.8 Hz, 2 x 
ArCH), 129.4 (d, J = 8 . 7  Hz, 2 x ArCH), 137.4 (ArCN), 162.6 (d, J = 248.1 Hz, ArCF),
172.3 (C=0).
IR Umax/(cm') 3436 (OH), 1650 (0=0), 1500,1353, 1216,1097.
MS m/z (E f  mode) 183 (M+, 6 8 %), 152 (57), 124 (100), 95 (27), 82 (14), 75 (14). 
C9H 10O2NF requires 183.0696, found 183.0695.
M p t: 95 -97 °C
A-(3,4-Dihydroquinolin-l(2H)-yl) 2-acetoxyacetamide (485)
o
To a solution of acetoxy acetic acid (602 mg, 5.10 mmol, 1 eq), 1,2,3,4- 
tetrahydroquinolone (0.70 ml, 5.60 mmol, 1.1 eq) and 1-hydroxy benzotriazole (138 mg,
1.02 mmol, 0.2 eq) in CH2CI2 (40 ml) was added EDCI (2.50 g, 13.1 mmol, 1.2 eq) and the 
reaction allowed to stir at room temperature for 4 h. The reaction mixture was washed with 
1M HC1 and water then dried (MgSC>4) and concentrated in vacuo to give a crude yellow 
oil. The crude product mixture was purified by flash chromatography using 80 % ethyl 
acetate in petroleum ether as eluant to give iV-(3,4-dihydroquinolin-l(2H)-yl) 2- 
acetoxyacetamide 485 (880 mg, 3.77 mmol, 74 %) as a white solid.
‘H NMR (400 MHz, CDC13) 5 1.77-2.02 (2H, m, CH2), 2.11 (3H, s CftCO), 2.72 (2H, t, J 
= 8.0 Hz, Ctf2Ph), 3.92 (2H, t, J = 7.2 Hz, CH2N), 4.78 (2H, s, CH2 CO), 7.11-7.29 (4H, m, 
4 x ArH).
13C NMR (100 MHz, CDCI3) 8  20.5 (CH3CO), 23.7 (CH2), 26.6 (CH2), 43.1 (CH2N), 62.2 
(CH2CO), 123.8 (ArCH), 125.9 (ArCH), 126.4 (ArCH), 128.4 (ArC), 128.8 (ArCH), 137.7 
(ArC), 166.4 (C=0, amide), 170.6 (C=0, ester).
IR r)max/(cm*') 3056,2934,1732 (C=0, ester), 1644 (C=0, amide), 1492,1401,1230.
MS m/z (EH mode) 223 (M+, 25%), 133 (100), 177 (10), 77 ( 1 2 ), 43 (41).
C13H 15NO3 requires 223.1052, found 223.1052.
Mpt: 8 6 - 8 8  °C.
186
2-Hydroxy-N-(3,4-dihydroquinoIin-1 (2H)-yl)acetamide (486)
o
HO----
To a solution of iV-(3,4-dihydroquinolin-l(2H)-yl) 2-acetoxyacetamide 485 (880 mg, 3.77 
mmol, 1 eq) in MeOH (20 ml) and H2O (10 ml) was added K2CO3 (2.18 g, 15.8 mmol, 4 
eq) and the reaction allowed to stir at room temperature for 24 h. H2O (30 ml) was added 
to the reaction and the aqueous layer was extracted with ethyl acetate. The combined 
organic layers were dried (MgSCU) and concentrated in vacuo to give 2 -Hydroxy-A^-(3,4- 
dihydroquinolin-l(2H)-yl)acetamide 486 (583 mg, 2.90 mmol, 77 %) as a yellow solid 
which was used without further purification.
'H  NMR (400 MHz, CDCI3) 8  1.95-2.06 (2H, m, C //2), 2.73-2.78 (2H, broad signal, 
Ctf2Ar), 3.62 (2H, broad signal, CH2N), 3.81 (1H, t, J= 6.5 Hz, OH), 4.31 (2H, broad 
singlet, C //2OH), 7.19-7.25 (4H, m, 4 x ArH).
I3C NMR (100 MHz, CDCI3) 8  23.9 (CH2), 27.1 (CH2), 43.6 (CH2N), 61.4 (CH20), 123.9 
(ArCH), 126.8 (ArCH), 128.8 (ArC), 129.3 (2 x ArCH), 137.6 (ArC), C=0 not detected.
IR omax/(cm'') 3371 (OH), 3059,2940, 1647 (C=0), 1487,1421, 1093.
MS m/z (EI+ mode) 191 (M+, 92%), 160 (45), 132 (100), 117 (20), 77 (25).
Cn Hi3N 0 2 requires 191.0946, found 191.0947.
Mpt: 78 °C.
iV-(Benzyl)-iV-methyl 2-acetoxyacetamide (499)
To a solution of acetoxy acetic acid (0.83 g, 7.05 mmol, 1 eq), 7V-benzylmethyl amine (1.0 
ml, 121.2 mmol, 1.1 eq) and 1-hydroxy benzotriazole (209 mg, 1.55 mmol, 0.2 eq) in 
CH2CI2 (40 ml) was added EDCI (5.14 g, 26.9 mmol, 1.2 eq) and the reaction was allowed
o
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to stir at room temperature for 18 h. The reaction mixture was washed with 1M HC1 and 
H2O then dried (MgS0 4 ) and concentrated in vacuo. The crude product mixture was 
purified by flash chromatography using 30 % ethyl acetate in petroleum ether as eluant to 
give AC(benzyl)-A-methyl 2-acetoxyacetamide 499 (1.59 g, 6.56 mmol, 93 %) as clear oil.
'H  NMR (400 MHz, CDCI3) 5 2.06 (3H, s, CH3CO of one rotamer), 2.33 (3H, s, C //3CO 
of one rotamer), 2.89 (3H, s, CH3N of one rotamer), 2.99 (3H, s, C //3N of one rotamer), 
4.49 (2 H, s, C //2N of one rotamer), 4.61 (2H, s, C //2N of one rotamer), 4.78 (4H, s, 
CH2CO of both rotamers) 7.21-7.42 (10H, m, 5 x ArH  of both rotamers).
13C NMR (100 MHz, CDCI3 ) 8  20.9 (CH3CO of one rotamer), 21.1 (CH3CO of one 
rotamer), 33.7 ( C H 3 N  of one rotamer) 34.4 (CH3N of one rotamer), 51.5 (CH2N of one 
rotamer), 52.7 (CH2N of one rotamer), 61.7 (CH2O of one rotamer), 61.8 (CH2O of one 
rotamer), 126.4 (2 xArCH of one rotamer), 127.6 (2 x ArCH of one rotamer), 127.9 (ArCH 
of one rotamer), 128.2 (2 x ArCH of one rotamer), 128.7 (2 x ArCH of one rotamer), 129.1 
(ArCH of one rotamer) 135.9 (ArC of one rotamer), 136.9 (ArC of one rotamer), 166.9 
(C=0 of amide, one rotamer), 167.2 (C=0 of amide, one rotamer), 171.1 (C=0).
IR t)ma*/(cm') 1746 (C=0 of ester), 1665 (C=0 of amide), 1495, 1232, 1067.
MS m/z (EI+ mode) 221 (M+, 2%), 161 (50), 118 (48), 91 (100), 65 (15), 43 (34). 
C 12H 15O3N requires 221.1052, found 221.1050.
A-Benzyl-2-hydroxy-A-methylacetamide (500)"
o
ho^ A n/
To a solution of A-(benzyl)-A-methyl 2-acetoxyacetamide 499 (1.19 g, 5.38 mmol, 1 eq) in 
MeOH (20 ml) and H20  (10 ml) was added K2CO3 (2.97 g, 21.5 mmol, 4 eq) and The 
reaction allowed to stir at room temperature for 24 h. H20  (20 ml) was added to the 
reaction and the aqueous layer was extracted with EtOAc. The combined organic layers 
were dried (MgS0 4 ) and concentrated in vacuo to give A-benzyl-2-hydroxy-./V-
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methylacetamide 500 (0.92 g, 5.16 mmol, 96 %) as clear which was used without further 
purification.
'H  NMR (400 MHz, CDC13) 8  2.74 (3H, s, CH3N of one rotamer), 2.96 (3H, CH3N of one 
rotamer), 3.71 (2H, broad s, OH of both rotamers), 4.21 (2H, s, C //2N of one rotamer), 
4.26 (2H, s, CH2N of one rotamer), 4.55 (2H, s, CH2 O of one rotamer), 4.31 (2H, s, CH2 O 
of one rotamer), 6.91-7.49 (10 H, m, 5 x ArH of both rotamers).
13C NMR (100 MHz, CDCI3) 6  32.4 (CH3N of one rotamer), 33.9 (CH3N of one rotamer),
51.2 (CH2N of one rotamer), 51.4 (CH2N of one rotamer), 59.9 (CH2 O of one rotamer),
60.3 (CH2O of one rotamer), 126.0 (2 x ArCH of one rotamer), 127.3 (2 x ArCH of one 
rotamer), 127.6 (ArCH of one rotamer), 127.9 (2 x ArCH of one rotamer), 128.7 (2 x 
ArCH of one rotamer), 129.1 (ArCH of one rotamer) 132.9 (ArC of one rotamer) 133.9 
(ArC of one rotamer), 169.5 (C=0 of one rotamer), 169.6 (C=0 of one rotamer).
IR tW (c m  ‘) 3398 (OH), 1639 (C=0), 1494, 1453,1384,1069.
MS m/z (EI+mode) 179 (M \ 33%), 118 (10), 91 (100), 8 8  (17), 65 (16).
C 10H 13O2N require 179.0946, found 179.0946.
Fluorous tagged oxindoles
General procedure for purification using Fluorous solid phase extraction (FSPE)
Crude reaction mixtures were loaded onto a fluorous silica gel column using 80 % MeCN / 
H2O. Non-fluorous tagged components were eluted from the column with 80 % 
MeCN/H2 0  (fluorophobic solvent). Fluorous-tagged components were then eluted using 
MeCN (fluorophilic solvent).
l-Ethyl-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfanyl)-l,3-
dihydro-indol-2-one (502)
o
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To a solution of oxalyl chloride (70 pi, 0.77 mmol, 1.1 eq) in CH2CI2 (5 ml) at -  78 °C was 
added DMSO (0.1 ml, 1.40 mmol, 2 eq). After stirring for 35 min a solution of H-ethyl-2- 
hydroxy-H-phenylacetamide 491 (125 mg, 0.70 mmol, 1 eq) in CH2CI2 (5 ml) was added. 
After stirring for a further 1 h at -  78 °C, NEt3 (0.49 ml, 3.48 mmol, 5 eq) was added and 
the reaction was allowed to stir at room temperature for 1 h 30 min. CH2CI2 was added to 
the reaction mixture and the organic layer was washed with NaHCC>3 , dried (MgSC>4), 
filtered and concentrated in vacuo to give the crude glyoxamide which was used without 
further purification. CH2CI2 (10 ml) was added to the crude glyoxamide 492 followed by 
1H, 1H,2H, 2H-perfluorodecane-l-thiol (0.14 ml, 0.49 mmol, 0.7 eq) and the reaction was 
allowed to stir at room temperature for 20 h. TFAA (0.89 ml, 6.26 mmol, 9 eq) was then 
added and after 1 h, BF3- OEt2 (0.44 ml, 3.48, 5 eq) was added. After stirring for 1 h the 
reaction was quenched with NaHCC^, the organic layer was washed with water, dried 
(MgSC>4 ), filtered and concentrated in vacuo. The crude reaction mixture was purified by 
fluorous chromatography to give l-ethyl-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfanyl)-l,3-dihydro-indol-2-one 502 (182 mg, 0.28 mmol, 59 % 
over 2  steps) as a yellow solid.
NMR (400 MHz, CDC13) 6  1.28 (3H, t, J = 7.2 Hz, CH3), 2.31-2.44 (2H, m, CF2CH2), 
2.73-2.82 (1H, m 1H from CH2S), 2.87-2.97 (1H, m, 1H from CH2S), 3.71-3.87 (2H, m, 
CH2N), 4.33 (1H, s, CH), 6.87 (1H, d, J = 7.8 Hz, ArH), 7.10 (1H, t, J = 7.5 Hz, ArH), 7.33 
(1H, t, J = 7.8 Hz, ArH), 7.40 (1H, d, J= 7.5 Hz, ArH).
13C NMR (100 MHz, CDC13) 5 12.8 (CH3), 21.2 (CH2S), 32.4 (CF2 CH2, t, J = 21.9 Hz),
35.4 (CH2N), 45.3 (CH), 108.9 (ArCH), 123.3 (ArCH), 125.7 (ArCH), 125.8 (ArC), 129.8 
(ArCH), 143.5 (ArC), 174.9 (C=0).
IR UmaxAcm'1) 3060, 2979, 1712 (C=0), 1612, 1353, 1236, 1201.
MS m/z (EC mode) 639 (M+, 10%), 161 (100), 83 (11).
C20H 14NOF17S requires 639.0525, found 639.0527.
Mpt 41-44 °C
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5-Bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfanyl)-l- 
propyl-1,3-dihydro-indol-2-one (503)
To a solution of oxalyl chloride (0.39 ml, 4.5 mmol, 1.1 eq) in CH2CI2 (30 ml) at -  78 °C 
was added DMSO (0.58 ml, 8.2 mmol, 2 eq). After stirring for 35 min a solution of N-(4- 
bromophenyl)-A-propyl-2-hydroxyacetamide 494 (1.10 g, 4.1 mmol, 1 eq) in CH2CI2 (30 
ml) was added. After stirring for a further 1 h at -  78 °C, NEt3 (2.88 ml, 20.5 mmol, 5 eq) 
was added and the reaction was allowed to stir at room temperature for 18 h. CH2CI2 was 
added to the reaction mixture and the organic layer was washed with NaHCOs, dried 
(MgSCU) and concentrated in vacuo to give the crude glyoxamide 495 (684 mg, 2.54 
mmol, 62 %) which was used without further purification. CH2CI2 (10 ml) was added to 
the crude glyoxamide followed by 1H, 1H,2H, 2H-perfluorodecane-l-thiol (0.52 ml, 1.77 
mmol, 0.7 eq) and the reaction allowed to stir at room temperature for 20 h. TFAA (3.36 
ml, 2.27 mmol, 9 eq) was added. After 1 h EtfV CM2 (1.61 ml, 12.7 mmol, 5 eq) was 
added. After stirring for lh the reaction was quenched with NaHCC^, the organic layer was 
washed with H2O, dried (MgSC^) and concentrated in vacuo. The crude reaction mixture 
was purified by fluorous chromatography to give 5-bromo-3- 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfanyl)-l-propyl-l,3-dihydro- 
indol-2-one 503 (1.10 g, 1.51 mmol, 85 % from glyoxamide) as an orange solid.
JH NMR (400 MHz, CDC13) 5 0.90 (3H, t, J = 7.4 Hz, CH3), 1.58-1.67 (2H, m, CH2), 2.28-
2.42 (2H, m, CF2 CH2), 2.78-2.78 (1H, m, 1H from Ctf2S), 2.87-2.94 (1H, m, 1H from 
CH2S), 3.52-3.66 (2H, m, CH2N), 4.24 (1H, s, CHS), 6.66 (1H, d, J = 8.3 Hz, ArH), 7.37 
(1H, dd, J = 8.3, 1.9 Hz, ArH), 7.44 (1H, s, ArH).
13C NMR (100 MHz, CDC13) 5 11.7 (CH3), 21.0 (CH2), 21.5 (CH2S), 32.3 (CF2CH2, t, J = 
22.0 Hz), 42.4 (CH2N), 44.9 (CH), 110.5 (ArCH), 115.8 (ArC), 127.7 (ArC), 128.8 
(ArCH), 132.7 (ArCH), 142.9 (ArC), 174.7 (C=O).
IR tW C crn 1) 2967, 2935, 2877, 1714 (C=0), 1606, 1481, 1238, 1203, 1145.
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MS m/z (ET mode) 733 (M+, 18%), 731 (M+, 18%), 253 (100), 210 (11). 
C2 iHi5 0 NBrFnS requires 730.9786, found 730.9781.
5-Fluoro-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsuIfanyl)-l- 
methyl-1,3-dihydro-indol-2-one (504)
To a solution of oxalyl chloride (0.53 ml, 6.02 mmol, 1.1 eq) in CH2CI2 (20 ml) at -  78 °C 
was added DMSO (0.77 ml, 10.9 mmol, 2 eq). After stirring for 35 min a solution of N-(4- 
fluorophenyl)-iV-methyl-2-hydroxyacetamide 497 (1.00 g, 5.47 mmol, 1 eq) in CH2CI2 (10 
ml) was added. After stirring for a further 1 h at -  78 °C, NEt3 (3.85 ml, 27.4 mmol, 5 eq) 
was added and the reaction was allowed to stir at room temperature for 18 h. CH2CI2 was 
added to the reaction mixture and the organic layer was washed with NaHC0 3 , dried 
(MgS04) and concentrated in vacuo to give the crude glyoxamide which was used without 
further purification. CH2CI2 ( 1 0  ml) was added to the crude glyoxamide 498 followed by 
1H, 1H,2H, 2H-perfluorodecane-l-thiol (0.89 ml, 3.05 mmol, 0.7 eq) and the reaction was 
allowed to stir at room temperature for 20 h. TFAA (5.80 ml, 39.2 mmol, 9 eq) was added, 
then, after 1 h BF3 OEt2 (2.75 ml, 21.8 mmol, 5 eq) was added. After stirring for lh the 
reaction was quenched with NaHC0 3 , the organic layer was washed with water, dried 
(MgS04) and concentrated in vacuo. The crude reaction mixture was purified by fluorous 
chromatography to give 5-fluoro-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfanyl)-l-methyl-l,3-dihydro-indol-2-one 504 (1.96 g, 2.44 mmol, 
80 % from glyoxamide) as a white solid.
'H  NMR (400 MHz, CDCI3) 8  2.37-2.48 (2H, m, CF2CH2), 2.80-2.90 (1H, m, 1H from 
CH2S), 2.95-3.00 (1H, m, 1H from CH2S), 3.24 (3H, s, CH3N), 4.30 (1H, s, CH), 6.79 (1H, 
dd, J = 8.5, 4.0 Hz, ArH), 7.07 (1H, apparent td, J = 6.7, 2.0 Hz, ArH), 7.16 (1H, dq, J = 
7.7, 0.8 Hz, ArH).
13C NMR (100 MHz, CDC13) 6  21.5 (CH2S), 26.9 (CH3N), 32.2 (CF2 CH2, t, J =21.8 Hz),
45.4 (CH), 109.3 (ArCH, d, J = 7.9 Hz), 113.6 (ArCH, d, J = 25.1 Hz), 116.2 (ArCH, d, J =
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23.4 Hz), 127.1 (A rC , d, J = 8 . 6  Hz), 140.3 (ArCN), 159.8 (ArCF, d, J = 240.4 Hz), 175.0 
(C=0).
IR 'U m a x /(c m '1)  2932, 1714 (C=0 ), 1494, 1265,1240,1211,1149.
MS m/z (E f  mode) 643 (M+, 10%), 165 (100), 164 (62), 109 (10).
C19H 11ONF18S requires 643.0274, found 643.0265.
M pt: 85 °C
l-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyIsulfanyl)-5,6-dihydro-lH- 
pyrrolo[3,2,l-ij]quinolin-2(4H)-one (488)
o
To a solution of oxalyl chloride (0.18 ml, 2.10 mmol, 1.1 eq) in CH2CI2 (10 ml) at -  78 °C 
was added DMSO (0.27 ml, 3.78 mmol, 2 eq). After stirring for 35 min a solution of 2- 
hydroxy-iV-(3,4-dihydroquinolin-l(2H)-yl)acetamide 486 (361 mg, 1.89 mmol, 1 eq) in 
CH2CI2 (10 ml) was added. After stirring for a further 1 h at -  78 °C, NEt3 (1.32 ml, 9.45 
mmol, 5 eq) was added and the reaction was allowed to stir at room temperature for 1 h 30 
min. CH2CI2 was added to the reaction mixture and the organic layer was washed with 
NaHCC>3 , dried (MgS0 4 ) and concentrated in vacuo to give the crude glyoxamide 487 
which was used without further purification. CH2CI2 ( 1 0  ml) was added to the crude 
glyoxamide followed by lH,lH,2H,2H-perfluorodecane-l-thiol (0.39ml, 1.32 mmol, 0.7 
eq) and the reaction was allowed to stir at room temperature for 20 h. TFAA (2.50 ml, 17.0 
mmol, 9 eq) was then added and after 1 h, BF3 CEt2 (1.19 ml, 9.45, 5 eq) was added. After 
stirring for lh the reaction was quenched with NaHCC^, the organic layer was washed with 
water, dried (MgS0 4 ) and concentrated in vacuo. The crude reaction mixture was purified 
by fluorous chromatography to give l-(3,3,4,4,5,5,6 ,6 ,7,7,8 ,8 ,9,9,10,10,10-
heptadecafluorodecylsulfanyl)-5,6-dihydro-lH-pyrrolo[3,2,l-ij]quinolin-2(4H)-one 488 
(559 mg, 0.86 mmol, 65 % over 2 steps) as a yellow solid.
*H NMR (400 MHz, CDC13) 5 1.89-1.99 (2H, m, CH2), 2.25-2.39 (2H, m, CF2C//2), 2.68- 
2.79 (3H, m, ArCH2 and 1H from CH2S), 2.81-2.90 (1H, m, 1H from CH2S), 3.60- 3.71
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(2H, m CH2N), 4.43 (1H, s, CH), 6.91 (1H, t, J = 7.6 Hz, ArH), 7.00 (1H, d, J = 7.6 Hz, 
ArH), 7.12 (1H, d, J = 7.6 Hz, ArH).
13C NMR (100 MHz, CDC13) 8  21.1 (CH2 and CH2 S), 24.3 (CH2), 32.0 (CF2 CH2, t, J =
21.5 Hz), 39.1 (CH2N), 46.0 (CH), 120.7 (ArC), 122.6 (ArCH), 122.7 (ArCH), 123.8 
(ArC), 128.2 (ArCH), 139.8 (ArC), 173.8 (C=0).
IR tW (c m '')  3055,2942, 1703 (C=0), 1626,1479,1194,1143.
MS m/z (EI+ mode) 651 (M+, 11%), 173 (100), 144 (14).
C21H 14F 17NOS requires 651.0525, found 651.0526.
Mpt: 71°C
4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-HeptadecafluorodecyIsulfanyl)-2-methyl-l,2- 
dihydroisoquinolin-3(4//)-one (505)
To a solution of oxalyl chloride (0.27 ml, 3.10 mmol, 1.1 eq) in CH2 CI2 (2 ml) at -  78 °C 
was added DMSO (0.40 ml, 5.60 mmol, 2 eq). After stirring for 35 min a solution of N- 
benzyl-A-methyl-2-hydroxacetamide 500 (500 mg, 2.80 mmol, 1 eq) in CH2CI2 (10 ml) 
was added. After stirring for a further 1 h at -  78 °C, NEt3 (2.20 ml, 15.5 mmol, 5 eq) was 
added and the reaction was allowed to stir at room temperature for 18 h. CH2CI2 was added 
to the reaction mixture and the organic layer was washed with NaHCOs, dried (MgSCU) 
and concentrated in vacuo to give the glyoxamide (353 mg, 2.02 mmol, 72 %) which was 
used without further purification. CH2CI2 (16 ml) was added to the crude glyoxamide 501. 
followed by 1H, 1H, 2H, 2H-perfluorodecane-l-thiol (0.41 ml, 1.40 mmol, 0.7 eq) and the 
reaction was allowed to stir at room temperature for 20 h. TFAA (2.70 ml, 18.0 mmol, 9 
eq) was added, then, after 1 h BF3 OEt2 (1.27 ml, 10 mmol, 5 eq) was added. After stirring 
for lh the reaction was quenched with NaHCC^, the organic layer was washed with water, 
dried (MgSC^) and concentrated in vacuo. The crude reaction mixture was purified by 
flash chromatography using CH2CI2 as eluant to give 4- 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfanyl)-2-methyl-l,2- 
dihydroisoquinolin-3(4H)-one 505 (402 mg, 0.64 mmol, 45 % from glyoxamide) as a 
yellow oil.
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‘H NMR 5 2.30-2.50 (2H, m, CF2CH2), 2.78-2.88 (1H, m, 1H from CH2S), 2.97-3.06 (1H, 
m, 1H from CH2S), 3.06 (3H, s, NCH3), 4.15 (1H, d, J = 15.8 Hz, 1H from CH2N), 4.49 
(1H, s, CHCO), 4.78 (1H, d, J = 15.8 Hz, 1H from CH2N), 7.09-7.30 (4H, m, 4 x ArH).
13C NMR 8  23.5 (CH2 S), 32.0 (t, J = 21.8 Hz, CF2CH2), 35.2 (NCH3), 46.9 (CH), 52.6 
(CH2N), 125.9 (ArCH), 128.3 (ArCH), 128.4 (ArCH), 128.6 (ArCH), 132.5 (ArC), 132.8 
(ArC), 167.7 (C=0).
IR iw /(cm -‘) 1654 (C=0), 1195,1143.
MS m/z (C f  mode) 640 ((M+H+), 100%), 178 (15), 162 (45), 107 (5).
C20H 15NOF17S requires 640.0603, found 640.0604.
Mpt 55-58 °C.
Ethyl 4-(2-acetoxy-iV-butylacetamido)benzoate (506)
To a solution of acetoxy acetic acid (339 mg, 2.87 mmol, 1 eq), ethyl-4-(Af- 
butylamino)benzoate 505 (0.70 g, 3.16 mmol, 1.1 eq) and 1-hydroxy benzotriazole (78 mg, 
0.57 mmol, 0.2 eq) in CH2CI2 (40 ml) was added EDCI (658 mg, 3.44 mmol, 1.2 eq) and 
the reaction was allowed to stir at room temperature for 18 h. The reaction mixture was 
washed with 1M HC1 and H2O then dried (MgSCU) and concentrated in vacuo. The crude 
reaction mixture was purified by flash chromatography using 2 0  % ethyl acetate in 
petroleum ether as eluant to give ethyl 4-(2-acetoxy-iV-butylacetamido)benzoate 506 (406 
mg, 1.26 mmol, 44 %) as a yellow oil.
‘H NMR (400 MHz, CDC13) 8  0.90 (3H, t, J = 7.3 Hz, CH3), 1.18-1.37 (2H, m, CH2), 1.41 
(3H, t, J = 7.1 Hz, CH3CH20 ) 1.47-1.53 (2H, m, CH2), 2.14 (3H, s, C //3CO), 3.75 (2H, t J 
= 7.6 Hz, CH2N), 4.35 (2H, s, CH2CO), 4.42 (2H, q, J = 7.1 Hz, CH2 O), 7.32-7.35 (2H, m, 
2 x ArH), 8.14 (2H, apparent dd, J = 6 .6 , 1.8 Hz, 2 x ArH).
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13C NMR (100 MHz, CDC13) 8  14.1 (CH3), 14.7 (CH3), 20.7 (CH2), 20.9 (CH3CO), 30.1 
(CH2), 49.7 (CH2N), 61.8 (CH20), 62.1 (CH2CO), 182.5 (2 x ArCH), 131.0 (ArC), 131.7 
(2 x ArCH), 144.9 (ArC), 165.9 (C=0), 166.3 (C=0), 170.9 (C=0).
IR W ( c m '‘) 2928, 1748 (C=0, ester), 1715 (C=0, ester), 1680 (C=0, amide), 1604, 
1508, 1367,1271, 1100.
MS m/z (EI+ mode) 321 (M+, 55%), 265 (35), 221 (55), 178 (100), 165 (53), 132 (25), 101 
(83), 73 (44).
C17H23O5N requires 321.1576, found 321.1577.
Methyl 4-(iV-butyl-2-hydroxyacetamido)benzoate (507)
C ^ O M e
To a solution of ethyl 4-(2-acetoxy-7V-butylacetamido)benzoate 506 (298 mg, 0.93 mmol, 
1 eq) in MeOH (20 ml) and H20  (10 ml) was added K2CO3 (0.65 g , 4.70 mmol, 5 eq) and 
the reaction allowed to stir at room temperature for 24 h. H20  (20 ml) was added to the 
reaction and the aqueous layer was extracted with EtOAc. The combined organic layers 
were dried (MgS0 4 ) and concentrated in vacuo to give 4-(iV-butyl-2- 
hydroxyacetamido)benzoic acid (170 mg, 0.68 mmol, 73 %) as a clear oil which was used 
without further purification. To a solution of 4-(A-butyl-2-hydroxyacetamido)benzoic acid 
(170 mg, 0.68 mmol, 1 eq) in MeOH : Toluene (1 ml : 5 ml) was added 
trimethylsilyldiazomethane (0.69 ml of 2M soln in hexane, 1.38 mmol, 2 eq) and the 
reaction allowed to stir at rt for 5 min. The reaction was then concentrated in vacuo to give 
methyl 4-(A-butyl-2-hydroxyacetamido)benzoate 507 (183 mg, 0.68 mmol, 100 %) as a 
yellow oil which was used without further purification.
‘H NMR (400 MHz, CDC13) 8  0.82 (3H, t, J = 7.2 Hz, CH3), 1.19-1.30 (2H, m, CH2), 1.19- 
1.46 (2H, m, CH2), 3.34 (1H, s, OH), 3.77 (4H, apparent singlet, CH2N and Ctf2 OH), 3.87 
(3H, s, CH3O), 7.18 (2H, apparent d, J = 8.0 Hz, 2 x ArH), 8.05 (2H, apparent d, 2  x ArH).
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13C NMR (100 MHz, CDCI3 ) 5 12.7 (CH3), 18.9 (CH2), 28.7 (CH2), 48.4 (CH2N), 51.4 
(OCH3), 59.6 (CH20), 119.2 (ArC), 127.1 (2 x ArCH), 130.3 (2 x ArCH), 142.8 (ArC),
165.0 (C=0), 170.0 (C=0).
IR iw /tc m '1) 3427 (OH), 2955, 2930, 1719 (C=0, ester), 1658 (C=0, amide), 1435, 
1274, 1100.
MS m/z (EI+ mode) 265 (M+, 40%), 209 (65), 164 (100), 132 (19), 57 (28).
C14H19O4N requires 265.1314, found 265.1314.
Modifications a-to the oxindole carbonyl
Ethyl 2-(5-fluoro-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorosulfanyl)-l-
methyl-2-oxo-2,3-dihydro-l/7-indol-3-yI)acetate (510)
EtO
To a solution of diisopropylamine (0.05 ml, 0.34 mmol, 1.2 eq) in THF (3 ml) at -78°C 
was added «-BuLi (0.14 ml of 2.46 M soln in THF, 0.34 mmol, 1.2 eq) and the reaction 
was allowed to stir for 45 min. A solution of 5-fluoro-3- 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfanyl)-l-methyl-l,3-dihydro- 
indol-2-one 504 (178 mg, 0.28 mmol, 1 eq) in THF (5 ml) was added by cannula. After 
stirring for 1 h at -78 °C, ethyl bromoacetate (0.09 ml, 0.84 mmol, 1.1 eq) was added and 
the reaction allowed to stir for 2.5 h gradually warming up to room temperature. The 
reaction was quenched with aqueous saturated NH4CI solution. The aqueous layer was 
extracted with ethyl acetate and the combined organic layers were dried (MgSCU) and 
concentrated in vacuo. The crude product was purified by fluorous chromatography to give 
ethyl 2-(5-fluoro-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfanyl)-l- 
methyl-2-oxo-2,3-dihydo-l//-indol-3-yl)acetate 510 (181 mg, 0.25 mmol, 89 %) as an 
orange oil.
*H NMR (400 MHz, CDC13) 5 0.99 (3H, t, J = 7.1 Hz, CH3), 2.07-2.20 (2H, m, CH2CF2),
2.57-2.65 (1H, m, 1H from C//2 S), 2.68-2.76 (1H, m, 1H from CH2 S), 3.02 (1H, d, J =
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16.6 Hz, 1H from CH2CO), 3.20 (3H, s, NCH3), 3.27 (1H, d, J = 16.6 Hz, 1H from 
CH2 CO), 3.80-3.93 (2H, m, CH20), 6.73 (1H, m, ArH), 6.97 (2H, m, ArH).
13C NMR (100 MHz, CDCI3 ) 5 14.2 (CH3CH2), 19.9 (CH2 S), 27.1 (CH3N), 31.8 (CH2 CF2, 
t, J = 21.9 Hz), 40.3 (CH2CO), 50.9 (CCH2), 61.5 (CH20), 109.4 (ArCH, d, J = 7.8 Hz),
111.9 (ArCH, d, J = 25.1 Hz), 116.3 (ArCH, d, J = 23.7 Hz), 130.2 (ArC, d, J = 8.0 Hz),
140.0 (ArC, d, J = 1.8 Hz), 159.7 (ArCF, d, J = 240.5 Hz), 168.6 (C=0 amide), 176.1 
(C=0 ester).
JR 'Umax/(cm'1) 1715 (C=0 amide and ester), 1613, 1496, 1194, 1144.
MS mJz (E f  mode) 729 (M+, 27%), 251 (65), 178 (100), 177 (55), 148 (20).
C23H 17NO3SF18 requires 729.0642, found 729.0639.
5-Bromo-3-(3,3>4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfanyl)-3- 
methyl-1 -propyl-1,3-dihydro-indol-2-one (511)
To a solution of diisopropylamine (0.05 ml, 0.35 mmol, 1.2 eq) and LiCl (62 mg, 1.45 
mmol, 5 eq) in THF (5 ml) at -78 °C was added zi-BuLi (0.17 ml of a 2.05 M soln in THF, 
0.35 mmol, 1.2 eq) and the reaction allowed to stir for 45 min. A solution of 5-bromo-3- 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfanyl)-l-propyl-l,3-dihydro- 
indol-2-one 503 (211 mg, 0.29 mmol, 1 eq) in THF (4 ml) was added by cannula. After 
stirring for 1 h at -  78 °C, Mel (24 pi, 0.39 mmol, 1.1 eq) was added and the reaction 
allowed to stir for 18 h gradually warming up to room temperature. The reaction was 
quenched with aqueous saturated NH4CI. The aqueous layer was extracted with ethyl 
acetate and the combined organic layers were dried (MgSCU) and concentrated in vacuo to 
give 5-bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfanyl)-3- 
methyl-1-propyl 1,3-dihydro-indol-2-one 511 (208 mg, 0.28 mmol, 96 %) as a brown oil 
which was used without further purification.
*H NMR (400 MHz, CDC13) 5 0.89 (3H, t, J = 7.4 Hz, C //3), 1.59 (3H, s, CH3), 1.55-1.67 
(2H, m CH2), 2.06-2.21 (2H, m, CF2CH2), 2.53-2.65 (2H, m, CH2 S), 3.51-3.68 (2H, m,
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CH2N), 6 . 6 8  (1H, d, J = 8.3 Hz, ArH), 7.36 (1H, dd, J = 8.3, 2.0 Hz, ArH), 7.39 (1H, d, J =
2.0 Hz, ArH).
13C NMR (100 MHz, CDCI3) 8  10.2 (CH3), 19.0 (CH2S), 19.7 (CH2), 21.4 (CH3Cquat),
30.6 (CF2CH2, t, J = 21.9 Hz), 40.9 (CH2N), 49.1 (CMe), 109.1 (ArCH), 114.6 (ArC),
126.1 (ArCH), 131.0 (ArCH), 132.1 (ArC), 140.1 (ArC), 175.7 (C=0).
IR UmaxAcm'1) 2965,1714 (C=0), 1604,1481,1238. 1195,1145.
MS mJz (EI+ mode) 747 (M+, 3%), 745 (M+, 32%), 405 (20), 337 (10), 299 (35), 268 (35), 
91 (45), 44 (100).
C22H 17NOBrF17S requires 744.9943, found 744.9954.
5-FIuoro-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfanyl)-l- 
methyl-l//-indol-2 -yl methyl carbonate
F
To a solution of 5-fluoro-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-
heptadecafluorodecylsulfanyl)-l-methyl-l,3-dihydro-indol-2-one 504 (146 mg, 0.23 mmol, 
1 eq) was added NEt3 (0.13 ml, 0.92 mmol, 4 eq) and methyl chloroformate (0.07 mml, 
0.92 mmol, 4 eq) in CH2CI2 ( 8  ml) and the reaction was allowed to stir at rt for 2 h. The 
reaction mixture was washed with saturated aqueous NaHC0 3 , dried (MgS0 4 ) and 
concentrated in vacuo to give 5-fluoro-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfanyl)-l-methyl-lH-indol-2-yl methyl carbonate (154 mg, 0.22 
mmol, 96 %) as an orange oil which was used without further purification.
'H  NMR (400 MHz, CDCI3) 8  2.26 (2H, m, CH2CF2), 2.76 (2H, t, J = 8.1 Hz, CH2 S), 3.56 
(3H, s, NCH3), 3.93 (3H, s, CH3O), 6.95 (1H, apparent td, J = 6.9, 2.5 Hz, ArH), 7.16 (1H, 
m, ArH), 7.28 (1H, dd, J = 9.1, 2.4 Hz, ArH).
I3C NMR (100 MHz, CDC13) 8  26.8 (CH2 S), 29.4 (NCH3), 32.7 (CH2CF2, t, J = 21.7 Hz),
56.9 (CH3O), 104.7 (ArCH, d, J = 24.6 Hz), 111.1 (ArCH, d, J = 9.3 Hz), 111.4 (ArCH, d,
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J = 26.0 Hz), 128.8 (ArC), 129.6 (2 x ArC), 146.6 (ArC), 152.9 (C=0), 159.3 (ArCF, d, J 
= 235.7 Hz).
IR «„„/(cmJ ) 2941,1780 (C=0), 1652,1487,1241,1200,1149.
MS m/z (EC mode) 701 (M \ 42%), 642 (27), 210 (100), 177 (20), 83 (15), 59 (15). 
C21H 13NO3F 18S requires 701.0329, found 701.0330.
Methyl 5-fluoro-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyIthio)-l- 
methyl-2-oxo-2,3-dihydro-lH-indole-3-carboxylate (512)
MeO.
To a solution of 5-fluoro-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-
heptadecafluorodecylsulfanyl)-l-methyl-lH-indol-2-yl methyl carbonate (154 mg, 0.22 
mmol, 1 eq) in toluene ( 6  ml) was added dimethylaminopyridine (9 mg, 0.07 mmol, 30 
mol %) and the reaction was heated at 70 °C for 3 h. After cooling, CH2CI2 (10 ml) was 
added and the organic layer was washed with H2O, dried (MgSCU) and concentrated in 
vacuo. The crude product was purified using fluorous chromatography to give methyl 5- 
fluoro-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfanyl)-l-methyl-2- 
oxo-2,3-dihydro-l//-indole-3-carboxylate 512 (92 mg, 0.13 mmol, 60 %) as a yellow oil.
'H  NMR (400 MHz, CDC13) 8  2.26-2.39 (2H, m, CH2CF2), 3.00 (2H, t, J = 8.1 Hz, C //2S), 
3.20 (3H, s, NCH3), 3.72 (3H, s, Ctf3 0 ), 6.74 (1H, dd, J = 8 .6 , 4.0 Hz, ArH), 6.99-7.10 
(2H, m, 2 x ArH).
13C NMR (100 MHz, CDC13) 5 20.9 (CH2S), 27.3 (CH3N), 31.8 (CH2 CF2, d, J = 21.7 Hz),
54.4 (CH30), 58.0 (CCO), 109.8 (ArCH, d, J = 8.0 Hz), 113.5 (ArCH, d, J = 25.3 Hz), 
117.2 (ArCH, d, J = 23.3 Hz), 126.8 (ArC, d, J = 8.5 Hz), 139.6 (ArC), 159.7 (ArCF, d, J =
241.4 Hz), 167.1 (C=0), 171.9 (C=0).
IR 1746 (C=0), 1716 (C=0), 1495, 1198,1144.
MS m/z (EF mode) 701 (M+, 10%), 642 (20), 191 (100), 135 (10).
C2 ]H]3N0 3 F]8S requires 701.0329, found 701.0328.
200
Methyl-3-(5-bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10
heptadecafUiorodecylsulfanyl)-2-oxo-l-propyI-2,3-dihydro-l/Z-indoI-3-yl)propanoate
(513)
MeO.
To a solution of 5-bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfanyl)-l-propyl-l,3-dihydro-indol-2-one 504 (84 mg, 0.11 mmol, 
1 eq) in MeOH (5 ml) was added NaOMe (15 mg, 0.28 mmol, 2.5 eq) and methyl acrylate 
(13 pi, 0.14 mmol, 1.3 eq) was added and the reaction allowed to stir for 18 h gradually 
warming up to room temperature. The reaction was quenched with aqueous saturated 
NH4 CI. The aqueous layer was extracted with CH2CI2 and the combined organic layers 
were dried (MgSCU) and concentrated in vacuo. The crude reaction mixture was purified 
by fluorous chromatography to give methyl-3-(5-bromo-3- 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfanyl)-2-oxo-l-propyl-2,3- 
dihydro-l//-indol-3-yl)propanoate 513 (64 mg, 0.08 mmol, 71 %) as a white solid.
‘H NMR (400 MHz, CDCI3) 5 0.90 (3H, t, J = 7.4 Hz, CH3), 1.58-1.67 (2H, m, C //2CO), 
1.95-2.03 (1H, m, one CH of CH2CS), 2.08-2.21 (3H, m, one CH of CH2CS and RfCH2), 
2.28-2.43 (2H, m, CH2CH3), 2.56-2.71 (2H, m, CH2 S), 3.52 (3H, s, OCH3), 3.60 (2H, t, J =
7.3 Hz, CH2N), 6.69 (1H, d, J = 8.3 Hz, ArH), 7.35 (1H, d, J = 2.0 Hz, ArH), 7.38 (1H, dd, 
J=  8.3, 2.0 Hz, ArH).
13C NMR (100 MHz, CDCI3 ) 8  11.7 (CH3), 20.0 (CH2S), 21.1 (CH2 CH3), 29.7 (CH2CS),
31.1 (CH2CO), 31.8 (CF2CH2 ,t, J = 21.7 Hz), 42.4 (CH2N), 52.2 (OCH3), 53.6 (CS), 110.6 
(ArCH), 116.1 (ArC), 127.9 (ArCH), 130.7 (ArC), 132.9 (ArCH), 142.1 (ArC), 172.5 
(C=0), 175.7 (C=0).
IR rW (c m -1) 2938, 1735 (C=0), 1708 (C=0), 1604,1481,1195, 1143.
MS (FAB+ mode) 818 (M \ 60%), 340 (85), 340 (85), 306 (100), 278 (83), 236 (20), 70 
(28).
C25H22N0 3 SnFBr requires 818.0232, found 818.0213.
Mpt 53 °C
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5-Bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafIuorodecylsulfonyl)-l- 
propyl-1,3-dihydro-indoI-2-one (514)
To a solution of 5-bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfanyl)-l-propyl-l,3-dihydro-indol-2-one 503 (564 mg, 0.77 mmol, 
1 eq) in CH2CI2 (15 ml) was added mCPBA (709 mg of 57-86 % mCPBA, -3.08 mmol, -4  
eq) and the reaction allowed to stir at room temperature for 2 h. The reaction mixture was 
washed with saturated aqueous NaHCC>3 , dried (MgS0 4 ) and concentrated in vacuo. The 
crude product was purified using fluorous phase chromatography to give 5-bromo-3- 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfonyl)-l-propyl-l,3-dihydro- 
indol-2-one 514 (463 mg, 0.61 mmol, 79 %) as an orange solid.
'H  NMR (400 MHz, CDCI3) 5 0.89 (3H, t, J = 7.4 Hz, CH,), 1.59-1.68 (2H, m, CH,), 
2.63-2.76 (2H, m, CH2CV2), 3.52-3.74 (3H, m, CH,N and 1H from CH2S 0 2), 3.79-3.86 
(1 H, m, 1H from CH2S 0 2), 4.76 (1H, s, CH), 6.71 (1H, d, J = 8.4 Hz, ArH), 7.49 (1H, dd, J 
= 8.4, 1.5 Hz, ArH), 7.69 (1H, d, J = 1.5 Hz, ArH).
I3C NMR (100 MHz, CDC13) 8  11.5 (CH3), 20.9 (CH2), 24.7 (CF2 CH2, t, J = 22.6 Hz),
42.7 (CH2N), 44.4 (CH2S 02), 65.6 (CH), 111.1 (ArCH), 116.5 (ArC), 118.9 (ArC), 130.6 
(ArCH), 134.4 (ArCH), 144.2 (ArC), 167.0 (C=0).
IR \ W ( c m ‘) 2971,2922,1731 (C=0), 1482, 1197,1138.
MS m/z (EI+ mode) 763 (M+, 8 %), 252 (100), 210 (10), 173 (11), 116 (10). 
C2 iHi5 0 3 NBrFi7 S requires 762.9685, found 762.9683.
Mpt: 132 °C.
202
5-Bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfonyl)-3-
methyl-l-propyl-l,3-dihydro-indol-2-one (515)
To a solution of 5-bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfonyl)-l-propyl-l,3-dihydro-indol-2-one 514 (321 mg, 0.41 mmol, 
1 eq) in DMF ( 8  ml) was added K2CO3 (0.57 g, 4.1 mmol, 10 eq), and methyl iodide (0.25 
ml, 4.10 mmol, 10 eq) and the reaction was heated at 40 °C for 2 h. EtOAc (10 ml) was 
added to the reaction and the organic layer was washed with water, dried (MgS0 4 ) and 
concentrated in vacuo. The crude reaction was purified using fluorous chromatography to 
give 5-bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfonyl)-3- 
methyl-1-propyl-l,3-dihydro-indol-2-one 515 (292 mg, 0.38 mmol, 92 %) as an orange 
solid.
‘H NMR (400 MHz, CDCI3) S 0.89 (3H, t, J = 7.4 Hz, CH3), 1.61-1.70 (2H, m, CH2), 1.84 
(3H, s, CH3C), 2.54-2.66 (3H, m, CH2CF2), 3.30-3.38 (1H, m, 1H from CH2 S 0 2), 3.51- 
3.58 (1H, m, 1H from CH2N), 3.69-3.80 (2H, m, 1H from CH2N and 1H from C //2S 0 2), 
6.75 (1H, d, J = 8.4 Hz, ArH), 7.49 (1H, dd, J = 8.4, 2.0 Hz, ArH), 7.62 (1H, d, J = 2.0 Hz, 
ArH).
13C NMR (100 MHz, CDC13) 5 11.5 (CH3), 18.8 (CH3C), 20.9 (CH2), 24.2 (CF2CH2 lt, J =
24.0 Hz), 40.4 (CH2 S 02), 42.8 (CH2N), 70.3 (CCH3), 111.0 (ArCH), 116.5 (ArC), 125.0 
(ArC), 129.8 (ArCH), 134.3 (ArCH), 143.2 (ArC), 171.2 (C=0).
IR iW (c m  ') 2976, 2943, 1707 (C=0), 1482,1197,1145.
MS m/z (FAB+mode) 778 ((M+H)+, 14%), 266 (100), 188 (27), 69 (28).
C22Hi8 0 3 NBrFi7S requires 777.9919, found 777.9904.
Mpt: 106 °C.
203
3-Benzyl-5-bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-
heptadecafluorodecylsulfonyl)-l-propylindol-2-one (516)
Bn
To a solution of 5-bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfonyl)-1-propyl-l,3-dihydro-indol-2-one 514 (472 mg, 0.62 mmol, 
1 eq) in DMF (15 ml) was added K2CO3 (856 mg, 6.20 mmol, 10 eq), KI (103 mg, 0.62 
mmol, 1 eq) and benzyl bromide (0.37ml, 3.10 mmol, 5 eq) and the reaction heated at 60 
°C for 3 h. EtOAc (10 ml) was added to the reaction and the organic layer was washed with 
water, dried (MgS0 4 ) and concentrated in vacuo. The crude reaction was purified using 
fluorous chromatography to give 3-benzyl-5-bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfonyl)-l-propyl-l,3-dihydro-indol-2-one 516 (481 mg, 0.58 mmol, 
94 %) as a white solid.
'H  NMR (400 MHz, CDC13) 5 0.62 (3H, t, J = 7.4 Hz, CH3), 1.25-1.34 (2H, m, CH2), 2.57- 
2.70 (2H, m, CH2CF2), 3.27-3.53 (3H, m, CH2N and 1H from CH2S 0 2), 3.54 (1H, d, J =
12.8 Hz, 1H from PhCH2), 3.67 (1H, d, J = 12.8 Hz, 1H from PhCH2), 3.80-3.90 (1H, m, 
1H from CH2S 0 2), 6.48 (1H, d, J = 8.4 Hz, ArH), 6.84 (2H, apparent dd, J = 7.7, 1.4 Hz, 2 
x ArH), 6.96-7.09 (3H, m, 3 x ArH), 7.37 (1H, dd, J = 8.4, 2.0 Hz, ArH), 7.77 (1H, d, J =
2.0 Hz, ArH).
13C NMR (100 MHz, CDCI3) 8  11.4 (CH3), 20.6 (CH2), 24.2 (CF2 CH2, t, J = 22.5 Hz),
37.7 (PhCH2), 41.0 (CH2S 02), 42.6 (CH2N), 75.4 (CCH2Ph), 110.9 (ArCH), 116.1 (ArC),
122.7 (ArC), 128.1 (ArCH), 128.7 (2 x ArCH), 130.2 (ArCH), 130.4 (2 x ArCH), 132.0 
(ArC), 134.2 (ArCH), 143.7 (ArC), 169.8 (C=0).
IR tW (c m '')  2949,2874,1710 (C=0), 1605,1485,1197,1133.
MS m/z (FAB+ mode) 854 ((M+H)+, 17%), 342 (100), 314 (35), 264 (20), 69 (27). 
C28H2 2 0 3 NBrFnS requires 854.0232, found 854.0223.
Mpt: 124-126 °C.
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l-Ethyl-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10 
heptadecafluorodecylsulfonyl)-1,3-dihydro-indol-2-one (517)
To a solution of l-ethyl-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfanyl)-l,3-dihydro-indol-2-one 502 (118 mg, 0.18 mmol, 1 eq) in 
CH2C12 (10 ml) was added mCPBA (182 mg of 57-86 % mCPBA, -0.74 mmol,-4  eq) and 
the reaction allowed to stir at room temperature for 45 min. The reaction mixture was 
washed with saturated aqueous NaHCOs, dried (MgS0 4 ) and concentrated in vacuo. The 
crude product was purified using fluorous phase chromatography to give l-ethyl-3- 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfonyl)-l,3-dihydro-indol-2- 
one 517 (99 mg, 0.15 mmol, 81 %) as an orange-brown solid.
*H NMR (400 MHz, CDC13) 5 1.23 (3H, t, J = 7.24 Hz, CH3), 2.61-2.75 (2H, m, CF2C//2),
3.57-3.85 (4H, m, CH2S and CH2N), 4.76 (1H, s, CH), 6.87 (1H, d, J = 7.9 Hz, ArH), 7.11 
(1H, t, J = 8.0 Hz, ArH), 7.41 (1H, t, J = 7.8 Hz, ArH), 7.58 (1H, d, J = 7.6 Hz, ArH).
13C NMR (100 MHz, CDC13) 6  12.8 (CH3), 24.7 (CF2 CH2, t, J = 22.7 Hz), 35.9 (CH2S),
44.2 (CH2), 66.0 (CH), 109.6 (ArCH), 116.7 (ArC), 123.9 (ArCH), 127.7 (ArCH), 131.5 
(ArCH), 144.7 ArC), 166.9 (C=0).
IR v mJ(crr il) 2887, 2944, 2886, 1708 (C=0), 1610, 1195, 1143.
3-Benzyl-l-ethyI-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfanyl)- 
l,3-dihydro-indol-2-one (518)
Bn
To a solution of l-ethyl-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfonyl)-l,3-dihydro-indol-2-one 517 (29.3 mg, 0.04 mmol, 1 eq) in
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DMF (5 ml) was added K2CO3 (55 mg, 0.4 mmol, 10 eq), KI (3 mg, 0.02 mmol, 0.5 eq) 
and benzyl bromide (0.05ml, 0.4 mmol, 10 eq) and the reaction heated at 60 °C for 18 h. 
EtOAc (10 ml) was added to the reaction and the organic layer was washed with water, 
dried (MgS0 4 ) and concentrated in vacuo. The crude prodict mixture was purified using 
fluorous chromatography to give 3-benzyl-l-ethyl-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfanyl)-l,3-dihydro-indol-2-one 518 (30 mg, 0.04 mmol, 100 %) as 
a brown solid.
‘H NMR (400 MHz, CDC13) 6  0.82 (3H, t, J = 7.2 Hz, CH3), 2.52-2.65 (2H, m, CF2CH2), 
3.32-3.43 (2H, m, 1H from CH2N and 1H from CH2 S), 3.56-3.80 (4H, m, 1H from CH2N 
and 1H from CH2 S and PhC/^) 6.61 (1H, d, J = 7.8 Hz, ArH), 6.83 (2H, apparent dd, J = 
7.7, 1.2 Hz, 2 x ArH), 6.94- 7.03 (3H, m, 3 x ArH), 7.10 (1H, t, J = 8.1 Hz, ArH), 7.26 
(1H, t, J = 8.4 Hz, ArH), 7.76 (1H, d, J = 7.6 Hz, ArH).
13C NMR (100 MHz, CDC13) S 12.1 (CH3), 24.3 (CF2 CH2, t, J = 22.3 Hz), 35.5 (CH2N),
37.6 (CH2Ph), 41.1 (CH2S 0 2), 109.3 (ArCH), 120.9 (ArC), 123.6 (ArCH), 127.4 (ArCH),
127.8 (ArCH), 128.4 (2 x ArCH), 130.5 (2 x ArCH), 131.4 (ArCH), 132.3 (ArC), 143.9 
(ArC), 169.7 (C=0).
IR rW (c m '')  3066, 2979,2929,1700 (C=0), 1610,1488,1369, 1195,1133.
MS m/z (EI+ mode) 761 (M+, 11%), 250 (100), 222 (100), 193 (15), 91 (24)
C27H20O3NF17S requires 761.0892, found 761.0895.
Mpt 96 -  98 °C.
2-Bromo-A-(4-bromophenyl)-A-propyIacetamide (521)
o
Br
To a solution of 4-bromo-A-propyl aniline (379 mg, 1.77 mmol, 1 eq) in CH2CI2 (80 ml) 
was added NEt3 (0.5 ml, 3.54 mmol, 2 eq) and bromoacetyl bromide (0.23 ml, 2.66 mmol,
1.5 eq) and the reaction allowed to stir at room temperature for 3 h. The reaction mixture 
was then washed with 2M NaOH, dried (MgSOzO and concentrated in vacuo to give 2-
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bromo-Af-(4-bromophenyl)-N-propylacetamide 521 (522 mg, 1.65 mmol, 93 %) as an 
orange oil which was used without further purification.
‘H NMR(400 MHz, CDC13) 5 0.83 (3H, t, J = 7.4 Hz, Ctf3), 1.41-1.51 (2H, m, CH2), 3.53- 
3.63 (4H, m, C7/2N and CH2CO), 7.10 (2H, apparent d, J = 8 . 6  Hz, 2 x ArH), 7.46 (2H, 
apparent d, J = 8 . 6  Hz, 2 x ArH).
13C NMR (100 MHz, CDC13) 5 11.4 (CH3), 21.1 (CH2), 27.4 (CH2), 51.9 (CH2CO), 122.9 
(ArC), 130.2 (2 x ArCH), 133.5 (2 x ArCH), 141.0 (ArC), 166.4 (C=0).
IR t)inax/(cm ') 2962,2931,2873,1656 (C=0), 1484,1211,1118,1010.
MS m/z (El* mode) 334 (M+, 39%), 292 (40), 254 (40), 184 (100), 155 (14).
CnHi3NOBr2 requires 332.9364, found 332.9362.
Af-(4-Bromophenyl)-2-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-
heptadecafluorodecyIsulfanyI)-iV-propylacetamide (522)
o
Br
To a solution of 2-bromo-iV-(4-bromophenyl)-./V-propylacetamide 521 (548 mg, 1.60 
mmol, 1 eq) in DMF (5 ml) was added NEt3 (0.45 ml, 3.20 mmol, 2 eq) and 1H,1H,2H,2H- 
perfluorodecane-1-thiol (0.47 ml, 1.60 mmol, 1 eq) and the reaction allowed to stir at rt for 
1 h. 30% EtOAc in petroleum ether was added and the organic layer was washed with 
H2O, dried (MgSCU) and concentrated in vacuo. The crude product was purified by 
fluorous chromatography to give 7V-(4-bromophenyl)-2-
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfanyl)-Af-propylacetamide 522 
(874 mg, 1.20 mmol, 75 %) as a clear oil.
'H  NMR (400 MHz, CDC13) 5 0.82 (3H, t, J = 7.4 Hz, CH,), 1.41-1.50 (2H, m, C/C), 2.27-
2.30 (2H, m, CF2C //2), 2.81 (2H, t, J = 8.0 Hz, CH2S), 2.95 (2H, s, CH2CO), 3.56 (2H, t, J 
= 7.6 Hz, C //2N), 7.05 (2H, apparent d, J = 8.4 Hz, 2 x ArH), 7.49 (2H, apparent d, J = 8 . 8  
Hz, 2 x ArH).
207
,3C NMR (100 MHz, CDC13) 5 11.0 (CH3), 20.8 (CH2), 23.3 (CH2S), 31.6 (CF2 CH2,t, J =
21.5 Hz), 33.4 (CH2 CO), 51.1 (CH2N), 122.2 (ArC), 130.1 (2 x ArCH), 133.0 (2 x ArCH),
141.0 (ArC), 168.4 (C=0).
IR rw A cm '1) 2969,1654 (C=0), 1486, 1241,1213.
MS m/z (EH mode) 733 (M+, 4%), 654 (3), 493 (35), 255 (62), 213 (100), 184 (28), 43 
(32).
C2,HnNOBrFnS requires 732.9943, found 732.9938.
(Zs)-Methyl 3-(4-(2-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfanyl)- 
A-propylacetamido)phenyl)acryIate (523)
OMe
A flask containing N-(4-bromophenyl)-2-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfanyl)-7V-propylacetamide 522 (208 mg, 0.28 mmol, 1 eq), 
Pd(OAc) 2  (18 mg, 0.08 mmol, 30 mol %), P(o-Tol) 3  (26 mg, 0.08 mmol, 30 mol %) was 
flushed with argon. Methyl acrylate (0.50 ml, 5.60 mmol, 20 eq), NEt3 (0.04 ml, 0.31 
mmol, 1.1 eq) and 0 -xylene (3ml) were added and the reaction was heated at 100 °C for 18 
h. The reaction was allowed to cool, CH2CI2 was added and the organic layer was washed 
with water, dried (MgS0 4 ) and concentrated in vacuo. The crude reaction mixture was 
purified by flash chromatography using 20 % EtOAc in petroleum ether as eluant to give 
(£)-methyl 3-(4-(2-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfanyl)-AL 
propylacetamido)phenyl)acrylate 533 ( 8 8  mg, 0.12 mmol, 43 %) as a yellow oil.
]H NMR (400 MHz, CDC13) 5 0.87 (3H, t, J = 7.2 Hz, CH3), 1.43-1.53 (2H, m, CH2), 
2.27-2.43 (2H, m, CH2 CF2), 2.82 (2H, t, J = 8.0 Hz, CH2 S), 2.98 (2H, s, CH2CO), 3.63 
(2H, t, J = 6.3 Hz, CH2N), 3.75 (3H, s, OC//3), 6.38 (1H, d, J = 16.0 Hz, C//=CHC02Me), 
7.18-7.20 (2H, m, 2 x ArH), 7.51 (2H, apparent d, J = 8.4 Hz, 2 x ArH), 7.61 (1H, 
apparent d, J = 16.0 Hz, CH=C//C0 2 Me).
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13C NMR (100 MHz, CDC13) 5 11.5 (CH3), 21.3 (CH2), 23.7 (CH2S), 32.0 (CF2CH2, t, J =
21.9 Hz), 33.8 (CH2CO), 51.6 (CH2N), 52.2 (CH3O), 119.6 (CH=CHC02Me), 129.3 (2 x 
ArCH), 129.7 (2 x ArCH), 134.8 (ArC), 143.5 (CH=CHC02Me), 143.9 (ArC), 167.4 
(C=0), 168.8 (C=0).
IR t>max/(cm ') 1715 (C=0, ester), 1638 (C=0, amide), 1509,1236, 1200.
MS mJz (EF mode) 739 (M+, 10%), 493 (18), 219 (100), 190 (25), 176 (14), 43 (13). 
C25H22O3NF17S requires 739.1049, found 739.1046.
(Z£)-Methyl 3-(3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfonyl)-3-
(3-methoxy-3-oxopropyl)-2-oxo-l-propyl-2,3-dihydro-lH-indol-5-yl)acrylate (524)
MeO.
MeO.
O
A flask containing 5-bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-
heptadecafluorodecylsulfonyl)-l-propyl-l,3-dihydro-indol-2-one 514 (76 mg, 0.10 mmol, 
1 eq), Pd(OAc) 2  (7 mg, 0.03 mmol, 30 mol %), P(o-Tol)3  (9 mg, 0.03 mmol, 30 mol %) 
was flushed with argon. Methyl acrylate (0.05 ml, 0.5 mmol, 5 eq), NEt3 (0.02 ml, 0.11 
mmol, 1.1 eq) and o-xylene (5 ml) were added and the reaction was heated at 100 °C for 18 
h. The reaction was allowed to cool, CH2CI2 was added and the organic layer was washed 
with water, dried (MgS0 4 ) and concentrated in vacuo. The crude reaction mixture was 
purified by flash chromatography using 30 % EtOAc in petroleum ether as eluant to give 
(£)-methyl 3-(3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfonyl)-3-(3- 
methoxy-3-oxopropyl)-2-oxo-l-propyl-2,3-dihydro-lH-indol-5-yl)acrylate 524 as a yellow 
oil (impure, yield not determined).
]H NMR (400 MHz, CDC13) 6  0.91 (3H, t, J = 7.3 Hz, CH3), 1.62-1.72 (2H, m, CH2), 
1.85-1.93 (1H, m, 1H from Ctf2C(quat)), 2.00-2.10 (1H, m, 1H from CH2C(quat)), 2.54- 
2.81 (4H, m CH2CF2 and CH2CO), 3.32-3.38 (1H, m, 1H from CH2S 0 2), 3.50 (3H, s, 
CH3O), 3.58-3.92 (6 H, m, CH2N, CH3Q and 1H from CH2S 0 2), 6.34 (1H, d, J = 15.8 Hz,
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CH=CHC02Me), 6.90 (1H, d, J = 8.2 Hz, ArH), 7.53 (1H, dd, J = 8.2, 1.6 Hz, ArH), 7.59 
(1H, d, J = 16.0 Hz, CH=CHC02Me), 7.63 (1H, d, J = 1.5 Hz, ArH).
13C NMR (100 MHz, CDC13) 8  11.6 (CH3), 21.1 (CH2), 24.2 (CF2 CH2), 26.9 
(CH2C(quat)), 29.2 (CH2CO), 40.7 (CH2N), 43.0 (CH2S 0 2), 52.2 (CH30), 52.4 (CH30),
73.8 (C(quat)), 110.1 (ArCH), 117.9 (CH=CHC02Me), 120.1 (ArC), 126.1 (ArCH), 130.7 
(ArC), 132.4 (ArCH), 143.7 (CH=CHC02Me), 146.2 (ArC), 167.6 (C=0), 170.5 (C=0),
171.7 (C=0).
IR iW /Ccm'1) 1737 (C=0 ), 1708 (C=0 ), 1636,1608,1196,1136.
MS m/z (FAB+ mode, Nal) 878 ((M + Na)+,100%), 856 (15), 367 (74), 344 (6 6 ), 312 (47), 
271 (17).
C29H26N0 7 SFnNa requires 878.1056, found 878.1060.
3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-HeptadecafluorodecylsuIfonyl)-5-(3- 
hydroxyprop-l-ynyl)-3-methyl-l-propyl-l,3-dihydro-indol-2-one (525)
HO-
A flask containing 5-bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-
heptadecafluorodecylsulfonyl)-3-methyl-1 -propyl-l,3-dihydro-indol-2-one 515 ( 6 6  mg, 
0.08 mmol, 1 eq) and palladium (0 ) tetrakis(triphenylphosphine) (18 mg, 0 . 0 2  mmol, 2 0  
mol %) was flushed with argon. Propargyl alcohol (14 pi, 0.16 mmol, 3 eq) and 
triethylamine (3 ml) was added and the reaction was heated at 80 °C. The reaction was 
allowed to cool, CH2CI2 was added and the organic layer was washed with water, dried 
(MgSCU) and concentrated in vacuo. The crude product mixture was purified using 
fluorous chromatography to give 3-(3,3,4,4,5,5,6 ,6 ,7,7,8 ,8 ,9,9,10,10,10-
heptadecafluorodecylsulfon yl)-5-(3-hydroxyprop-l-ynyl)-3-methyl-l-propyl-1,3-dihydro- 
indol-2-one 525 (33 mg, 0.05 mmol, 59 %) as a yellow oil.
‘H NMR (400 MHz, CDC13) 8  0.90 (3H, t, J = 8.1 Hz, CH3), 1.61-1.70 (2H, m, CH2), 1.83 
(3H, s, CHjC), 2.53-2.66 (2H, m, CH2CF2), 3.30-3.37 (1H, m, 1H from CH2S 0 2), 3.52-
2 1 0
3.60 (1H, m, 1H from Ctf2N), 3.70-3.79 (2H, m, 1H from Ctf2N and 1H from CH2S 0 2), 
4.42 (2H, s, C7 7 2OH), 6.82 (1H, d, J = 8.2 Hz, ArH), 7.44 (1H, dd, J = 8.2, 1.6 Hz, ArH), 
7.57 (1H, d, J = 1.6 Hz, ArH).
13C NMR (100 MHz, CDC13) 5 11.5 (Ctf3), 18.7 (CH/C), 21.0 (Ctf2), 24.2 (CH2 CF2 .t, J =
22.0 Hz), 40.4 (CH2S 02), 42.8 (CH2N), 52.0 (CH2 OH), 70.1 (CCH3), 85.2 (Calkyne), 87.9 
(Caikyne), 109.6 (ArCH), 118.3 (ArC), 123.4 (ArC), 130.0 (ArCH), 135.1 (ArCH), 144.1 
(ArC), 171.6 (C=0).
IR iW ( c m ')  2938,2359 (C=C), 1711 (C=0), 1490, 1197, 1142, 1089.
MS m/z (E l+ mode) 753 (M+, 5%), 242 (100), 200(3), 77 (2).
C25H2 0O4NF17S requires 753.0842, found 753.0845.
3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-HeptadecafluorodecyIsulfonyI)-3-methyl-l-
propyl-5-(2-(trimethylsiIyl)ethynyI)-l,3-dihydro-indol-2-one (526)
TMS
A flask containing 5-bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-
heptadecafluorodecylsulfonyl)-3-methyl-l-propyl-l,3-dihydro-indol-2-one 515 (49 mg, 
0.06 mmol, 1 eq) and palladium (0) tetrakis(triphenylphosphine) (15 mg, 0.02 mmol, 20 
mol %) and copper (I) iodide (2 mg, 0.01 mmol, 20 mol %) was flushed with Argon. 
Trimethyl silylacetylene (0.09 ml, 0.63 mmol, 10 eq) and triethylamine (3 ml) was added 
and the reaction was heated at 60 °C. The reaction was allowed to cool, CH2CI2 was added 
and the organic layer was washed with water, dried (MgSCU) and concentrated in vacuo. 
The crude product mixture was purified using fluorous chromatography to give 3- 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfonyl)-3-methyl-l-propyl-5- 
(2-(trimethylsilyl)ethynyl)-l,3-dihydro-indol-2-one 526 (41 mg, 0.05 mmol, 82 %) as a 
yellow oil.
'H  NMR (400 MHz, CDC13) S 0.26 (9H, s, (Ctf3 )3Si), 0.97 (3H, t, J = 7.4 Hz, CH3), 1.69- 
1.78 (2H, m, CH2), 1.91 (3H, s, Ctf3C), 2.60-2.73 (2H, m, CH2CF2), 3.36-3.43 (1H, m, 1H
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from CH2S 0 2), 3.60-3.66 (1H, m, 1H from CH2S 02), 3.77-3.85 (2H, m, CH2N), 6.87 (1H, 
d, J = 8.2 Hz, ArH), 7.55 (1H, dd, J = 8.2,1.5 Hz, ArH), 7.67 (1H, d, J = 1.5 Hz, ArH).
13C NMR (100 MHz, CDC13) 5 0.00 ((CH3)3Si), 11.2 (CH3), 18.3 (CH3C), 20.7 (CH2) 23.9 
(CH2CF2, t, J = 22.0 Hz), 40.1 (CH2SO2), 42.9 (CH2N), 69.8 (CMe), 94.7 (CaU:yne), 104.1 
(Caiky„e), 109.1 (ArCH), 118.7 (ArC), 123.0 (ArC), 129.8 (ArCH), 135.0 (ArCH), 143.7 
(ArC), 171.3 (C=0).
IR ,umax/(cm'1) 2969, 2882,2155 (C C ), 1716 (C=0), 1614,1489, 1199,1143.
MS m/z (FAB mode, Nal) 818 ((M+Na)+, 2%), 796 (9), 284 (100), 212 (32), 73 (30). 
C27H26N03SFi7SiNa requires 818.1029, found 818.1016.
3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-HeptadecafluorodecylsuIfonyl)-3-methyl-l-
propyl-5-p-tolyl-1,3-dihydro-indol-2-one (527)
A flask containing 5-bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-
heptadecafluorodecylsulfonyl)-3-methyl-l-propyl-l,3-dihydro-indol-2-one 515 (106 mg, 
0.14 mmol, 1 eq), palladium (0) tetrakis(triphenylphosphine) (35 mg, 0.03 mmol, 20 mol 
%) and methylbenzene boronic acid (57 mg, 0.42 mmol, 3 eq) was flushed with argon. 
Na2CC>3 (0.21 ml of 2M aqueous solution, 0.42 mmol, 3 eq), H2O (1 ml) and 1,4-dioxane 
(5 ml) were added and the reaction was heated at 80 °C for 3.5 h. The reaction was allowed 
to cool, CH2CI2 was added and the organic layer was washed with water, dried (MgS0 4 ) 
and concentrated in vacuo. The crude product mixture was purified using fluorous 
chromatography to give 3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-
heptadecafluorodecylsulfonyl)-3-methyl-l-propyl-5-p-tolyl-l,3-dihydro-indol-2-one 527 
(95 mg, 0.12 mmol, 87 %) as a white solid.
‘H NMR (400 MHz, CDC13) 5 1.01 (3H, t, J = 7.4 Hz, CH3), 1.75-1.84 (2H, m, CH2), 1.98 
(3H, s, CH3C), 2.42 (3H, s, CH3Ar), 2.63-2.76 (2H, m, CH2CF2), 3.41-3.51 (1H, m, 1H 
from CH2SO2), 3.67-3.74 (1H, m, 1H from CH2N), 3.86-3.90 (2H, m, 1H from CH2N and
2 1 2
1H from CH2 S 0 2), 7.01 (1H, d, J = 8.2 Hz, ArH), 7.26 (2H, apparent d, J = 8.0 Hz, 2  x 
ArH), 7.46 (2H, apparent d, J = 8.1 Hz, 2 x ArH), 7.65 (1H, dd, J = 8.2, 1.8 Hz, ArH), 7.79 
(1H, d, J = 1.8 Hz, ArH).
13C NMR (100 MHz, CDC13) 8  11.6 (CH3), 18.8 (CH3C), 21.0 (CH2), 21.5 (CH3Ar), 24.1 
(CF2 CH2, t, J = 22.7 Hz), 40.4 (CH2S 02), 42.8 (CH2N), 70.4 (CCH3), 109.8 (ArCH), 123.7 
(ArC), 125.4 (ArCH), 127.2 (2 x ArCH), 129.9 (ArCH), 130.0 (2 x ArCH), 137.5 (ArC),
137.6 (ArC), 137.7 (ArC), 143.0 (ArC), 171.6 (C=0).
IR tw A c m '1) 2972,2941,1721 (C=0), 1488,1198,1143.
MS m/z (FAB+ mode, Nal) 812 ((M + Na)+, 100%), 301 (55), 278 (100), 220 (20), 69 (20). 
C29H24N03SF,7Na requires 812.1103, found 812.1101.
Mpt: 143-145 °C
3-benzyl-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecylsulfonyl)-l- 
propyl-5-(thiophen-2-yl)-l,3-dihydro-indol-2-one (528)
Ca1=^ Bn"
A flask containing 3-benzyl-5-bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfonyl)-1-propyl-l,3-dihydro-indol-2-one 516 (123 mg, 0.14 mmol, 
1 eq), palladium (0) tetrakis(triphenylphosphine) (35 mg, 0.03 mmol, 20 mol %) and 
thiophene-2-boronic acid (54 mg, 0.42 mmol, 3 eq) was flushed with argon. Na2CC>3 (0.21 
ml of 2M aqueous solution, 0.42 mmol, 3 eq), H2O (1 ml) and 1,4-dioxane (5 ml) were 
added and the reaction was heated at 80 °C for 3.5 h. The reaction was allowed to cool, 
CH2CI2 was added and the organic layer was washed with water, dried (Mg SO4) and 
concentrated in vacuo. The crude product mixture was purified using fluorous 
chromatography to give 3-benzyl-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfonyl)-l-propyl-5-(thiophene-2-yl)l,3-dihydro-indol-2-one 528 
(110 mg, 0.13 mmol, 92 %) as a clear oil.
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‘H NMR (400 MHz, CDC13) 5 0.64 (3H, t, J = 7.4 Hz, CH3), 1.28-1.37 (2H, m, CH2), 2.59- 
2.69 (2H, m, CH2CF2), 3.31-3.45 (2H, m, 1H from CH2N and 1H from CH2 S 0 2), 3.49-3.58 
(1H, m, CH2N), 3.63 (1H, d, J = 12.8 Hz, 1H from PhCff2), 3.70 (1H, d, J = 12.8 Hz, 1H 
from PhCtf2), 3.80-3.88 (1H, m, 1H from CH2S 0 2 ), 6.61 (1H, d, J = 8.2 Hz, ArH), 6.85 
(1H, d, J = 1.7 Hz, ArH), 6.87 (1H, d, J = 1.2 Hz, ArH), 6.95-7.04 (4H, m, 4 x ArH), 7.22- 
7.25 (2H, m, 2 x ArH), 7.49 (1H, dd, J = 8.2,1.8 Hz, ArH), 7.88 (1H, d, J = 1.8 Hz, ArH). 
t3C NMR (100 MHz, CDCI3) 8  11.5 (CH3), 20.8 (CH2), 24.3 (CF2 CH2, t, J = 22.3 Hz),
37.7 (PhCH2), 41.1 (CH2S 02), 42.6 (CH2N), 75.5 (CCH2Ph), 109.8 (ArCH), 121.5 (ArC),
123.5 (ArCH), 124.8 (ArCH), 125.2 (ArCH), 128.0 (ArCH), 128.5 (ArCH), 128.6 (2 x 
ArCH), 129.1 (ArCH), 130.4 (ArC), 130.5 (2 x ArCH), 132.3 (ArC), 143.7 (ArC), 143.8 
(ArC), 170.0 (C=0).
IR i W f c m 1) 1710 (C=0), 1489,1200,1136.
MS m/z (FAB+ mode) 858 ((M+H)+, 16%), 346 (100), 318 (26), 288 (10), 69 (20). 
C32H25NO3SF17 requires 858.1004, found 858.1007.
3-benzyI-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecylsulfonyl)-l- 
propyl-5-(pyridin-3-yI)-l,3-dihydro-indol-2-one (529)
Bn
A flask containing 3-benzyl-5-bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfonyl)-l-propyl-l,3-dihydro-indol-2-one 516 (82 mg, 0.10 mmol, 
1 eq), palladium (0) tetrakis(triphenylphosphine) (23mg, 0.02 mmol, 20 mol %) and 
pyridine-3-boronic acid (37 mg, 0.30 mmol, 3 eq) was flushed with argon. Na2CC>3 (0.15 
ml of 2M aqueous solution, 0.30 mmol, 3 eq), H20  (1 ml) and 1,4-dioxane (5 ml) were 
added. The reaction was heated at 80 °C for 3.5 h. The reaction was allowed to cool, 
CH2CI2 was added and the organic layer was washed with water, dried (MgSCU) and 
concentrated in vacuo. The crude product mixture was purified using fluorous 
chromatography to give 3-benzyl-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-
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heptadecafluorodecylsulfonyl)-l-propyl-5-(pyridin-3-yl)-l,3-dihydro-indol-2-one 529 (59 
mg, 0.07 mmol, 72 %) as a white solid.
NMR (400 MHz, CDC13) 5 0.76 (3H, t, J = 7.4 Hz, CH3), 1.42-1.51 (2H, m, CH2), 
2.70-2.81 (2H, m, CH2CF2), 3.46-3.55 (2H, m, 1H from CH2N and 1H from CH2 S02), 
3.62-3.69 (1H, m, 1H from CH2N), 3.74 (1H, d, J = 12.8 Hz, 1H from PhCH2), 3.82 (1H, 
d, J = 12.8 Hz, 1H from PhCH2), 3.98-4.03 (1H, m, 1H from CH2 S 0 2), 6.82 (1H, d, J = 8.2 
Hz, ArH), 6.91 (1H, s, ArH), 6.96 (1H, s, ArH), 7.06-7.14 (3H, m, 3 x ArH), 7.41-7.44 
(1H, m, ArH), 7.57 (1H, dd, J = 8.2, 1.8 Hz, ArH), 7.90-7.94 (2H, m, 2 x ArH), 8 . 6 6  (1H, 
s, ArH  of pyridine ring), 8.89 (1H, s, ArH of pyridine ring).
13C NMR (100 MHz, CDC13) 6  11.5 (CH3), 20.8 (CH2), 24.2 (CF2 CH2, t, J = 21.9 Hz),
37.8 (PhCH2), 41.0 (CH2S 0 2), 42.7 (CH2N), 75.5 (CCH2Ph), 110.0 (ArCH), 121.7 (ArC),
124.1 (ArCH), 126.0 (ArCH), 128.0 (ArCH), 128.7 (2 x ArCH), 130.3 (ArCH), 130.4 (2 x 
ArCH), 132.3 (ArC), 133.5 (ArC), 134.6 (ArCH), 136.1 (ArC), 144.7 (ArC), 148.5 
(ArCH), 149.0 (ArCH), 170.2 (C=0).
IR Umax/tcm'1) 2935, 1713 (C=0), 1617, 1199, 1135.
MS m/z (FAB+ mode) 853 ((M+H)+, 85%), 342 (100), 265 (14), 91 (5).
C33H2603N2FnS requires 835.1393, found 853.1396.
Mpt: 51-53 °C.
1 -Ethyl-1,3-dihydro-indoI-2-one (530)100
o
To a solution of l-ethyl-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfanyl)indolin-2-one 502 (131 mg, 0.21 mmol, 1 eq) in THF (3.5 
ml) was added Sml2 (6.9 ml of a 0.1 M soln in THF, 0.69 mmol, 3.3 eq) and the reaction 
was allowed to stir at room temperature for 24 h. CH2C12 (10 ml) was added to the reaction 
and the organic layer was washed with water, dried (MgS0 4 ) and concentrated in vacuo. 
The crude product mixture was purified by fluorous chromatography to give 1-ethyl-1,3- 
dihydro-indol-2-one 530 (19 mg, 0.12 mmol, 55 %) as a white solid.
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‘H NMR (400 MHz, CDC13) 8  1.20 (3H, t, J = 7.2 Hz, Cff3), 3.45 (2H, s, CH2 CO), 3.70 
(2H, q, J = 7.2 Hz, CH2), 6.77 (1H, d, J = 7.9 Hz, ArH), 6.96 (1H, t, J = 7.9 Hz, ArH), 7.19 
(2H, apparent t, J = 6.3 Hz, 2 x ArH).
13C NMR (100 MHz, CDC13) 8  13.3 (CH3), 35.0 (CH2N), 36.3 (CH2CO), 108.6 (ArCH),
122.5 (ArCH), 124.9 (ArCH), 125.2 (ArC), 128.2 (ArCH), 144.7 (ArC), 175.1 (C=0).
IR rW fc in '1) 3052,2942,1697 (C=0), 1612,1492,1463,1348,1241,1241.
MS m/z (E f  mode) 161 (M+, 76%), 146 (20), 132 (20), 118 (90), 91 (20), 84 (100), 47 
(20).
CioHnNO requires 161.0841, found 161.0841.
Mpt 92 -  94 °C.
5-FIuoro-l-methyl-l,3-dihydro-indol-2-one (531)98
o
F
To a solution of 5-fluoro-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfanyl)-l-methyl-l,3-dihydro-indol-2-one 504 (170 mg, 0.26 mmol, 
1 eq) in THF (3 ml) was added Sml2 (6.5 ml of a 0.1 M soln in THF, 0.65 mmol, 2.5 eq) 
and the reaction allowed to stir at room temperature for 24 h. NaHCOs was added to the 
reaction and the organic layer was extracted with EtOAc. The combined organic layers 
were dried (MgSC^) and concentrated in vacuo. The crude product mixture was purified by 
fluorous chromatography to give 5-fluoro-l-methyl-l,3-dihydro-indol-2-one 531 (31 mg, 
0.19 mmol, 71 %) as an orange oil.
'H  NMR (400 MHz, CDC13) 8  3.13 (3H, s, Ctf3N), 3.45 (2H, s, CH2CO), 6.65 (1H, dd, J =
8.4,4.4 Hz, ArH), 6.89-6.94 (2H, m, 2 x ArH).
13C NMR (100 MHz, CDC13) 8  26.7 (CH3N), 36.4 (CH2CO), 108.7 (ArCH, d, J = 7.9 Hz),
112.9 (ArCH, d, J = 24.8 Hz), 114.4 (ArCH, d, J = 23.1 Hz), 126.4 (d, J = 9.1 Hz, ArC),
138.5 (ArCN), 159.5 (ArCF, d, J = 238.6 Hz), 175.0 (C=0).
IR v>max/(cm'1) 1695 (C=0 ), 1621, 1494, 1348, 1 2 2 2 , 1133.
MS m/z (EI+ mode) 165 (M+, 100%), 150 (10), 136 (99), 109 (20), 96 (10).
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C9H8NOF requires 165.1670, found 165.1676.
Methyl 5-fluoro-l-methyl-2-hydroxy-indole-3-carboxylate (532)
O OH 
F
To a solution of methyl 5-fluoro-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfanyl)-l-methyl-2-oxo-2,3-dihydro-lH-indole-3-carboxylate 512 
(114 mg, 0.16 mmol, 1 eq) in THF (5 ml) was added Sml2 (4.0 ml of a 0.1 M soln in THF, 
0.40 mmol, 2.5 eq) and the reaction allowed to stir at room temperature for 15 min. EtOAc 
was added to the reaction and the organic layer was washed with 1M HC1. The combined 
organic layers were dried (MgS0 4 ) and concentrated in vacuo. 80 % MeCN / H2O was 
added and the precipated fluorous thiol was removed by filtration to give methyl 5-fluoro-
l-methyl-2-hydroxy-indole-3-carboxylate 532 (33 mg, 0.15 mmol, 92 %) as a clear oil and 
as a 1 : 1  mixture of tautomers.
‘H NMR (400 MHz, CDC13) 8  3.15 (3H, s, NCHx one tautomer), 3.53 (3H, s, N C / / 3 , one 
tautomer), 3.73 (3H, s, CH3O, one tautomer), 3.89 (3H, s, CH3O, one tautomer), 4.37 (1H, 
s, CH), 6.70 (1H, dd, J = 8.4, 4.4 Hz, ArH), 6.79 (1H, td, J = 9.2, 2.4 Hz, ArH), 6.92-7.06 
(3H, m, 3 x ArH), 7.31 (1H, d, J = 48.0 Hz, ArH).
13C NMR (100 MHz, CDC13) 5 26.7 (NCH3 of one tautomer), 27.5 (NCH3 of one 
tautomer), 51.3 (CH3O of one tautomer), 52.3 (CH), 53.2 (CH3O of one tautomer), 84.6 
(CS), 105.6 (ArCH of one tautomer, d, J = 26.0 Hz), 108.5 (ArCH of one tautomer, d, J =
25.0 Hz), 108.9 (ArCH of one tautomer, d, J = 8.0 Hz), 109.3 (ArCH of one tautomer, d, J 
= 9.0 Hz), 113.0 (ArCH of one tautomer, d, J = 25.0 Hz), 115.6 (ArCH of one tautomer, d, 
J = 23.0 Hz), 124.5 (ArC of one tautomer), 124.6 (ArC of one tautomer), 128.4 (ArC of 
one tautomer), 140.6 (ArC of one tautomer), 159.2 (ArCF of one tautomer, d, J = 240 Hz),
159.7 (ArCF of one tautomer, J = 235 Hz), 166.8 (C=0), 170.1 (C=0).
IR Umax/fam'1) 3229 (OH), 1650 (broad C=0 of ester & amide), 1541, 1458, 1214.
MS m/z (EC mode) 223 (M+, 50%), 191 (100), 164 (45), 135 (35), 109 (19), 84 (35). 
C11H 10O3NF requires 223.0645, found 223.0646.
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5,6-Dihydro-lH-pyrrolo[3,2,l“ij]quinolin-2(4H)-one (489)101
o
To a solution of l-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfanyl)-5,6 
dihydro-lH-pyrrolo[3,2,l-ij]quinolin-2(4H)-one 488 (118 mg, 0.18 mmol, 1 eq) in THF (5 
ml) was added Sml2 (4.5 ml of a 0.1 M soln in THF, 0.45 mmol, 2.5 eq) and the reaction 
allowed to stir at room temperature for 24 h. NaHCC>3 was added to the reaction and the 
aqueous layer was extracted with EtOAc. The combined organic layers were dried 
(MgSCU) and concentrated in vacuo. The crude product mixture was purified by fluorous 
chromatography to give 5,6-dihydro-lH-pyrrolo[3,2,l-ij]quinolin-2(4H)-one 489 (27 mg, 
0.16 mmol, 87 %) as a white solid.
'H  NMR (400 MHz. CDCI3) 5 2.00-2.06 (2H, apparent pentet, J = 5.9 Hz, CH2), 2.79 (2H, 
t, J = 6.1 Hz, ArCH2), 3.52 (2H, s, CH2CO), 3.74 (2H, t, J = 5.9 Hz, CH2N), 6.95 (1H, t,
7.8 Hz, ArH), 7.05 (1H, d, J = 7.7 Hz, ArH), 7.09 (1H, d, J = 7.3 Hz, ArH).
13C NMR (100 MHz, CDCI3) 5 21.6 (CH2), 24.8 (CH2), 36.9 (CH2), 39.9 (CH2), 120.5 
(ArC), 122.1 (ArCH), 122.5 (ArCH), 123.6 (ArC), 126.9 (ArCH), 141.5 (ArC), 174.5 
(C=0).
IR tW (c m  ‘) 3041, 2924, 1691 (C=0), 1600, 1479, 1345.
MS m/z (E f mode) 173 (M+, 100%), 144 (67), 117 (15), 83 (65), 47 (13).
CuHnNO requires 173.0841, found 173.0840.
Mpt: 89-90°C.
Ethyl 2-(5-fluoro-l-methyl-2-oxo-l,3-dihydro-indol-3-yl)acetate (533)
o
F
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To a solution of ethyl 2-(5-fluoro-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfanyl)-l-methyl-2-oxo-2,3-dihydo-l//-indol-3-yl)acetate 510 (115 
mg, 0.16 mmol, 1 eq) in THF ( 6  ml) was added Sml2 (4.8 ml of 0.1 M soln in THF, 0.48 
mmol, 3.0 eq) and the reaction allowed to stir at room temperature for 15 min. NaHCOs 
was added to the reaction and the organic layer was extracted with EtOAc. The combined 
organic layers were dried (MgSCU) and concentrated in vacuo. The crude product mixture 
was purified by fluorous chromatography to give ethyl 2-(5-fluoro-l-methyl-2-oxo-l,3- 
dihydro-indol-3-yl)acetate 533 (26 mg, 0.10 mmol, 65 %) as a yellow oil.
'H NMR (400 MHz, CDC13) 8  1.15 (3H, t, J = 7.1 Hz, CH3CH2), 2.69 (1H, dd, J = 17.1,
8.3 Hz, 1H from CH2CH), 3.00 (1H, dd, J = 17.1, 4.2 Hz, 1H from CH2CH), 3.15 (3H, s, 
CH3N), 3.70 (1H, dd, J = 8.3, 4.2 Hz, CH), 4.13-4.11 (2H, m, CH2O), 6 . 6 8  (1H, dd, J =
8.4,4.2 Hz, ArH), 6.89-6.98 (2H, m, 2 x ArH).
13C NMR (100 MHz, CDC13) 8  14.5 (CH3), 26.8 (CH3N), 35.2 (CH2CH), 42.5 (CH), 61.4 
(CH20), 108.7 (ArCH, d, J = 8.5 Hz), 112.6 (ArCH, d, J = 25 Hz), 114.8 (ArCH, d, J = 23.7 
Hz), 130.1 (ArC, d, J = 8 . 6  Hz), 140.7 (ArC), 159.6 (ArC, d, J = 239 Hz), 171.2 (C=0),
176.7 (C=0).
IR 'Omax/(cm'1) 1705 (C=0 ), 1622, 1492, 1274, 1093.
MS mJz (EH mode) 251(M+, 25%), 177 (100), 148 (15), 135 (1 2 ), 82 (10).
C13H 14NO3F requires 251.0958, found 251.0957.
5-Bromo-1 -propyl-1,3-dihydro-indol-2-one (534)
o
Br
To a solution of 5-bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfanyl)-l-propyl-l,3-dihydro-indol-2-one 503 (292 mg, 0.40 mmol, 
1 eq) in THF (10 ml) was added Sml2 (10 ml of a 0.1 M soln in THF, 1.0 mmol, 2.5 eq) 
and the reaction was allowed to stir at room temperature for 24 h. CH2CI2 (10 ml) was 
added to the reaction and the organic layer was washed with water, dried (MgSCU) and 
concentrated in vacuo. The crude product mixture was purified by fluorous
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chromatography to give 5-bromo-l-propyl-l,3-dihydro-indol-2-one 534 (57 mg, 0.22 
mmol, 56 %) as a white solid.
’H NMR (400 MHz, CDCI3) S 0.89 (3H, t, J = 7.4 Hz, Cff3), 1.57-1.66 (2H, m, CH2), 3.45 
(2H, s, CH2CO), 3.58 (2H, t, J = 7.4 Hz, Ctf2N), 6.63 (1H, d, J = 8.2 Hz, ArH), 7.30-7.33 
(2H, overlapping doublet and singlet, 2 x ArH).
13C NMR (100 MHz, CDC13) 6  11.8 (CH3), 21.1 (CH2), 36.0 (CH2CO), 42.1 (CH2N),
110.1 (ArCH), 115.1 (ArC), 127.0 (ArC), 128.0 (ArCH), 131.0 (ArCH), 144.2 (ArC),
174.7 (C=0).
IR iW tc m '1) 2965, 2935,2877,1695 (C=0), 1606,1484,1342,1105.
MS m/z (EC mode) 253 (M \ 56%), 224 (25), 196 (25), 117 (100), 84 (56), 47 (12).
CiiHi2ONBr requires 253.0102, found 253.0101.
Mpt 105 -  108 °C.
2-Methyl-l,4-dihydro-2//-isoquinolin-3-one (535) 65
To a solution of 4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfanyl)-2- 
methyl-l,2-dihydroisoquinolin-3(4H)-one 505 (153 mg, 0.24 mmol, 1 eq) in THF (5 ml) 
was added Sml2 (6.0 ml of a 0.1 M soln in THF, 0.60 mmol, 2.5 eq) and the reaction 
allowed to stir at room tern temperature for 24 h. CH2C12 (10 ml) was added to the reaction 
and the organic layer was washed with water, dried (MgS0 4 ) and concentrated in vacuo. 
The crude product mixture was purified by fluorous chromatography to give 2-methyl-1,4- 
dihydro-2H-isoquinolin-3-one 535 (39 mg, 0.18 mmol, 74 %) as a yellow oil.
‘H NMR (400 MHz, CDC13) 8  3.05 (3H, s, NCH3), 3.55 (2H, s, Cff2N), 4.43 (2H, s, 
CH2CO), 7.08-7.10 (2H, m, 2 x ArH), 7.14-7.24 (2H, m, 2 x ArH).
13C NMR (100 MHz, CDC13) 8  34.8 (CH3), 37.9 (CH2N), 53.3 (CH2CO), 125.4 (ArCH),
126.9 (ArCH), 127.7 (ArCH), 127.9 (ArCH), 131.3 (ArC), 132.6 (ArC), 169.2 (C=0).
IR iW (c m -‘) 3033,2922,1632 (C=0), 1493,1457,1401, 1088.
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MS m/z (ET mode) 161 (M+, 14%), 118 (10), 104 (22), 85 (100), 83 (100), 47 (46). 
CioHnNO requires 161.0841, found 161.0841.
Methyl 3-(5-bromo-2-oxo-l-propyI-l,3-dihydro-indol-3-yl)propanoate (536)
MeO'
To a solution of methyl-3-(5-bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfanyl)-2 -oxo-l-propyl-2,3-dihydro-l//-indol-3-yl)propanoate 513 
(37 mg, 0.05 mmol, 1 eq) in THF (5 ml) was added SmH (1.3 ml of a 0.1 M soln in THF, 
0.13 mmol, 2.5 eq) and the reaction was allowed to stir at room temperature for 18 h. 
NaHCC>3 was added to the reaction and the organic layer was extracted with EtOAc. The 
combined organic layers were dried (MgSCU) and concentrated in vacuo. The crude 
product mixture was purified by fluorous chromatography to give methyl 3-(5-bromo-2- 
oxo-1-propyl-l,3-dihydro-indol-3-yl)propanoate 536 (13 mg, 0.038 mmol, 76 %) as a 
yellow oil.
'H NMR (400 MHz, CDCI3 ) 8  0.89 (3H, t, J = 7.4 Hz, CH3), 1.56-1.66 (2H, m, CH2), 2.09-
2.31 (3H, m, Cff2CH and 1H from CH2CO), 2.35-2.44 (1H, m, 1H from CH2CO), 3.44 
(1H, t, J = 6.0 Hz, CHCO), 3.50-3.64 (5H, m, CH2N and OCH3), 6.64 (1H, d, J = 8.2 Hz, 
ArH), 7.30-7.33 (2H, m, 2 x ArH).
13C NMR (100 MHz, C D C I 3 )  5 11.8 (CH3), 21.1 (CH2CH3), 26.0 (CH2CH), 30.3 
(CH2C 0 2Me), 42.0 (CH2N), 44.7 (CH), 52.0 (OCH3), 110.1 (ArCH), 115.3 (ArC), 127.7 
(ArCH), 130.7 (ArC), 131.3 (ArCH), 143.3 (ArC), 173.5 (C=0, amide), 176.9 (C=0, 
ester).
IR tw / ( c m ') 2963, 2930,1734 (C=0, ester), 1701 (C=0, amide), 1605,1482,1339.
MS m/z (Efmode) 339 (M+, 36%), 309 (44), 267 (100), 265 (99), 238 (33), 210 (20), 116 
(20).
Ci5Hi8C>3NBr requires 339.0470, found 339.0476.
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3-Methyl-l-propyI-5-p-tolyl-l,3-dihydro-indol-2-one (537)
To a solution of 3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfonyl)-3- 
methyl-l-propyl-5-/?-tolyl-l,3-dihydro-indol-2-one 527 (75 mg, 0.09 mmol, 1 eq) in THF 
(5 ml) was added Sml2 (2.3 ml of a 0.1 M soln in THF, 0.23 mmol, 2.5 eq) and the reaction 
allowed to stir at room temperature for 15 min. NaHC03 was added to the reaction and the 
organic layer was extracted with EtOAc. The combined organic layers were dried (MgS0 4 ) 
and concentrated in vacuo. The crude product mixture was purified by fluorous 
chromatography to give 3-methyl-l-propyl-5-/?-tolyl-l,3-dihydro-indol-2-one 537 (24 mg, 
0.085 mmol, 94 %) as a clear oil.
]n  NMR (400 MHz, CDC13) 5 0.91 (3H, t, J = 7.4 Hz, CH3), 1.44 (3H, d, J = 7.6 Hz, 
C //3CH), 1.60-1.70 (2H, m, CH2), 2.32 (3H, s, CH3Ar), 3.41 (1H, q, J = 7.6 Hz, CH), 3.63 
(2H, t, J = 7.0 Hz, CH2N), 6.81 (1H, d, J = 8.2 Hz, ArH), 7.16 (2H, apparent d, J = 8.0 Hz, 
2 x ArH), 7.38-7.40 (4H, m, 4 x ArH).
13C NMR (100 MHz, CDC13) 5 11.8 (CH3), 16.0 (CH3CH), 21.2 (CH2), 21.5 (CH3Ar), 41.1 
(CHCO), 41.9 (CH2N), 108.9 (ArCH), 122.8 (ArCH), 126.8 (ArCH), 127.1 (2 x ArCH),
129.9 (2 x ArCH), 131.7 (ArC), 136.0 (ArC), 137.2 (ArC), 138.6 (ArC), 140.0 (ArC),
179.0 (C=0).
IR Dmax/(cm ') 2965, 2930, 2872, 1706 (C=0), 1617, 1486, 1348, 1207.
MS m/z (E l+ mode) 279 (M+, 100%), 250 (10), 222 (65), 207 (14).
Ci9H2iNO requires 279.1623, found 279.1625.
2 2 2
3-Methyl-l-propyl-5-(2-(trimethylsilyl)ethynyl)-l,3-dihydro-indol-2-one (538)
TMS
To a solution of 3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfonyl)-3- 
methyl-l-propyl-5-(2-(trimethylsilyl)ethynyl)-l,3-dihydro-indol-2-one 526 (75 mg, 0.09 
mmol, 1 eq) in THF ( 6  ml) was added Sml2 (2.3 ml of a 0.1 M soln in THF, 0.23 mmol,
2.5 eq) and the reaction allowed to stir at room temperature for 15 min. NaHCOs was 
added to the reaction and the organic layer was extracted with EtOAc. The combined 
organic layers were dried (MgSCU) and concentrated in vacuo. The crude product mixture 
was purified by fluorous chromatography to give 5-(3-hydroxyprop-l-ynyl)-3-methyl-l- 
propyl-l,3-dihydro-indol-2-one 538 (23 mg, 0.08mmol, 8 8  %) as a yellow oil.
!H NMR (400 MHz, CDC13) 5 0.18 (9H, s, (C J^ S i) , 0.88 (3H, t, J = 7.4 Hz, Ctf3), 1-38 
(3H, d, J = 7.6 Hz, C //3CH), 1.56-1.66 (2H, m, CH2), 3.32 (1H, q, J = 7.6 Hz, CH), 3.58 
(2H, t, J = 7.4 Hz, CH2N), 6 . 6 8  (1H, d, J = 8.1 Hz, ArH), 7.27 (1H, s, ArH), 7.31 (1H, dd, J 
= 8.1, 1.6 Hz, ArH).
13C NMR (100 MHz, CDC13) 6  0.00 ((CH3)3Si), 11.3 (CH3), 15.4 (CH3CH), 20.7 (CH2),
40.2 (CH), 41.5 (CH2N), 93.0 (Calkyne), 105.2 (Calkyne), 107.9 (ArCH), 116.7 (ArC),
127.2 (ArCH), 130.7 (ArC), 132.1 (ArCH), 143.7 (ArC), 178.5 (C=0).
IR Dmax/lcm'1) 2965, 2149 (C=C), 1715 (C=0), 1615, 1488, 1347.
MS m/z (EC mode) 285 (M+, 100%), 270 (85), 228 (2 2 ), 106 (8 ), 73 (7).
CnH^NOSi requires 285.1549, found 285.1548.
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3-Benzyl-1 -propyl-5-(pyridin-3-yl)-1,3-dihydro-indol-2-one (539)
To a solution of 3-benzyl-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfonyl)-1 -propyl-5-(pyridin-3-yl)-1,3-dihydro-indol-2-one 529 (87 
mg, 0.10 mmol, 1 eq) in THF (5 ml) was added Sml2 (2.5 ml of a 0.1 M soln in THF, 0.25 
mmol, 2.5 eq) and the reaction allowed to stir at room temperature for 15 min. NaHCOs 
was added to the reaction and the organic layer was extracted with EtOAc. The combined 
organic layers were dried (MgS0 4 ) and concentrated in vacuo. The crude product mixture 
was purified by fluorous chromatography to give 3-benzyl-l-propyl-5-(pyridin-3-yl)-1,3- 
dihydro-indol-2-one 539 (24 mg, 0.071 mmol, 71 %) as a clear oil.
]H NMR (400 MHz, CDC13) 5 0.82 (3H, t, J = 7.4 Hz, CH3), 1.49-1.60 (2H, m, CH2), 2.87 
(1H, dd, J = 13.5, 9.2 Hz, 1H from C //2Ph), 3.46-3.55 (2H, m, 1H from CH2Ph and 1H 
from C//2N), 3.62-3.72 (2H, m, 1H from CH2N and CH), 6.79 (1H, d, J = 8.1 Hz, ArH), 
6.85 (1H, s, Ar//), 7.10-7.27 (6 H, m, 6  x Ar//), 7.36 (1H, dd, J = 8.1, 1.3 Hz, Ar//), 7.62- 
7.65 (1H, m, ArH), 8.47 (1H, s, Ar//), 8.61 (1H, s, ArH).
I3C NMR (100 MHz, CDC13) 5 10.3 (CH3), 19.7 (CH2), 35.9 (PhCH2), 40.6 (CH2N), 40.1 
(CH), 107.7 (ArCH), 122.5 (ArCH), 122.6 (ArCH), 125.8 (ArCH), 125.6 (ArCH), 127.3 
(ArCH), 128.4 (ArC), 128.5 (2 x ArCH), 130.3 (ArC), 132.9 (2 x ArCH), 136.6 (2 x ArC),
143.0 (ArC), 146.7(ArCH), 146.8 (ArCH), 175.8 (C=0).
IR iw /tc m -1) 2965, 2930, 1702 (C=0), 1617, 1475, 1350.
MS m/z (EC mode) 342 (M+, 100%), 251 (83), 209 (18), 194 (15), 91 (32), 84 (31), 47 (5). 
C23H22N 0 2 requires 342.1732, found 342.1733.
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3-Benzyl-l-propyl-5-(thiophen-2-yl)-indolin-2-one (540)
To a solution of 3-benzyl-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfonyl)-1 -propyl-5-(thiophene-2-yl)-1,3 -d ih y d ro -in d o l-2 -o n e  528
(82 mg, 0.10 mmol, 1 eq) in THF (5 ml) was added Sml2 (2.4 ml of a 0.1 M soln in THF,
0.24 mmol, 2.5 eq) and the reaction was allowed to stir at room temperature for 15 min. 
NaHCC>3 was added to the reaction and the organic layer was extracted with EtOAc. The 
combined organic layers were dried (MgSCU) and concentrated in vacuo. The crude 
product mixture was purified by fluorous chromatography to give 3-benzyl-l-propyl-5- 
(thiophen-2-yl)-l,3-dihydro-indol-2-one 540 (27 mg, 0.075 mmol, 75 %) as a yellow oil.
‘H NMR (400 MHz, CDC13) 8  0.78 (3H, t, J = 7.4 Hz, CII,), 1.43-1.56 (2H, m, CH,), 2.85- 
2.95 (1H, m, 1H from PhC//2), 3.43-3.50 (2H, m, 1H from PhCtf2  and 1H from CH2N), 
3.56-3.67 (2H, m, 1H from CH,N and CH), 6.67 (1H, d, J = 8.1 Hz, ArH), 6.88-7.00 (3H, 
m , 3 x ArH), 7.05-7.37 (6 H, m, 6  x ArH), 7.38 (1H, dd, J = 8.1, 1.2 Hz, ArH).
13C NMR (100 MHz, CDC13) 5 11.7 (CH3), 21.0 (CH2), 37.2 (PhCH2), 42.0 (CH2N), 53.8 
(CH), 108.8 (ArCH), 122.5 (ArCH), 122.9 (ArCH), 124.4 (ArCH), 126.0 (ArCH), 127.1 
(ArCH), 128.4 (ArCH), 128.7 (2 x ArCH), 128.8 (ArC), 129.5 (ArC), 130.0 (2 x ArCH),
138.0 (ArC), 143.7 (ArC), 144.8 (ArC), 177.1 (C=0).
IR rW (c m  ‘) 2961, 2924, 2873,1701 (C=0), 1486,1339,1103.
MS (C f  mode, isobutane) 348 ((M+H)+, 100%).
C22H22NOS requires 348.1422, found 348.1423.
3-Benzyl-1 -ethyl-1,3-dihydro-indol-2-one (541)
o
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To a solution of 3-benzyl-l-ethyl-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfanyl)-l,3-dihydro-indol-2-one 518 (141 mg, 0.19 mmol, 1 eq) in 
THF (5 ml) was added SmH (4.7 ml of a 0.1 M soln in THF, 0.47 mmol, 2.5 eq) and the 
reaction allowed to stir at room temperature for 3 h. CH2CI2 (10 ml) was added to the 
reaction and the organic layer was washed with water, dried (MgS0 4 ) and concentrated in 
vacuo. The crude product mixture was purified by fluorous chromatography to give 3- 
benzyl-l-ethyl-l,3-dihydro-indol-2-one 541 (30.0 mg, 0.13 mmol, 67 %) as an orange oil.
]H NMR (400 MHz, CDCI3) 5 1.04 (3H, t, J = 7.2 Hz, CH3), 2.88 (1H, dd, J = 13.6, 8 . 8  
Hz, 1H from PhCH2), 3.38 (1H, dd, J = 13.6, 4.4 Hz, 1H from PhCH2), 3.54 (1H, m, 1H 
from CH2 N), 3.61-3.74 (2H, m, CH and 1H from CH2N), 6.67 (1H, d, J = 7.8 Hz, ArH), 
6.75 (1H, d, J = 7.4 Hz, ArH), 6.85 (1H, td, J = 7.5, 0.9 Hz, ArH), 7.04-7.18 (6 H, m, 6  x 
ArH).
13C NMR (100 MHz, CDCI3) 6  12.8 (CH3), 34.9 (CH2N), 37.2 (PhCH2), 47.4 (CH), 108.4 
(ArCH), 122.2 (ArCH), 125.0 (ArCH), 126.9 (ArCH), 128.3 (ArCH), 128.5 (2 x ArCH),
129.0 (ArC), 129.9 (2 x ArCH), 138.0 (ArC), 143.7 (ArC), 177.0 (C=0).
IR iW /tc m 1) 2923, 1710 (C=0), 1612, 1488, 1467, 1363, 1230.
MS m/z (EC mode) 251 (M+, 80%), 160 (100), 132 (12), 91 (89).
CnHnNO requires 251.1310, found 251.1311.
5-(3-Hydroxyprop-l-ynyl)-3-methyl-1 -propyl-1,3-dihydro-indol-2-one (542)
o
To a solution of 3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfonyl)-5- 
(3-hydroxyprop-l-ynyl)-3-methyl-l-propyl-l,3-dihydro-indol-2-one 525 (63 mg, 0.08 
mmol, 1 eq) in THF (5 ml) was added Sml2 (2.0 ml of a 0.1 M soln in THF, 0.20 mmol,
2.5 eq) and the reaction allowed to stir at room temperature for 15 min. NaHCC>3 was 
added to the reaction and the organic layer was extracted with EtOAc. The combined
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organic layers were dried (MgSCU) and concentrated in vacuo. The crude product mixture 
was purified by fluorous chromatography to give 5-(3-hydroxyprop-l-ynyl)-3-methyl-l- 
propyl-l,3-dihydro-indol-2-one 542 ( 8  mg, 0.033 mmol, 42 %) as a yellow oil.
NMR (400 MHz, CDC13) 5 0.88 (3H, t, J = 7.4 Hz, CH3), 139 (3H, d, J = 7.6 Hz, 
CH3 CH), 1.56-1.67 (2H, m, CH2), 3.34 (1H, q, J = 7.6 Hz, CH), 3.53-3.62 (2H, m, Ctf2N), 
4.29 (2H, s, CH2OH), 6.70 (1H, d, J = 8.1 Hz, ArH), 7.23 (1H, s, ArH), 7.28 (1H, d, J = 8.1 
Hz, ArH).
13C NMR (100 MHz, CDCI3) 8  11.7 (CH3), 15.8 (CH3CH), 21.1 (CH2), 40.7 (CH), 42.0 
(CH2N), 52.1 (CH2OH), 86.1 (C alkyne), 86.7 (C alkyne), 108.5 (ArCH), 116.5 (ArC), 
127.3 (ArCH), 131.3 (ArC), 132.3 (ArCH), 144.1 (ArC), 178.9 (C=0).
IR t>mM/(cm'‘) 3381 (OH), 2965, 2930, 2873, 1685 (C=0), 1615,1487,1348.
MS m/z (EI+ mode) 243 (M+, 100%), 214 (23), 186 (45), 168 (10), 84 (21).
Ci5H 170 2N requires 243.1259, found 243.1259.
3-BenzyI-5-bromo-l-propyl-l,3-dihydro-indol-2-one (543)
o
To a solution of 3-benzyl-5-bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- 
heptadecafluorodecylsulfonyl)-l-propyl-l,3-dihydro-indol-2-one 516 (140 mg, 0.16 mmol, 
1 eq) in THF (5 ml) was added Sml2 (3.5 ml of a 0.1 M soln in THF, 0.35 mmol, 2.2 eq) 
and the reaction was allowed to stir at room temperature for 15 min. NaHC03 was added to 
the reaction and the organic layer was extracted with EtOAc. The combined organic layers 
were dried (MgSC>4) and concentrated in vacuo. The crude reaction mixture was purified 
by filtration through a short pad of silica washing with 30 % EtOAc / petroleum ether to 
give 3-benzyl-5-bromo-l-propyl-l,3-dihydro-indol-2-one 543 (54 mg, 0.16 mmol, 98 %) 
as a yellow oil.
‘H NMR (400 MHz, CDC13) 8  0.75 (3H, t, J = 7.4 Hz, CHi), 1.41-1.53 (2H, m, CH2), 2.90 
(1H, dd, J = 13.7, 8.5 Hz, 1H from PhC//2), 3.33-3.43 (2H, m, 1H from PhCH2N and 1H
227
from CH2N), 3.54-3.64 (2H, m, 1H from CH2N and CH), 6.53 (1H, d, J = 8.3 Hz, ArH), 
6.92 (1H, s, ArH), 7.03-7.07 (2H, m, 2 x ArH), 7.10-7.19 (3H, m, 3 x ArH), 7.24 (1H, d, J 
= 8.3 Hz, ArH).
13C NMR (100 MHz, CDCI3 ) 5 11.6 (CH3), 20.9 (CH2), 36.9 (PhCH2), 41.9 (CH2N), 47.3 
(CH), 109.9 (ArCH), 114.8 (ArC), 127.2 (ArCH), 128.1 (ArCH), 128.7 (2 x ArCH), 129.8 
(2 x ArCH), 130.9 (ArC), 131.1 (ArCH), 137.4 (ArC), 143.3 (ArC), 176.6 (C=0).
IR ■omax/(cm'1) 1697 (C=0), 1604,1482,1350,1102.
MS m/z (Efmode) 343 (M+, 32%), 252 (22), 91 (100), 65 (5).
CigHigONBr requires 343.0572 found 343.0560
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Appendix I
Crystal structure o f oxindole 382
234
Table 1. Crystal data and structure
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions
Volume
Z
Density (calculated)
Absorption coefficient 
F(000)
Crystal size
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta = 29.93° 
Absorption correction 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [t>2sigma(I)J 
R indices (all data)
Largest diff. peak and hole
refinement for km3402.
km3402
c J6h 15no2
253.29 
100(2) K 
0.71073 A 
Monoclinic 
P12t /a l
a =8.3006(2) A ot=90°.
b = 10.7427(2) A (5= 95.137(1)°.
c= 14.3728(4) A y = 90°.
1276.49(5) A3 
4
1.318 Mg/m3 
0.087 mm*1 
536
0.50 x 0.13 x 0.12 nun3 
2.85 to 29.93°.
-ll<=h<=ll, -13<=k<=15, -20<=1<=20 
11672
3652 [R(int) = 0.030]
99.0%
None
Full-mairix least-squares on F2 
3652 / 0/173
1.002
R1 = 0.043, wR2 = 0.106 
R1 = 0.056, wR2 = 0.115 
0.32 and -0.19 e.A'3
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2x 103) 
for km3402. U(eq) is defined as one third of the trace of the orthogonalized U'i tensor.
x y z U(eq)
C(l) 891(1) 14353(1) 6330(1) 20(1)
C(2) 1589(1) 13500(1) 5623(1) 20(1)
C(3) 1292(1) 12221(1) 5991(1) 17(1)
C(4) 506(1) 12344(1) 6813(1) 16(1)
C(5) 38(1) 11334(1) 7318(1) 17(1)
C(6) 380(1) 10145(1) 6978(1) 17(1)
C(7) 1170(1) 9998(1) 6167(1) 19(1)
C(8) 1626(1) 11048(1) 5674(1) 19(1)
C(9) 116(2) 7948(1) 7153(1) 27(1)
C(10) -510(1) 14089(1) 7793(1) 20(1)
C(ll) 584(1) 14081(1) 8692(1) 18(1)
C(12) 260(2) 13328(1) 9436(1) 25(1)
C(13) 1271(2) 13363(1) 10266(1) 32(1)
C(14) 2592(2) 14151(1) 10356(1) 31(1)
C(15) 2916(1) 14905(1) 9612(1) 28(1)
C(16) 1924(1) 14870(1) 8781(1) 22(1)
N(l) 286(1) 13613(1) 7001(1) 18(1)
0(1) 849(1) 15491(1) 6321(1) 27(1)
0(2) -96(1) 9174(1) 7507(1) 21(1)
T ab le  3. B ond leng th s [A] and  angles [°] fo r km34Q2.
C(l)-0(1) 1.2228(14)
C(l)-Nd) 1.3793(14)
C(l)-C(2) 1.5204(15)
C(2)-C(3) 1.5006(15)
C(2)-H(2A) 0.9900
C(2)-H(2B) 0.9900
C(3)-C(8) 1.3771(15)
C(3)-G(4) 1.4063(14)
C(4)-C(5) 1.3801(15)
C(4)-N(l) 1.4045(13)
C(5)-C(6) 1.4062(15)
C(5)-H(5) 0.9500
C(6)-0(2) 1.3694(13)
C(6)-C(7) 1.3965(15)
C(7)-C(8) 1.4021(15)
C(7)-H(7) 0.9500
C(8)-H(8) 0.9500
C(9)-0(2) 1.4288(14)
0(1)-C(1)-N(1) 124.90(10)
0(1)-C(1)-C(2) 127.37(10)
N(l)-C(l)-C(2) 107.73(9)
C(3)-C(2)-C(l) 103.39(9)
C(3)-C(2)-H(2A) 111.1
C(1)-C(2)-H(2A) 111.1
C(3)-C(2)-H(2B) 111.1
C(1)-C(2)-H(2B) 111.1
H(2A)-C(2)-H(2B) 109.0
C(8)-C(3)-C(4) 119.08(10)
C(8)*C(3)-C(2) 132.63(9)
C(4)-C(3)-C(2) 108.29(9)
C(5)-C(4)-N(l) 127.88(9)
C(5)-C(4)-C(3) 122.82(10)
N(l)-C(4)-C(3) 109.30(9)
C(4)-C(5)-C(6) 117.14(9)
C(4)-C(5)-H(5) 121.4
C(6)-C(5)-H(5) 121.4
0(2)-C(6)-C(7) 123.90(10)
0(2)-C(6)-C(5) 114.93(9)
C(7)-C(6)-C(5) 121.17(10)
C(6)-C(7)-C(8) 119.94(10)
C(6)-C(7)-H{7) 120.0
C(8)-C(7)-H(7) 120.0
C(3)-C(8)-C(7) 119.85(10)
C(3)-C(8)-H(8) 120.1
C(7)-C(8>H(8) 120.1
0(2)-C(9)-H(9A) 109.5
0(2)-C(9)-H(9B) 109.5
H(9 A) -C(9>-H(9B) 109.5
0(2)-C(9)-H(9C) 109.5
C(9)-H(9A) 0.9800
C(9)-H(9B) 0.9800
C(9)-H(9C) 0.9800
C(10)-N(l) 1.4592(14)
C(10)-C(11) 1.5108(15)
C(10)-H(10A) 0.9900
C(lO)-HdOB) 0.9900
C(ll)-C(12) 1.3875(16)
C(ll)-C(16) 1.3947(16)
C(12)-C(13) 1.3967(18)
C(12)-H(12) 0.9500
C(13)-C(14) 1.382(2)
C(13)-H(13) 0.9500
C(14)-C(15) 1.3858(19)
C(14)-H(14) 0.9500
C(15)-C(16) 1.3892(16)
C(15)-H(15) 0.9500
C(16)-H(16) 0.9500
H(9A)-C(9)-H(9C) 109.5
H(9B)-C(9)-H(9C) 109.5
N(l)-C(10)-C(ll) 112.69(8)
N(1)-C(10)-H(10A) 109.1
C(11)-C(10)-H(10A) 109.1
N(1 )-C(l 0)-H( 10B) 109.1
C(11)-C(10)-H(10B) 109.1
H(10A)-C(10)-H(10B) 107.8
C(12) -C(l 1 )-C( 16) 119.46(11)
C(12)-C(ll)-C(10) 121.26(10)
C(16)*C(11)-C(10) 119.27(10)
C(ll)-C(12)-C(13) 119.95(12)
C(ll)-C(12)-H(12) 120.0
C(l3)-C(12)-H(12) 120.0
C(14)-C(13)-C(12) 120.51(12)
C(14)'C(13)-H(13) 119.7
C(12)-C(13)-H(13) 119.7
C(13)-C(14) C(15) 119.54(12)
C(13)-C(14)-H(14) 120.2
C(15)-C(14)-H(14) 120.2
C(14)-C(15)-C(16) 120.42(12)
Cd4)-C(15)-H(15) 119.8
C(16)-C(15)-H(15) 119.8
C(15)-C(16)-C(ll) 120.13(11)
C(15)-C(16)-H(16) 119.9
C(11)-C(16)-H(16) 119.9
C(l)-N(l)-C(4) 111.30(9)
C(l)-N(l)-C(10) 124.22(9)
C(4)-N(l)-C(l0) 124.46(9)
G(6)-0(2)-C(9) 116.96(8)
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Table 4. Anisotropic displacement parameters (A2x l(P)for km3402. The anisotropic 
displacement factor exponent takes the form: -2jc*1 h2a*2Uu +... + 2 h k a* b* U12 1
Uu IJ22 u33 U23 U13 u 12
C(l) 21(1) 18(1) 19(1) 2(1) -4(1) 0(1)
C(2) 25(1) 19(1) 16(1) 1(1) -1(1) 0(1)
C(3) 18(1) 19(1) 15(1) 0(1) -2(1) -1(1)
C(4) 14(1) 16(1) 17(1) -2(1) -2(1) 1(1)
€(5) 16(1) 16(1) 16(1) -1(1) 0(1) 1(1)
C(6) 17(1) 16(1) 16(1) 1(1) -1(1) 0(1)
C(7) 22(1) 16(1) 18(1) -3(1) 1(1) 2(1)
C(8) 22(1) 21(1) 16(1) -2(1) 1(1) 0(1)
C(9) 39(1) 15(1) 27(1) -1(1) 7(1) -1(1)
C(10) 16(1) 19(1) 24(1) -4(1) 2(1) 2(1)
C (ll) 17(1) 17(1) 21(1) -3(1) 5(1) 3(1)
C(12) 30(1) 23(1) 25(1) -1(1) 11(1) -1(1)
C(13) 45(1) 33(1) 20(1) 2(1) 11(1) 10(1)
C(14) 32(1) 38(1) 22(1) -8(1) -1(1) 14(1)
C(15) 19(1) 32(1) 32(1) -7(1) -2(1) 3(1)
C(16) 18(1) 21(1) 25(1) -1(1) 2(1) 1(1)
N(l) 19(1) 14(1) 19(1) -2(1) 0(1) 2(1)
0(1) 35(1) 16(1) 27(1) 2(1) -2(1) 0(1)
0(2) 29(1) 15(1) 20(1) 0(1) 5(1) 0(1)
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2* 103)
for km3402.
X y z U(eq)
H(2A) 1028 13616 4992 24
H(2B) 2760 13654 5596 24
H(5) -493 11438 7872 20
H(7) 1398 9187 5950 22
H(8) 2165 10950 5123 23
H(9A) -468 7873 6532 40
H(9B) -308 7338 7576 40
H(9C) 1270 7792 7109 40
H(10A) -1477 13575 7876 24
H(10B) -879 14951 7656 24
H(12) -650 12787 9382 30
H(13) 1050 12842 10774 39
H(14) 3273 14177 10923 37
H(15) 3822 15448 9671 33
H(16) 2159 15383 8273 26
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Table 6. Torsion angles [°] for km3402.
0(1)-C(1)-C(2)-C(3) -179.75(11) C(10)-C(ll)-C(l2)-C(13) -178.44(10)
N(l)-C(l)-C(2)-C(3) -0.02(11) C(11 )-C( 12)-C( 13)-C( 14) 0.42(18)
C(l)-C(2)-C(3)-C(8) 179.59(11) C(12)-C(13)-C(14)-C(15) -0.40(19)
C(l)-C(2)-C(3)-C(4) 0.21(11) C(13)-C(14)-C(15)-C(16) -0.07(19)
C(8)-C(3)-C(4)-C(5) -0.51(15) C(14)-C(15)-C(16)-C(ll) 0.53(18)
C(2)-C(3)-C(4)-C(5) 178.96(9) C(12)-C(ll)-C(16)-C(15) -0.51(17)
C(8)-C(3)-C(4)-NC1) -179.81(9) C(10)-C(ll)-C(16)-C(15) 178.00(10)
C(2)-C(3)-C(4)-N(t) -0.33(11) 0(1)-C(1)-N(1)-C(4) 179.56(10)
N(l)-C(4)-C(5)-C(6) 179.20(9) C(2)-C(l)-N(l)-C(4) -0.18(11)
C(3)-C(4)-C(5)-C(6) 0.04(15) O(l)-C(l)-N(l)-C(10) 0.78(17)
C(4)-C(5)-C(6)-0(2) 179.48(9) C(2)-C(l)-N(l)-C(10) -178.96(9)
C(4)-C(5)-C(6)-C(7) 0.43(15) C(5)-C(4)-N(l)-C(l) -178.92(10)
0(2)-C(6)-C(7)-C(8) -179.39(9) C(3)-C(4)-N(l)-C(l) 0.33(12)
C(5)-C(6)-C(7)-C(8) -0.43(16) C(5)-C(4)-N(l)-C(10) -0.14(16)
C(4)-C(3>C(8)-C(7) 0.51(15) C(3)-C(4)-N( 1)-C(10) 179.10(9)
C(2)-C(3)-C(8)-C(7) -178.81(11) C(ll)-C(10)-N(l)-C(l) -101.78(12)
C(6)-C(7)-C(8)-C(3) -0.05(16) C(ll)-C(10)-N(l)-C(4) 79.60(13)
N(l)-C(10)-C(ll)-C(12) -114.72(12) C(7)-C(6)-0(2)-C(9) -5.53(15)
N(1)-C(10)*C(11)-C(16) 66.79(13) C(5)-C(6)-0(2)-C(9) 175.46(9)
C(16)-C(ll)-C(12)-C(13) 0.04(17)
238
Appendix II
Sample NMR spectra o f modified heterocycles before and after FSPE
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